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Abstract 
The Influence of Hydroxyapatite Nanoparticles on Human Mesenchymal Stromal Cells: 
Application for Tissue Engineered Constructs 
Simon William Partridge 
Arthritis Research UK – Tissue Engineering Centre, Institute of Cellular Medicine, Faculty of 
Medical Sciences, Newcastle University 
Osteoarthritis (OA) is a debilitating disease characterised by degradation of the articular 
cartilage and changes in the subchondral bone. Presently the gold standard treatment for OA 
is total joint replacement using metal, ceramic and non-degradable polymer materials. Tissue 
engineering using novel bioresorbable biomaterials has the potential to stimulate 
regeneration of bone and cartilage for early stage intervention in OA suffers. This thesis 
investigates the synthesis of hydroxyapatite nanoparticles (HAp) and techniques to generate 
poly (lactic acid) (PLA) HAp nanocomposites. The effect of the synthesised HAp on isolated OA 
donor derived human mesenchymal stem cells (hMSC) was investigated in both 2D and 3D 
culture conditions. A highly controllable sol-gel synthesis method demonstrated control over 
HAp morphology and composition, with modification of titration rate, addition methodology 
and reaction pH. Two novel nanocomposite fabrication techniques were developed and 
characterised with transmission electron microscopy (TEM) demonstrating HAp dispersion at 
the nanoscale throughout PLA. Dip-coated HAp PLA and fibrin substrates were fabricated and 
demonstrated maintenance of hMSC adherence, proliferation and osteogenesis on 2D 
substrates. Investigations into fibrin encapsulated hMSC illustrated HAp uptake within the cell 
following 24 hours incubation. Further studies examining fibrin/HAp encapsulated hMSC 
showed increased osteogenic gene expression, peripheral matrix deposition and 
mineralisation following 21 days in culture. 3D printed PLA constructs infused with fibrin and 
fibrin/HAp encapsulated hMSC demonstrated significant osteogenic gene expression 
differences at day 21. However, these data were variable between cell isolations from 
different patients further illustrating hMSC heterogeneity and hMSC donor–donor variability 
in-vitro.  
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Chapter 1 – Introduction 
The ageing population coupled with the lifespan of existing prosthetic treatments for OA, 
contribute to the need for early stage interventions in the treatment of OA. To many, the total 
repair of tissues without the use of biomaterial scaffolding is the holy grail of regenerative 
medicine. However, tissue engineering exploits biomaterial properties and their potential to 
contribute to cellular repair mechanisms, which is a tangible approach already providing 
treatment to a number of disease conditions. 
OA disease progression is not only characterised by loss of cartilage, but also presents 
alterations in the underlying subchondral bone. This thesis presents data that aimed to 
investigate the synthesis and characterisation of materials suitable to be reorganised by 
endogenous repair mechanisms and to regenerate bone tissue in a number of biomedical 
applications. To assess the biological influence of these materials, discrete cell populations 
from donors diagnosed with OA were used in-vitro to characterise biological behaviour. 
Hydroxyapatite nanoparticles (HAp) is the main form of calcium phosphate mineral providing 
strength to collagen type I within our bones. Artificial hydroxyapatite has a number of 
biomedical applications, most notably for the enhancement of implant integration within 
bone tissues. Artificial HAp properties are known to have a greater effect on bone cell biology 
than traditional sintered/large grain sized hydroxyapatite. Consequently, there is renewed 
interest in HAp research for bone tissue engineering. 
Alone hydroxyapatite is very brittle but bone is a natural nanocomposite material with 
multiple orders of HAp/collagen type 1 organisation. Techniques to distribute HAp within a 
matrix, let alone self-assemble multifaceted 3D architecture are in their infancy. Bioresorbable 
polymers potentially present a flexible material for an artificial resorbable hard yet flexible 
nanocomposite.  
Cellular therapies are already demonstrating efficacy in the clinic for the treatment of a 
number of disease conditions, nevertheless there is apprehension over the stability of cell 
locality following surgery. Fibrin is a naturally occurring protein responsible for haemostasis 
during injury and is currently used as glue in surgical procedures. Fibrin is also present during 
bone fracture healing, making it an ideal candidate for cell delivery into hard prefabricated 
scaffold materials. 
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Currently, the procedures for the in-vitro assessment of biomaterials for use in bone tissue 
engineering are highly variable. An often adopted approach is to assess biomaterial 
interaction with isolated adult human multipotent mesenchymal stromal cells (hMSC). The 
approach presented in this thesis focuses on the development/characterisation of 
biomaterials and their subsequent influence on hMSC adhesion, proliferation and osteogenic 
potential. 
This thesis is organised as follows: 
Chapter 2 aims to cover musculoskeletal biology and how tissue engineering is being used for 
the early treatment of OA with a significant focus on the application of hydroxyapatite 
nanoparticles (HAp) and bioresorbable polymers for bone regeneration. 
Chapter 3 outlines standardised materials and methods used throughout the results chapters 
4 – 7. 
Chapter 4 presents the investigation of HAp synthesis parameters and cytotoxicity assays 
using patient derived hMSC.  
Chapter 5 demonstrates two novel nanocomposite fabrication methods of PLA with 
monodispersed HAp. The influence of PLA and HAp materials on hMSC adherence, growth and 
differentiation are assessed.  
Chapter 6 assesses the influence of fibrin and HAp materials on hMSC adherence growth and 
differentiation.  
Chapter 7 presents the development of a cell delivery fibrin “formulation” and the 3D 
influence of HAp on cells encapsulated within a fibrin matrix. Finally, the influence of 
fibrin/HAp encapsulated cells within a 3D printed PLA construct were investigated. 
Chapter 8 presents an overall discussion of the results displayed in the thesis, and their 
interpretation within the context of the wider field of tissue engineering and the treatment of 
OA.  
Chapter 1 
23 | P a g e  
 
1.1  Aims and objectives 
 The first aim is to synthesise and characterise HAp identifying key parameters that 
influence HAp crystal morphologies and compositions. 
 To assess the direct cytotoxicity of synthesised HAp in-vitro on OA patient derived 
human mesenchymal stem cell (hMSC) populations. 
 To investigate the influence of HAp filled within a PLA matrix and to develop 
techniques to improve HAp particle distribution. 
 To assess the potential influence of HAp on patient derived hMSC osteogenesis in the 
context of 2D PLA and fibrin substrates. 
 Investigate the interaction of patient derived hMSC with HAp at the nanoscale within 
a 3D fibrin matrix. 
 To investigate the potential for fibrin hydrogels filled with and without HAp as a carrier 
for hMSC delivery into prefabricated 3D printed PLA scaffolds. 
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Chapter 2 – Literature survey 
2.1  Osteoarthritis 
Osteoarthritis (OA) is a highly prevalent chronic disease of the articulating joint affecting more 
than 8 million people in the UK alone. With age being a significant risk factor for OA and the 
average population life span increasing there is a growing burden of disease. Loss or restriction 
in mobility can both drastically reduce the quality of life and increase the risk of secondary 
disease conditions. Consequently, there is a significant need for early stage intervention in OA 
treatment. Currently the treatment of OA is moderate exercise, dietary supplementation, 
topical/oral anti-inflammatories pain relief and finally referral to a joint replacement surgeon 
if symptoms impact greatly on the patients’ quality of life (NICE 2008). Factors associated with 
increased risk of OA are summarised below (Fauci, 2008). 
 
Figure 2-1: Risk factors that increase the joint to susceptibility of OA (systemic and intrinsic 
factors) or that increase the risk through increased join load. Modified from Fauci (2008) 
page 2160 figure 326-4. 
Cartilage, the tough durable tissue that provides the smooth articulating surface in joints is 
known to thin with age. This is partly due to the failure of adequate synthesis of matrix in 
response to loading. Reduction in matrix leads to increased shear stress of the basal layers 
and perpetuates cartilage damage (Goldring and Goldring, 2010). It has long been known that 
cartilage has a limited ability to repair itself when damaged (Hunter, 1742, Buckwalter and 
Lohmander, 1994). 
There are a variety of theories surrounding OA pathogenesis. It is assumed that damage to the 
cartilage induces the chemotaxis of local chondrocytes, these chondrocytes are impounded in 
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their own matrix and are unable to migrate to injury sites. The chondrocytes secrete 
metalloproteases to degrade the cartilage and migrate to the site of injury which further 
exacerbates OA pathogenesis (Goldring and Goldring, 2010). It is also hypothesised that 
irregularities in the subchondral bone interface is a potential cause for cartilaginous lesions 
and have been found in many patients with OA (Grynpas et al., 1991). 
Metals are traditionally used for joint replacement surgery and are usually successful 
however, studies show that patients undergo foreign body responses (fibrosis) and in some 
cases hypersensitivity to metallic implants (Steinemann, 1996, Deutman et al., 1977). 
Mechanical mismatch of materials can be induced by the prosthesis, and cause stress shielding 
of natural bone, this in turn leads to bone degradation with inevitable implant failure (Lewis 
et al., 1984). 
Considerable efforts have been made to improve integration of metals with the bone itself to 
avoid stress shielding. Ceramics are of significant interest in orthopaedics as they can be 
resorbable, allowing for osseointegration with natural bone tissue (Hench, 1989). Ceramics, 
unlike metals, have the ability to combine with inorganic phosphates to help promote further 
deposition of calcium phosphate minerals when implanted in body fluids. For example; 
Bioglass®, glass- ceramic Ceravital®, sintered hydroxyapatite, glass- ceramic apatite-
wollastonite and glass-ceramic Bioverit®. Efforts have been made to coat metal prosthesis 
with porous ceramics to improve osseointegration with host tissues and currently there are a 
number of ceramic coated metallic implants on the market (Kamitakahara et al., 2007).  
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2.2  Articular Cartilage 
The human musculoskeletal system refers to the organ systems that govern structural 
support, stability and movement of the body. The system comprises a variety of tissues 
including bone, cartilage, muscle, tendons, and ligaments, synovial and non-synovial joint 
systems which are still not fully understood. The musculoskeletal system is subject to a host 
of mechanical forces, tension, compression, bending, shear and torsion on a day-to-day basis. 
Bone tissue specifically is in a constant state of remodelling, augmenting the architecture and 
density of material to provide support in the most energy conservative manner. The adaptive 
nature of the musculoskeletal tissue is most notably demonstrated by its ability to regenerate 
following injury. Harnessing the body’s ability to repair, replace or enhance tissue function 
undoubtedly requires an understanding of regular physiological processes that govern these 
actions. 
Hyaline (Greek: glassy) articular cartilage has no neural, vascular or lymphatic system and is a 
connective tissue which covers the articulating surfaces of freely movable joints (Poole, 1997). 
Chondrocytes maintain the cartilage which is composed of a fibrillar matrix of proteoglycans 
(~30% dry w/w), collagens (50-90% dry w/w), non-collagenous proteins (NCP) and water 
(~70% wet w/w) (Bollet and Nance, 1966, Maroudas et al., 1980, Heinegard and Oldberg, 
1989). 
Proteoglycans are protein chains with glycosaminoglycan’s (chondroitin and keratan 
sulphates) attached in an array, forming a ‘bottlebrush-like’ structure (figure 2-2). These 
proteoglycan units can aggregate to form a macromolecule with a molecular weight of up to 
200,000 kDa (Mow and Lai, 1980). The proteoglycan concentration is relatively low at the 
articulating surface and increases closer to the subchondral bone, which correlates inversely 
with water content (Mow et al., 1984). 
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Figure 2-2: A hyaluronic acid backbone with proteoglycan aggregates. Negatively charged 
sites on the chondroitin and keratan sulphate chains cause this aggregation to expand and 
occupy a large space aqueous solution. Image modified from (McCormack and Mansour, 
1997). 
Collagen type II is the most predominant collagen in cartilage with other types present in 
smaller amounts. The collagen fibre architecture varies through the depth of the tissue 
however it is known to consist of type II collagen with type XI within the fibril and type IX 
integrated in the fibril surface making a complex heterofibril as demonstrated in figure 2-3 
(Eyre, 2002, Goldring and Goldring, 2010). 
 
Figure 2-3: A molecular model of collagen type II demonstrating interaction sites and known 
cross-linking sites between collagen II and IX molecules (Eyre, 2002).  
The morphology of articular cartilage is often described as having four zones between the 
articular surface and the subchondral bone. The structure of articular cartilage can be 
described using a ‘split line’ method (figure 2-4). The cartilage collagen is organised into broad 
layers arranged perpendicular to the split line axis. (Jeffery et al., 1991). The zone nearest the 
subchondral bone contains calcified and non-calcified collagen radially orientated and 
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arranged in tightly packed cross-linked bundles. The radial zone contains collagen maintaining 
a tightly packed radial arrangement, which becomes less distinct towards the intermediate 
zone with fibre networks encapsulating chondrocytes. In the superficial zone the fibres are 
thinner and the collagen structure is organised into several layers. The cells in this layer 
produce superficial zone protein (SZP also known as proteoglycan-4 or lubricin) that acts as a 
lubricant for joint mobility (Khalafi et al., 2007, Jeffery et al., 1991). Chondrocyte morphology 
and surrounding ECM composition varies throughout the distinct zones (Goldring and 
Goldring, 2010). 
 
Figure 2-4: A split line axis orientated cross-section of articular cartilage. The left half of the 
image represents the organisation of collagen leaves with respect to the split line axis. The 
right image represents the characteristic histological zones of cartilage: superficial, radiate 
and calcified (McCormack and Mansour, 1997). 
This complex architecture of connective tissue provides a low friction-bearing surface capable 
of absorbing and transmitting compressive, tensile and shear forces across the joint. Cartilage 
has been characterised as a biphasic material as it holds two properties when mechanically 
challenged. As loading of cartilage occurs there is a rapid displacement of water. This is a direct 
influence of matrix water permeability. Upon displacement, equilibrium of fluid flow is 
reached and the modulus of the matrix aggregate is then challenged. The aggregate modulus 
of cartilage is in the range of 0.45-0.59 MPa however taking into account the biphasic nature 
of cartilage, this value is closer to 0.45-0.8 MPa (Athanasiou et al., 1991, McCormack and 
Mansour, 1997).  
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2.3  Bone Biology 
Bone Structure and Composition 
Bone has a vital role in vertebrate physiology. Not only forming the structural endoskeleton, 
it houses a stable microenvironment for haematopoiesis (blood production) and homeostasis 
of essential minerals. Bone itself is a highly vascularised connective tissue which can be 
organised into several layers of structural hierarchy (figure 2-5) (Weiner and Wagner, 1998).  
 
Figure 2-5: Hierarchical structure of bone (Weiner and Wagner, 1998). 
The outer layer of cortical bone in very dense, whereas the internal structure has a spongy 
appearance and is called cancellous bone. Vertebrate bone is, in essence, a composite 
composed of 70% calcium phosphate bone mineral. The main form of which is hydroxyapatite, 
27% collagen type I protein and 3% other non-collagenous proteins (Weiner and Wagner, 
1998). Collagen type I is an extracellular protein consisting of three tropocollagen 
polypeptides coiled to form a triple helical structure approximately 300nm long. This protein 
self assembles into fibrils in the presence of phosphates and sodium chloride. These fibrils 
combine into bundles called fibres which present characteristic D pattern banding (figure 2-6) 
(Kadler et al., 1996). 
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Figure 2-6: a) Schematic of a collagen type I fibril. b & c) TEM image of collagen from positive 
and negative stain methodologies respectively (Kadler et al., 1996). 
The electron dense D-band pattern shown in the transmission electron micrograph is 
overlapping collagen presenting as a denser section (figure 2-6). The hierarchical design of 
bone organisation from the nano-macro scale makes it a marvel of nature. The intercalation 
of HAp within the collagen type 1 fibrils and orientation at the nanoscale makes bone an 
extremely complex nanocomposite material. 
Cell adherence  
Cells are surrounded by fat-based phospholipid membrane studded with proteins. These 
proteins are responsible for the sensitivity of the cell to the surround environment. 
Transporter proteins act as valves to regulate the movement of substances in and out of the 
cell. Membrane receptor proteins sense and communicate signals from neighbouring cells and 
the environment. Cell adhesion molecules (CAMs) are responsible for anchoring the cell to 
neighbouring cells or the ECM. 
Integrins are transmembrane proteins responsible for cells-ECM interaction. Cells cultured in-
vitro use integrins to adhere to ECM proteins from the culture media adsorbed to the growth 
substrate. Integrins bind to proteins containing a specific peptide sequence 
arginylglycylaspartic acid (RGD). Ergo the ability of cells to adhere to materials depends on the 
adsorption of proteins containing this sequence (Burridge & Chrzanowska-Wodnicka 1996; 
Gumbiner 1996). 
D-Pattern 
Banding 
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Biomineralisation 
Biomineralisation of HAp in-vivo has been described to occur in a matrix vesicle; formed and 
released from osteoblasts and other related cells. Nucleation of calcium and phosphate 
precursors is thought to occur within the vesicle. As the crystal grows it ruptures the 
membrane and is exposed to the extracellular environment. This theory describes two phases 
of HAp synthesis control: cellular and extracellular matrix (ECM) (Anderson, 1995). These 
crystals intercalate and align with tropocollagen protein gap domains within collagen type 1 
matrix (Palmer et al. 2009). There is evidence that other matrix non-collagenous proteins 
orchestrate nucleation and control growth of HAp crystals (Boskey, 1996).  
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Specialised bone cells 
Bone is maintained by two main cell types: osteoblasts (osteocytes when fully matured) and 
osteoclasts, these cells act antagonistically locally generating and resorbing bone respectively. 
This is tightly regulated by a mechanism of hormones, growth factors, physical stimuli, and 
ionic concentrations. This, in turn, maintains structural integrity of the skeleton and mineral 
ion concentration of the body (Weiner and Wagner, 1998). 
Osteoclasts are large multinucleated cells derived from hematopoietic stem cells (HSCs) found 
in the bone marrow and are critical in the regulation of bone formation. During bone 
remodelling osteoclasts form resorption pits in trabecular bone. In cortical bone osteoclasts 
cluster and burrow through old or damaged bone forming a tunnel. This tunnel is vascularised 
and lined with recruited osteoblasts which concentrically deposit new bone forming new 
osteons (Alberts et al. 2008). 
Osteoblasts are anchorage dependent cells; highly responsive to mechanical and chemical 
stimulation relayed through cell-cell and cell-ECM interactions. Specific receptors and trans-
membrane proteins such as integrin’s, cadherin’s and connexins mediate these stimuli leading 
to production of ECM and biomineralisation (Pirraco et al. 2010). Some osteoblasts become 
entrapped within the mineralised matrix and fully differentiate into osteocytes. Osteocytes 
are smaller than osteoblasts and maintain communication with surrounding osteoblasts 
through specialised filopodia, which also ensure mass transport with the extracellular fluid. 
The filopodia form a network of canaliculi between the dense bone regions. This is believed 
to be responsible for mechanical stimuli transduction and bone homeostasis (Pirraco et al. 
2010). 
The osteoblastic lineage is derived from multipotent mesenchymal stromal cells or 
mesenchymal stromal cells (hMSC). hMSC have the capacity to form an assortment cell types 
in tissue culture (figure 2-7). hMSC not only contribute to tissue formation, they play a vital 
role in HSC self-renewal and proliferation (Kemp et al. 2010). 
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Figure 2-7: Illustration of the multipotent potential of hMSC with different lineage 
progression pathways. Modified from (Alberts et al. 2008). 
Conventionally hMSC are characterised by their ability to adhere to tissue culture plastic from 
bone marrow aspirates. Significant efforts have been made to isolate hMSC with a 
reproducible capacity for differentiation into the various tissue lineages. However, currently 
there is no specific marker or characteristic that defines differentiation capacity. In an attempt 
to standardise hMSC for clinical applications, panels of positive and negative surface markers 
have been developed to reduce variability (Dominici et al. 2006). 
It is widely accepted that the functionality of hMSC depends on an assortment of 
subpopulation progenitors partially committed to one or two lineages. There is a lack of clarity 
with regards to the specific functionality of these hMSC subpopulations. This is exacerbated 
by donor-to-donor variation and intra-population heterogeneity (Phinney 2012). 
The proliferative and multipotent capacity of hMSC populations is also known to decline 
though in-vitro expansion (Muraglia et al. 2000; Sarugaser et al. 2009). Monolayer cultivation 
of hMSC on tissue culture plastic is known to favour both fibroblastic and osteoblastic 
differentiation (Engler et al. 2006).  
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Recently it has been demonstrated that specific differences in cytoskeletal structure are 
dependent on the substrate elasticity (Gupta et al. 2015). Findings by Gupta et al. (2015) 
reveals that the actin cytoskeleton acts as a rigidity sensor and behaves like a fluid-like 
material on soft substrates and as a solid-like material on stiffer ones, of which is 
morphologically evident in the cells actin filaments (figure 2-8A). 
 
Figure 2-8: The influence of substrate stiffness on actin filament ordering (Gupta et al. 2015).  
Stem cells have been found to differentiate into various lineage commitments based on the 
associated stiffness of the anatomical tissue (figure 2-9A). The observed changes in the 
differentiation of stem cells as a response to substrate stiffness is no doubt linked to these 
reported changes in focal adhesion and cytoskeletal structure (Engler et al. 2006) (figure 2-9B). 
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Figure 2-9: A) Scale of biological elastic modulus modified with coloured circles to show 
changes in hMSC gene expression on different substrate elasticities (B) (Janmey & Miller 
2011). B) Changes in hMSC marker expression of neurogenic (brain), myogenic (muscle) and 
osteogenic (bone) lineages when cultured on substrates with various elasticities. 
Blebbistatin is a control which inhibits myosin II synthesis, which is hypothesised to render 
the cells insensitive to elasticity. C2C12 fit and hFOB dotted lines represent differentiated 
myogenic and osteogenic cell types (Engler et al. 2006).  
 
The objective of this thesis was to use hMSC to provide an insight into endogenous cell 
responses to biomaterials for bone tissue engineering. The reparative and destructive 
processes associated with OA have been linked to functional alteration in hMSC populations 
(Luyten 2004). Ergo, the approach was to use hMSC located from the cancellous cavity of the 
femoral head donated from patients undergoing total hip replacement surgery as a 
consequence of OA progression. These cells hypothetically offer a more representative 
population for the in-vitro assessment for biomaterials aimed at the treatment of 
osteochondral defects in OA suffers.  
B 
A 
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Mechanisms of Bone Formation and Repair 
There are two major types of bone formation: intramembranous ossification and 
endochondral ossification. 
Endochondral ossification is observed during bone development and can be divided into five 
distinct stages (figure 2-10). Firstly, hMSC migrate to the bone region and commit to becoming 
cartilage cells (A). Secondly, the cartilage cells form dense nodules and differentiate into 
chondrocytes. In the third phase the chondrocytes proliferate and secrete cartilage specific 
ECM in the shape of the bone (B). During the fourth phase chondrocytes become hypertrophic, 
which alter the ECM to include collagen X and adding more fibronectin. These alterations 
result in mineralisation and vascularisation that converts hMSC into blood vessels (C-D). The 
hypertrophic chondrocytes undergo a metabolic change from aerobic to anaerobic 
respiration; they then die through apoptosis. The fifth and final stage is the progressive 
vascularisation of dying hypertrophic chondrocytes and differentiation of surrounding cells 
into osteoblasts to mineralise the bone collar (E-H) (Gilbert 2010). 
 
Figure 2-10: Schematic diagram of endochondral ossification. (Gilbert 2000) 
There are three main types of intramembranous ossification. Formation as a result of 
mechanical stimulation is called sesamoid bone, bone thickening is termed periosteal bone, 
and bone formed in the dermis of the skin is called dermal bone. hMSC first proliferate and 
condense to form nodules which, through growth factor stimulation, become pre-osteoblasts 
and begin to deposit and mineralise ECM. 
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Bone healing is a complex process involving the migration, proliferation, differentiation and 
activation of several cell types (Street et al. 2002). Bone healing occurs in two stages: firstly, 
the early inflammatory stage, the repair stage and finally the late remodelling stage. During 
the first few hours a fibrin hematoma develops containing inflammatory cells and fibroblasts. 
Furthermore, this encourages vascularisation and migration of hMSC. Fracture healing 
comprises a mixture of both endochondral and intramembranous ossification (figure 2-11) 
(Bahney et al. 2015a). Restoration of mechanical integrity occurs during the remodelling stage, 
which happens slowly over months to years, and is dependent on mechanical stress (Kalfas 
2001). 
 
Figure 2-11: Fracture healing illustration. A) Haematoma formation, B) intramembranous 
ossification occurs at the periosteum and endosteum of the fracture site. Within the callus 
cartilage cells condense and proliferate. C) Vascularisation, mineralisation of ECM, 
apoptosis of hypertrophic chondrocytes and proliferation of osteoblasts. D) Conversion of 
cartilage into bone, bridging the fracture site (Bahney et al. 2015b). 
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Regulation of osteoblastic differentiation by growth factors 
Growth factors are proteins secreted by cells that act as molecular signalling agents for cells. 
Growth factors are essential for the control of assorted functions including: proliferation, ECM 
production and differentiation. These proteins have three modes of action: (1) autocrine; 
whereby the factor effects the same cells which produce it, (2) paracrine; in which the factors 
influence cells in close proximity, and (3) endocrine; where the growth factor influences cells 
from a different anatomical site. Growth factors can influence a diverse number of cell types 
and can orchestrate a number of cellular functions in a range of different tissues. 
Bone morphogenetic proteins (BMP) refers to a group of growth factors responsible for the 
morphological formation of bone and cartilage. Runx2 (also known as CBFA1) is a master 
regulator of bone formation activated by BMPs and its expression is essential for the 
expression of many downstream genes important for osteoblast differentiation (Ducy et al. 
1997). There are two isoforms of Runx2 involved in osteogenesis type1 (T1) and type 2 (T2). 
T1 Runx2 is expressed during early differentiation of osteoblasts and promotes expression of 
BMP2. Subsequently, this upregulates transcription of T2 Runx2 to stimulate osteoblast 
differentiation and maturation. Previous studies have found that although T1 Runx2 is 
continually expressed in many cells it is rarely enhanced during osteogenesis and bone 
formation (Xiao et al. 1998). T2 Runx2 expression is believed to play a more crucial role in 
osteoblastic differentiation (Yang et al. 2011). 
During intramembranous ossification hMSC are exposed to relatively low level BMP, which 
promotes osteogenesis through expression of Runx2 and collagen II and IX. At later stages 
Runx2 is downregulated and OPN is upregulated, similar to developing chondrocytes, and are 
sometimes termed chondrocyte-like osteoblasts. Autocrine secretion of Indian hedgehog 
protein further matures the osteoblasts (Gilbert 2010). 
At the start of endochondral ossification stimulation of nearby sclerotome cells by Sonic 
hedgehog protein results in the commitment of hMSC into cartilage cells. During condensation 
of cartilage cells, BMP (in orchestration with other growth factors) appears vital for inducing 
the expression of N-cadherin, N-CAM and Sox9. N-cadherin and C-CAM are responsible for 
initiation and maintenance of the condensation. Sox9 is responsible for the production of 
cartilage ECM (collagen II and aggrecan) and proliferation of cartilage cells. Runx2 mediates 
transformation of cartilage cells into hypertrophic cartilage cells.  These hypertrophic cartilage 
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cells secrete vascular endothelial growth factor (VEGF), which promotes hMSC differentiation 
into endothelial cells and vascular taxis (Carlevaro et al. 2000).   
Osteopontin 
Osteopontin (OPN) also known as bone sialoprotein 1 or ETA -1 is a very important 
phosphorylated glycoprotein secreted by a number of cells; most notably osteoblasts. OPN is 
present where ever calcification occurs. It is important for the control of biomineralisation. 
Low levels of OPN have been linked to critical HAp nucleation where high levels of OPN is 
linked to HAp nucleation and growth inhibition (Gericke et al. 2005). OPN is postulated to bind 
to HAp through phosphorylated residues (Sodek et al. 2000). OPN also contains an integrin 
receptor binding arg-gly-asp (RGD) peptide domain; responsible for cell adhesion. OPN has 
transglutaminase-reactive glutamine residues that enable it to be cross-linked to form OPN 
polymers, which bind to HAp (Gericke et al. 2005). 
Alkaline Phosphatase 
ALP is an enzyme responsible for the liberation of phosphate from different molecules. In 
humans there are four isozymes: intestinal, placental, placental-like and tissue nonspecific 
(bone, liver and kidney). The tissue nonspecific isoform of ALP is abundantly expressed in 
osteoblasts and is used as a marker of osteoblastic differentiation. Actively dividing 
osteoblasts conserve ALP expression. However, when proliferation stops, ALP is expressed in 
high levels and appears necessary for the mineralisation of the ECM (Fernández-Tresguerres-
Hernández-Gil et al. 2006).  
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2.4  Tissue Engineering Biomaterials  
Tissue engineering refers to a field of research aimed at the repair, replacement or 
enhancement of defective or dysfunctional tissues. 
 
Figure 2-12: illustration of various treatment approaches used in tissue engineering. 
Figure 2-12 demonstrates various treatments strategies used in tissue engineering; the 
simplest being direct implantation of a biomaterial scaffold or enriched host cells. More 
complex approaches include ex-vivo expansion/modification of autologous, allogenic or 
xenogeneic cells in combination with scaffolds. Recently strategies have been employed to 
improve scaffold functionality pre-implantation using biomolecules or pre-mechanical 
stimulation (Huang & Ogawa 2010). 
The ideal biodegradable scaffold for bone regeneration would include a number of material 
and biological considerations. Firstly the material should have suitable mechanical properties 
to withstand physiological loads during the transition to the surrounding host tissue (Gerhardt 
& Boccaccini 2010). Secondly the degradation products of the material should be 
biocompatible and stimulate host bone tissue regeneration (Hannink & Arts 2011). Thirdly 
material surface chemistry should allow for host cell attachment, migration and bone 
formation (Tang et al. 2016). Fourthly the structure of the implant should include porosity to 
both encourage osteogenesis and host tissue integration (Hannink & Arts 2011).  
The human body is consisted of 213 bones without including the sesamoid bones (Clarke 
2008). Each bone has a variety of pore sizes depending on its function and on the individual 
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sex/age. Many groups have investigated different pore sizes to identify what pore range 
promotes specific cellular activities. It has been reported that pores <50 μm enhance hypoxic 
conditions promoting chondrogenesis. In addition, small pore size stimulates protein and cell 
adhesion as well as cellular migration and osseointegration. Pores with size <50 μm promote 
vascularisation and ossification (Perez & Mestres 2016). It has been reported that pore size 
<300 μm promote endochondral ossification (Hutmacher et al. 2007), pores >300 μm favour 
angiogenesis (Mantila Roosa et al. 2010) (Karageorgiou & Kaplan 2005; Mantila Roosa et al. 
2010). pores around 500 μm enhance tissue formation (Karageorgiou & Kaplan 2005) and 
pores around 1000 μm stimulate the osteoblast phenotype expression (Sicchieri et al. 2012). 
However, an optimal scaffold for bone tissue engineering should be made with a combination 
of pore sizes to trigger different functions simultaneously. 
The potential for MSCs to regenerate a variety of tissues has made them a subject of intense 
research in the fields of cellular therapy and regenerative medicine. The applications for MSCs 
in bone tissue engineering are as follows: 
1. To provide an indication into the influences of biomaterial properties such as architecture 
and chemical properties on stem cell behaviour. 
2. Autologous or allogenic co-delivery with pre-fabricated or in-situ fabricated biomaterial 
scaffold implants.  
3. Conditioning of biomaterial scaffolds prior to implantation. 
Specifically this thesis addresses the use of bioresorbable biomaterials to transiently replace 
bone and encourage endogenous reparative processes to locally regenerate host tissues 
(Hutmacher 2000). 
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Hydroxyapatite 
Hydroxyapatite and other calcium phosphates such as tri-calcium phosphate (TCP) and 
calcium carbonate have a long history as implant materials from the 1920s to the 1930s 
(Shepherd et al. 2012). Hydroxyapatite is a naturally occurring ceramic, calcium apatite 
mineral Ca5(PO4)3(OH), however the crystal unit cell contains two hydroxyapatite units and is 
often depicted Ca10(PO4)6(OH)2 with a Ca/P ratio of 1.67. Natural bone hydroxyapatite has a 
crystalline, non-stoichiometric nanostructure (exhibits Ca/P ratio of >1.67) containing 
various carbonate (CO23-) and phosphate (HPO42-), zinc (Zn2+), sodium (Na+), magnesium 
(Mg2+), strontium (Sr2+), potassium (K+), chloride (Cl-) and fluoride (F-) ions integrated with its 
structure (Markovic et al., 2011). 
 
Figure 2-13: A) The theoretical arrangement of the hydroxyapatite unit cell. B) Types of 
calcium ion sites within the hydroxyapatite lattice. Four columnar calcium Ca(I) sites (c-axis 
0 and ½) and six Ca(II) sites (z-axis ¼ and c-axis ¾). Modified from (Ratnayake et al. 2016). 
X-ray diffraction studies of hydroxyapatite Ca10(PO4)6(OH)2 has shown a crystalline hexagonal 
arrangement of Ca2+and PO43- ions around columns of OH- ions. The structure of the 
hydroxyapatite unit cells is a six-fold space group (P63/m) with unit cell dimensions of c = 6.884 
nm and a = b = 9.421 nm. Figure 2-13 demonstrates the theoretical arrangement of the 
hydroxyapatite unit cell (A) and organisation of different calcium ion sites (B) (Ratnayake et 
al. 2016). 
Chapter 2 
43 | P a g e  
 
Ionic substitutions of artificially synthesised hydroxyapatite have been a subject of intensive 
research during the past few decades to improve material, mechanical and biological 
properties (Ratnayake et al. 2016). Significant research has been carried out specifically in zinc, 
magnesium, strontium, fluoride, carbonate and silicon for use in both dental and orthopaedic 
applications. 
Zinc that can be found naturally in bone (110-300 μg/kg) is known to decrease with age and 
correlates with decreased bone strength (Shepherd et al. 2012). Zinc substituted HAp has 
demonstrated in-vitro enhanced activity of osteoblasts and inhibition of osteoclast function 
(Webster et al. 2004; Kishi & Yamaguchi 1994). 
Magnesium is highly prevalent in the body and has been found in the enamel (0.44 wt. %), 
dentin (1.23 wt. %) and bone (0.72 wt. %) (Shepherd et al. 2012). Magnesium is thought to 
play a role in  bone remodelling as it is found in high concentration at the start of remodelling 
and  decreases with increased calcification (Bigi et al. 1992).  
Strontium is present in the mineral phase of bone (0.008 – 0.01 wt. %) and is correlated with 
areas of high metabolic turnover (Blake et al. 1986). Strontium ranelate has been used 
therapeutically and combines two atoms of stable strontium with the organic moiety, ranelic 
acid used as a carrier for the strontium cations (Basu et al. 2015). Studies have demonstrated 
that administration of strontium ranelate increases the proliferation and activity of 
osteoblasts whilst decreasing osteoclast differentiation in-vitro (Peng et al. 2009; Caverzasio 
2008). These findings are also supported by in-vivo studies, which show strontium ranelate to 
decrease bone resorption and increase bone formation (Buehler et al. 2001). 
Fluorine is an important element for bone/dental growth and has successfully been used to 
treat patients with osteoporosis, however excessive intake could lead to osteosclerosis 
(abnormal hardening). Farley et al. (1987) demonstrated increased ALP activity and 
proliferation of osteoblasts in response to fluoride ions in-vitro (Farley et al. 1983). Another 
study showed a similar result in rat osteoblasts from rats treated with NaF ions present in the 
rats drinking water (Chavassieux et al. 1993). 
Silicon is also present in active bone growth areas with a 0.5 wt. % in mice and rats. Abnormal 
skeletal growth was also observed when Si was deficient from the diet (Carlisle 1970). More 
recent studies have demonstrated increased collagen type I and enhanced osteoblastic 
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differentiation in human osteoblast like cells in response to physiological levels of Si (10-20 
μM) in the form of orthosilicic acid (Reffitt et al. 2003). Bioglass and apatite-wollastonite are 
bioactive ceramics containing 40-34 wt. % SiO2 which plays a crucial role in their surface 
reactivity and can change their in-vitro and in-vitro activity (Gibson et al. 1999).   
Carbonate is the most abundant form of substitution in biological apatites and has been found 
at levels of 7.4 wt. % in bone, 5.6 wt. % in dentine and 3.5% in enamel (Bigi et al. 1997; Montel 
et al. 1981). Carbonated hydroxyapatite is supposedly vital for its role in bone metabolism and 
as such has been a significant effort in the use of carbonated apatites for orthopaedic 
applications (Ratnayake et al. 2016; Shepherd et al. 2012).  
High temperature sintering of hydroxyapatite powders to form solid implants and plasma 
spraying to coat metal implants require thermal stability of the ceramic powder (Cheang & 
Khor 1996). Typically hydroxyapatite is sintered at temperatures ranging from 800oC to 1200oC 
(Shepherd et al. 2012). The sintering of hydroxyapatite has been reported to convert some 
calcium phosphates into tri-calcium phosphate and octa-calcium phosphate. Impurities in the 
case of TCP are shown to strengthen the ceramic material, although the β form of TCP is a 
reported biodegradable bioceramic known to dissolve in physiological media and in-vivo 
(Royer et al. 1993; Best et al. 2008).  
Sintered hydroxyapatite has been used in combination with a polymeric template to produce 
blocks with fully interconnected pores (average diameter of 500 μm) with 77% porosity. These 
scaffolds were able to improve bone integration with a intramedullary titanium cylinder when 
implanted in a rabbit model (D’Lima et al. 1998). 
Previous in-vitro work has demonstrated osteoblast adherence, proliferation and ECM 
secretion on hydroxyapatite surfaces (Bagambisa & Joos 1990; Best et al. 1997; Kim 2003). 
Osteoclasts have also been observed forming resorption sites with characteristic actin ring 
formation on the surface of hydroxyapatite implants (Redey et al. 1999). Although numerous 
studies have demonstrated resorption sites, very few have demonstrated resorption lacunae 
indicating limited in-vivo remodelling potential of solid hydroxyapatite implants (Monchau et 
al. 2002; Webster et al. 2001) 
A number of commercially available hydroxyapatite coatings have been developed and is 
currently used in a variety of orthopaedic implants. A number of hip replacements utilise a 
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hydroxyapatite coating on metal implants to improve biological integration. One of the first is 
the Furlong® hip system, JRI orthopaedics. Johnson & Johnson – Depuy: Corail total hip 
system, Stryker: Restoration HA™ and Biomet: Porous HA coatings. Hydroxyapatite based 
bone substitute fillers have also been used in the clinic: Medtronic: bone cement with 
hydroxyapatite, Zimmer: CopiOs® bone void filler, Stryker: BoneSource® & HydroSet. 
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Artificial Hydroxyapatite Nanoparticle (HAp) Fabrication 
A number of studies have illustrated the bioactivity of nanoscale HAp over traditional 
hydroxyapatite to promote osteogenesis and bone-material interfaces (Webster et al. 2001; 
Yoshida et al. 2000; Hench 1991; Davies 2007; Ducheyne & Qiu 1999). However, control over 
particle dimensions, crystallinity and composition are likely contributing factors to their 
success in the clinic (Cai et al. 2007a). 
The influence of substitutions on artificial HAp with different ionic groups has significant 
impact on the final HAp crystal lattice parameters, morphology, crystallinity, solubility and 
thermal stability (table 2-1). 
 
Table 2-1: Substitutions in hydroxyapatite and the effect on crystal lattice parameters and 
solubility (Shepherd et al. 2012). 
Table 2-2 describes different synthetic routes for the production of artificial hydroxyapatite 
nanoparticles with different morphologies, crystallinities and stoichiometry. 
Given the complexity of substituted HAp fabrication, the first step in the development of the 
sol-gel methodology was to investigate parameters that influence the production of non-
substituted HAp. This will deepen the understanding on how different parameters influence 
the HAp physiochemical properties and will enable further research for better control over 
the fabrication of potentially more bioactive forms of HAp. 
Sol-gel precipitation involves the conversion of monomers into a colloidal solution of solid 
particles. Sol-gel is the most widely used method involving the mixing of calcium and 
phosphate precursor solutions under controlled environments. Typically, the resulting calcium 
phosphate crystals synthesised through this methodology are later calcined at high 
temperature (800 oC-1200oC) to produce crystalline HAp ceramic nanocrystals. 
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Investigation into the processing parameters using the sol-gel methodology for the fabrication 
of hydroxyapatite nanoparticles has not been entirely characterised. A variety of techniques 
for the fabrication HAp has been described in the literature (Bakan et al. 2013; Jadalannagari 
et al. 2011; Marković et al. 2011; Yubao et al. 1994; Wang et al. 2010; Iyyappan et al. 2016; 
Wang et al. 2007; Kumar et al. 2004; Ramesh et al. 2015; Vázquez-Hernández et al. 2010; Ha 
et al. 2015; Huang et al. 2012), where individual parameters have been studied without taking 
into consideration the influence and interactions of other parameters that influence the 
particle size, morphology and chemistry of the resulting particles. Despite the variety of 
techniques described in the literature, very few comment on the effects of multiple processing 
parameters on particle size and morphology (Salimi et al. 2012). 
Knowledge of calcium phosphate nucleation and growth kinetics is vital not only for 
understanding in-vivo systems, but also for in-vitro or ex-vivo synthesis of biomimetic HAp 
nanocrystals for tissue regeneration applications. In-vivo biomineralisation by osteoblasts and 
osteocytes require sufficient supersaturation of mineral precursors and is controlled though 
the action of control proteins and local pH regulation. This biomineralisation results in plate-
like, nanocrystalline, carbonated HAp nanoparticles (Marković et al. 2011). 
Several sol-gel processing methodologies have been investigated using a variety of precursor 
solutions. These are based on an aqueous system using calcium, phosphate and alkaline 
solutions to regulate the reaction. For calcium these include calcium chloride, calcium nitrate, 
calcium alkoxides, calcium acetate and calcium hydroxide. Precursors for phosphate include 
potassium di/tri-hydrogen phosphate, phosphate alkoxides, sodium phosphate tribasic (Liu et 
al. 2001). Alkaline solutions that have been used in the literature include sodium hydroxide, 
ammonia, ammonia hydroxide, potassium hydroxide (Cunniffe et al. 2010; Bakan et al. 2013; 
Yubao et al. 1994; Vázquez-Hernández et al. 2010) 
The reaction between these different calcium, phosphate and alkaline precursor solutions 
yield different by-products. These by-products are likely to influence HAp nucleation and 
growth. Efforts have been made in an attempt to coat metal implants with hydroxyapatite 
using sol-gel methodologies as an alternative to thermal spraying (Asri et al. 2016). 
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Temperature has been observed as a fundamental parameter of sol-gel synthesis governing 
crystal shape yielding needle-like morphology at low temperatures (35oC) and a more regular 
rounded shapes at higher temperatures (85oC) (Bouyer et al. 2000). 
Ion availability within the sol-gel solution is known to influence HAp crystal structure, indeed 
the affinity for specific ions during HAp nucleation and growth is known to vary according the 
conformation of the crystal lattice (Elliott et al. 2002). This will have ramifications on the HAp 
synthesised with different addition methodologies or titration rates.  
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Bouyer et al. (2000) investigated the influence of various addition rates of the phosphate 
component into a calcium precursor reservoir. This lead to differences in HAp morphology. 
Reaction pH i.e. OH- availability is a key component for HAp crystal formation (figure 2-14). 
Weakly acidic titration conditions of pH 4-6 is known to form a calcium phosphate phase 
known as dicalcium phosphate dehydrate (DCPD) CaHPO4 ∙ 2H2O or brushite at physiological 
temperatures. This phase is unstable and the DCPD loses its bonded molecular water to form 
monetite during storage, DCPD is rapidly transformed into HAp under physiological conditions 
(Kumta et al. 2005).  It was noted that calcium phosphate titrated at pH < 6 and with elevated 
temperatures (80oC – 100oC) resulted in formation of calcium deficient HAp with a Ca/P ratio 
of <1.67 (LeGeros et al. 2003). Octacalcium phosphate (OCP) is an intermediate between the 
DCPD to HAp transformation process and is thought to be regulated through local OH- ion 
changes. Alkaline solution conditions >pH 9 were reported to mediate a transformation from 
OCP to amorphous HAp (Lazić 1995). Previous research by Zhang et al. (2009) has clearly 
shown the importance of reaction pH on HAp crystal morphology (figure 2-14). The 
preparation method used here differs from the one described by Zhang and colleagues, ergo 
alterations in reaction pH were investigated. 
 
Figure 2-14: The role of OH-on hydroxyapatite nucleation and growth (Zhang et al. 2009) 
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The order of the crystal lattice is influenced over time increasing the stability of the final HAp 
crystal, this maturation is a consequence of time and pH (Kumta et al. 2005). Commonly 
calcium phosphates undergo post-process sintering to form highly crystalline hydroxyapatite; 
this is known to result in secondary crystal growth (Sanosh et al. 2009). 
Modification of crystal morphology, size and zeta potential are important factors in governing 
how cells interact with nanoparticles (Mahmoudi et al. 2011). Previous studies have used 
micelle facilitated crystal growth to limit growth size and spherical morphology of HAp (Cai et 
al. 2007b). A more biomimetic approach investigated the use of amino acid combinations, 
which are known to orchestrate in-vivo biomineralisation of collagen type 1 (Jahromi et al. 
2013). 
Recent developments in supercritical water hydrothermal synthesis (scWHS) technology could 
potentially produce a more scalable approach to the production of nanoparticles. The scWHS 
method uses a continual flow system which can be optimised to produce a variety of different 
material nanoparticles including HAp (Lester et al. 2006). This technology is currently under 
development by Promethean Particles Ltd (UK) SHYMAN funded by the EU FP7 framework 
project. Investigating the influence of HAp nanoparticles on mammalian cells in-vitro is a 
challenging process. A number of methods have been used to evaluate nanoscale HAp in-vitro; 
each with their advantages and disadvantages. Growing cells in a monolayer on tissue culture 
plastic and adding a suspension of HAp does not assess direct cell – surface nanoparticle 
interaction. Cultivating cells directly on loose powder runs the risk of monolayer disruption 
during medium replacement. Sintering the particles into pellets conceals any potential 
outcome of particle – cell interactions and alters the as synthesised crystallinity. Coating a 
substrate with HAp allows cellular interaction not only with the HAp but also the material 
substrate. The dip coating methodology theoretically simulates HAp liberation from the 
proposed bioresorbable polymer/HAp composite substrate resembling that which would 
occur at a composite – tissue interface. 
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Synthetic polymers 
Current understanding of the important influences of extracellular matrices on cell fate 
highlights the necessecity for control of these processes using artificial materials. Synthetic 
polymers hold a number of advantages over natural polymers, these include scaleability, 
consistency, reproducability and in some cases cost. The biodegradability of many synthetic 
polymers is appealing for bone tissue engineering, as it allows for ingrowth of bone from the 
native tissue, thereby eliminating potential stress sheilding (Chen & Liu 2014). 
Poly (α-hydroxyacids) are amongst the most commonly used polyesters in bio materials. Poly 
(lactic acid) (PLA) is synthesised from starch and sugars by a ring-opening polymerisation 
process and exhibits semicrystalline behaviour (Savioli Lopes et al. 2012). The lactic acid within 
PLA exsists as two enantiomers L- and D-lactic acid. The mechanical and biodegradation 
properties are directly influenced by the arrangement or tacticity of these enantiomers of 
which determines the polymer crystallinity. Pure L-lactic acid PLA results in a highly crystalline 
polymer, where as a L:D ratio of 50% in syndiotactic form results in an amorphous PLA material 
(Kister et al. 1998). 
 
Figure 2-15: Enantiomers of lactic acid (Nampoothiri et al. 2010) 
In general amorphous polymers biodegrade more readily due to loose association of the 
polymer chains, conversely crystalline polymers take considerably longer to biodegrade. Ergo 
medical grade polymers require consistancy in their structure to avoid uneven 
biodegradation, of which could lead to release of large regions of crystalline polymer. 
PLA is degraded though the hydrolysis of the ester bonds; the hydrolytic products of this 
process are transformed into non-toxic by-products. PLA has been demonstrated as a suitable 
bioresorbable polymer for fixation devices and has been used extensively as suture meshes 
(Lovald et al. 2009). Biodegradable implants are advantageous over metal as there is no 
requirement for removal and would allow the bone to gradually take over mechanical loading, 
which is vital to allow appropriate bone healing and remodelling within the scaffold region. 
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Other biodegradable polymers are studied for use in medical devices include polyglycolic acid 
(PGA), polyanhidrides, polyorthoester, polycaprolactone (PCL) and polyethylene glycol (PEG). 
Many have sought to combine these polymers to tailor the material degradation properties. 
For example L-PLA and PGA (Tai et al. 2007). 
For the purposes of studying the influence of polymer and HAp in-vitro, food grade PLA was 
selected as it is similar to medical grade PLA and as a model for process development. The 
degradation of PLA would also not occur in the in-vitro time scales of the experiments 
performed in this thesis. Future work would of course use medical grade polymers for in-vitro 
and in-vivo applications. 
2.4.3.1 Polymer nanocomposites 
Polymer nanocomposites are composed of a polymeric phase with one or more materials 
comprising nanoscale features of organic or inorganic phase distributed within the matrix. 
Nature is a master of nanocomposite materials, the most relevant example of which is bone. 
Evidence from the early 1990s demonstrated a significant improvement in mechanical and 
thermal properties with only a small addition of a nanoscale filler material (Hussain 2006). The 
properties of the nanocomposite material are not only dependent on the individual material 
properties, but also the morphology, distribution and interfacial characteristics of the two 
components. (Hussain 2006). Uneven distribution and lack of interfacial strength of 
nanoparticles within the polymeric matrix can lead to mechanical discrepancies and failure 
(Šupová 2009).Consequently, achieving a consistent dispersion of nanoparticles within 
polymer matrices will allow for optimal property improvements. 
Physically nanomaterials vary from traditional composite materials due to the fillers large 
surface area for a given volume. A number of important chemical and physical interactions 
depend on nanoparticle surface properties and morphology. As such nanostructured 
materials can have considerably different properties from materials with larger-dimensional 
fillers of the same composition. The surface area per unit volume of nanoparticles is inversely 
proportional to the materials diameter, therefore the smaller the particle diameter the 
greater the surface area per unit volume (Chen et al. 2013). 
Nanocomposites can be made by several techniques. Thermo-mechanical methods including 
compounding, milling and compression or injection moulding are often employed to produce 
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nanocomposites. These methods are advantageous as they can be used with existing 
manufacturing processes and are highly scalable. The large material quantities required for 
extrusion processing can often be a limiting factor to when it comes experimental work. 
Researchers have however, produced hydroxyapatite polymer nanocomposites with good 
dispersion using these techniques (Mathieu et al. 2006).  
Physico-chemical methods involve the use of a solvent to solubilise the polymer and allow for 
nanoparticles dispersion before consolidation (Šupová 2009). The advantage of this method 
is that it allows direct control over dispersion and distribution of the particles using lower 
temperatures and smaller quantities of material for experimental work. The disadvantages 
include potential contamination of the final composite material with residual solvents and the 
generation of contaminated wash waste requiring specialist disposal. For the purposes of the 
experimental work presented in this thesis, a physico-chemical dispersion approach was 
adopted and thus introduced. 
Dispersion of a solid <1000 nm particles within a liquid is termed a colloid and is mainly 
governed by three forces: 
1: Van der Waals force refers to a number of physical interactions that can occur between 
elements and molecules, including the London dispersion force, dipole interaction and 
hydrogen bonds. Van der Waals forces can generally be attributed to the probability of 
electron distribution based on the electronegativity of the element alone and elements 
present within a molecule. In the case of HAp, electrons distribute to form a positive and 
negative dipole within the particle. The smaller the nanoparticle the more particles will be 
present in a given volume, thus increasing the frequency of dipole moments at any given time. 
HAp also has a number of hydroxyl groups present, of which are capable of forming hydrogen 
bonds with other electronegative paired hydrogen atoms (Luckham 2004). 
2: Electrostatic interaction of particles with one another and with the medium in which it 
resides, originates due to the presence of fixed or induced charges at the particle surface. The 
electrical double layer theory suggests that in a liquid, charged ionic moieties are attracted to 
an oppositely charged interface and form a diffuse layer near the surface  (Adamczyk 2003). 
3: Steric forces or simply the blocking of solid movement by the physical packing of 
surrounding molecules that will influence solid phase dispersion. An example of steric 
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interaction would be the adsorption of a polymer chain to the surface of the HAp. The 
adsorbed polymer does not lie flat, instead parts adsorb to the surface with others extending 
away into the medium. Those repelled from the particle surface would therefore repel from 
similar neighbouring moieties resulting in repulsion of particles from one another (Rozenberg 
& Tenne 2008).  
Researchers have used a number of different techniques to overcome these forces and 
disperse nanoparticles within polymers. These include solution chemistry to functionalise the 
nanoparticle surface (Tanaka et al. 1999), the use of polymers to coat the surface of the 
nanoparticle (Lee & Shofner 2013; Rozenberg & Tenne 2008), in situ polymerisation of the 
nanocomposite (Li et al. 2003; Li et al. 2004), ultrasonic dispersion in solution (Safadi et al. 
2002), the use of surfactants (Kim et al. 2006; Tanaka et al. 1999) and gelation/crystallisation 
(used with carbon nanotubes) (Bin et al. 2003).  
Utilisation of a solvent with suitable polarity will also facilitate solid – liquid interaction. The 
viscosity of the medium is a good example of steric hindrance of particle dispersion and can 
be reduced by increasing the volume of solvent used to dissolve the polymer. 
Mixing of the solid phase with the liquid phase requires the input of energy into the system to 
initiate particle movement. The dispersion of nanoparticles requires very high energy to 
encourage initial separation from one another. Ultrasonic vibration (15-400 kHz) with the use 
of an ultrasonic water bath provides high energy throughout the solid and liquid phase 
maximising solid – solid phase separation. 
Surfactants are amphiphilic molecules containing both hydrophobic and hydrophilic domains. 
The polarity of the hydrophilic ‘head’ of the molecule determines its nomenclature (figure 
2-16). 
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Figure 2-16: Surfactant classification 1: Non-ionic, 2: cationic, 3: anionic and 4: amphoteric. 
Surfactants have previously been used to disperse nanoparticles prior to a number of 
processing techniques including electrospinning (Kim et al. 2006). Surfactants at a specific 
concentration self-assemble into hydrophilic/hydrophobic spheres called micelles depending 
on the preference of the medium. The concentration in which surfactants are able to form 
micelles is termed the critical micelle concentration (CMC). Cetrimonium bromide (CTAB) is a 
commonly used surfactant for the production on HAp and was therefore used for experiments 
(Cai et al. 2007b). Micelles can be used to stabilise solid – liquid suspensions through providing 
a physical and electrostatic barrier between the solid and liquid phases. 
Fibrin 
Minimally invasive techniques are a fast developing area of research, given the cost benefits 
achieved through lowering patient recovery time and reducing likelihood of infection (Bensaıd̈ 
et al. 2003). Localising cells with the ability promote osteogenesis within the implant site 
would reduce the healing dependency on endogenous cell recruitment. 
Fibrin is an insoluble protein involved in the clotting of blood during injury. Fibrin is formed 
from soluble fibrinogen molecule precursors and locally activated thrombin enzymes. 
Thrombin acts by exposing a specific polymerisation site in the middle (E domain) of the 
fibrinogen molecule. This facilitates hydrogen bonds to form between the E domain and 
terminal D domains of other fibrinogen molecules (figure 2-17) (Mosesson 2005). 
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Figure 2-17: Diagram of fibrinogen structure and its conversion into fibrin (Mosesson 2005)  
Polymerisation of fibrinogen molecules produces a lattice of overlapping E-D domain bonded 
chains, which are prone to branching, directly influencing the porosity of the fibrin network. 
With relatively low levels of activated thrombin the fibrinogen polymerisation site exposed at 
a slower rate resulting in more branching with a less porous matrix and vice versa (Blombäck 
et al. 1994). The fibrinogen molecules are covalently cross-linked by plasma 
protransglutaminase (factor XIII) which forms a disulphide bridge between D-D domains on 
adjacent molecules (Mosesson 2005). 
The crosslinking controlled by thrombin and density of the fibrinogen monomer are likely to 
influence the migration of cells within the implant site. In-vitro synthesised fibrin scaffolds 
have demonstrated the potential for cell migration using ~20-30 mg/mL fibrinogen by 
Dikovsky et al. (2006). Specific studies investigating the direct influence between crosslinking 
and fibrinogen density have demonstrated that fibrinogen concentration can influence cells 
spreading and proliferation of hMSC (Bensaıd̈ et al. 2003). 
Fibrin is also known to facilitate endothelial cell spreading, capillary tube formation and 
angiogenesis making it a promising option for the regeneration of vascularised tissues 
(Mosesson 2005). Literature has demonstrated cell attachment and proliferation to fibrin 
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material for both angiogenic and osteogenic promotion (Osathanon et al. 2008; Bensaıd̈ et al. 
2003; Catelas et al. 2006). Fibrin is also used to seal chondrocytes within the defect site during 
autologous chondrocyte implantation surgery (Richardson 2015). 
The mechanical properties of fibrin alone are insufficient to withstand direct loadbearing (80.9 
– 16.1 kPa) implantation and would therefore require support by a load bearing scaffold 
(Thomson et al. 2013). Fibrin has a significant disadvantage which is its gradual disintegration 
in the presence of cells, losing its shape and volume before the cells can replace the hydrogel 
with tissue. This disadvantage however can be overcome by balancing the degradation with 
specific cell concentrations and/or adding specific protease inhibitors (Ahmed et al. 2008). 
One such protease inhibitor currently used in fibrin glue is aprotinin (Yamada et al. 2003). The 
fibrin investigated in this thesis did not contain protease inhibitors, as the degradation of the 
hydrogel by the cells was favourable to promote extracellular matrix deposition by the 
encapsulated cells. The concentration of fibrinogen and thrombin used was based on previous 
research by Osathanon et al. (2008) to produce a hydrogel that would temporally localise 
specific cells within a hypothetical implant. 
Scaffold fabrication techniques for bone TE applications 
The choice of the biomaterial used for a TE application primarily influences the 
biocompatibility, bioactivity, biodegradation/ bioresorption, osteoconductivity and 
osteoinductivity of the scaffold. However, the architectural characteristics in combination 
with the selected material will affect the mechanical properties, the porosity, 
interconnectivity, surface roughness that are vital for the structural integrity of the scaffold 
and the regeneration of the damaged tissue. To date a variety of scaffold fabrication 
techniques have been developed to produce scaffolds that simulate the native tissue 
characteristics. Representative techniques of widely used polymeric scaffold fabrication 
techniques are reported in table 2-3. In all the techniques mentioned ceramic or glass- ceramic 
particles can be incorporated to prepare composite materials.  
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Method Description 
Solvent 
casting/ 
particulate 
leaching 
A polymer that has been dissolved using an organic solvent is mixed 
with water-soluble (e.g. salt, PVA) or acid-soluble particles (e.g. 
chitosan) with specific particle range. The solution is cast into a mould 
and the solvent is evaporated to produce a compact polymer 
structure. The dry polymeric construct is immersed in the solution 
that will dissolve the particles and polymeric matrix becomes porous 
(Vitale-Brovarone et al. 2010). 
Gas foaming 
Supercritical CO2 foaming: The carbon dioxide (CO2) at a temperature 
and pressure above its critical point is a supercritical liquid. An 
amorphous glassy polymer is soaked with supercritical CO2 (scCO2) at 
elevated temperatures. The scCO2 acts as plasticizer and decreased 
the Tg of the polymer making it rubbery. When the pressure drops, 
whilst the temperature remains stable the solution promote bubble 
nucleation that produces pores. As the solution is depressurised, the 
concentration of the plasticizer decreases, the Tg of the polymer 
increases and vitrification of the polymer occurs. As the pressure is 
decreased, the concentration of the plasticizer is also decreased. The 
polymer Tg increases and vitrification occurs resulting in a glassy 
polymer with a porous structure. (White et al. 2012) 
Freeze drying 
Thermally induced phase separation (TIPS): A polymer is dissolved at 
increased temperature in a solvent. After the polymeric solution is 
cast in moulds, the temperature is decreased to induce phase 
separation between the polymer lean (containing the solvent) and 
polymer rich phase. The frozen construct is freeze dried to sublime 
the solvent leaving a highly interconnected and porous polymeric 
scaffold   (Camarero-Espinosa et al. 2016). 
Freeze casting: A non-solvent soluble material is solubilised. The 
solution is cast in moulds and the temperature is reducing to promote 
ice-crystal formation. The frozen polymer is freeze dried resulting in 
an interconnected porous polymeric scaffold  (Deville et al. 2006). 
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Nonwoven 
Electrospinning: A polymer is dissolved in a solvent and poured in a 
syringe that is placed on the syringe pump. Electric or magnetic field 
is used to evaporate the solvent as is extruded from the syringe 
resulting polymeric fibres that are collected onto a conductive surface 
(Tuin et al. 2013; Rogers et al. 2014). 
Centrifugal spinning:  A dissolved polymer is loaded into the reservoir 
of the spinner is heated at high temperature. The molten or dissolved 
polymer is drawn from the orifices and is collected from the spinner 
(Zhang & Lu 2014). 
Solid Freeform 
Fabrication 
(SFF) 
 
A group of computer aided manufacturing (CAM) techniques use 
computer aided design (CAD) programs to rapidly generate 3D 
structures. The different SFF systems are divided to: laser based, 
nozzle-based and printer based  (Bose et al. 2013; Billiet et al. 2012). 
Below a couple of the most widely used SFF techniques are reported. 
Stereolithography (SLA): A liquid photocurable polymer is in a SLA 
apparatus, a laser source is moving on the x, y axis and polymerises 
the material layer by layer. SLA is a laser-based system. 
Fused filament fabrication (FFF): A polymeric filament passes 
through a nozzle that has a hot end to melt the polymer. The molten 
polymer deposits on the stage as the extruder moves on the x, y and 
z axis build the construct layer by layer. FFF is a nozzle-based system. 
Table 2-3: Examples of 3D scaffold polymeric techniques. 
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2.5  Current regenerative approaches for the treatment of OA 
Mosaicplasty or osteochondral grafting is a surgical technique where by cylindrical plugs of 
non-load bearing regions of cartilage are removed from the defect site. This is a lengthy, 
difficult to standardise procedure leading to some donor site morbidity. The results are largely 
successful with viability of the transplanted tissue and results in a fibrocartilage matrix 
deposited within the gaps between the implanted plugs (Richardson 2015). 
Microfracture is a surgical technique whereby the extent of the osteochondral defect is 
prepared by removal of defective cartilaginous tissue and debridement of the subchondral 
bone surface. Small holes are punctured in the subchondral bone surface to allow bone 
marrow to bleed into the prepared site. Microfracture results in tissue growth which, over 
time, forms cartilage ‘tufts’ and eventually fibrocartilage that is believed not to be as 
mechanically robust as hyaline cartilage (Richardson 2015). 
Autologous chondrocyte implantation (ACI) is a technique requiring two surgical procedures. 
The first includes removal of healthy cartilage from a non-load bearing region. Chondrocytes 
are isolated from this tissue and expanded in-vitro in a highly controlled good manufacturing 
practice (GMP) facility. Following up to two months of cell expansion, the second surgery 
involves preparation of the defect site removing defective tissue. A membrane is then sutured 
in place and sealed using fibrin glue forming a cavity into which the chondrocytes are injected 
(Richardson 2015). 
A similar procedure to ACI called matrix-assisted autologous chondrocyte implantation (MACI) 
is currently being trialled however, ongoing results have demonstrated little difference 
between the two methodologies (Richardson 2015). 
Recent efforts have been made using bioresorbable scaffolds, particularly aimed at larger 
defects, to maintain mechanical stability and functionality of the articulating joint surface. 
These scaffolds are designed to encourage host cells to regenerate and replace the material 
using natural reparative processes. Current clinical trials are taking place to investigate the 
potential for a number of artificial osteochondral scaffold (Nukavarapu & Dorcemus 2013). 
The foreseeable advances in the repair of osteochondral lesions are likely to include a mixture 
of current surgical, material and cellular therapies.
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Chapter 3 – Materials and Methods 
3.1  Materials 
Materials used in the following methods were purchased from Sigma Aldrich Co. (St. Louis, 
USA) unless otherwise stated. 
3.2  General laboratory procedure 
All laboratory procedures were carried out in accordance with University of Newcastle safety 
policy and publications. All experimental processes were performed subsequent to full risk 
assessment form and in compliance with Control of Substances Hazardous to Health 
regulations (COSHH). This comprises assessment covering the use, storage, disposal and 
general protection of staff and students. All laboratory work was carried out in compliance 
with the ‘University Safety Policy’ and the ‘Departmental Safety Policy’. Biological agents were 
used in compliance with university safety office (USO) regulations for containment of class II 
pathogens. All solutions were made using distilled water as a solvent unless stated otherwise. 
3.3  Materials and analysis 
A range of analytical techniques were employed to assess a variety of materials from ceramic 
powder to polymers and polymer ceramic composites. 
Poly (lactic acid) 
Poly (lactic acid) (PLA) filament 3mm diameter was requisitioned from NatureWorks LLC 
(Ingeo 4032D) with 60-68%L/40-32% D isomers and with relative viscosity 4.0. The molecular 
weight was 156,651 Dalton according to gas phase chromatography data performed by a 
fellow student. The use of this polymer allows for the processing parameters of various 
methods to be optimised at a fraction of the cost. This grade of polymer would not be used 
clinically due to the lack of characterisation with regards to its degradation. As a material 
substrate for in-vitro assessment (21 days), it can be argued that overall surface chemistry 
would be similar to that of medical grade PLLA or PDLA. 
Fourier transformed infrared spectroscopy (FTIR)  
Attenuated total reflection (ATR) is a sampling technique used in conjunction with infrared 
spectroscopy which enables samples to be examined directly. 
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Solid material samples were analysed using an ATR-FTIR Perkin Elmer Spectrum 100 with 
PerkinElmer’s Spectrum™ v6 FT-IR software. Spectra were collected by first cleaning the 
diamond/ZnSe crystal surface with acetone or 100% ethanol before and after use. The 
machine is first calibrated to background noise prior to data collection. Material samples were 
then loaded onto the detection area (enough to cover the surface with no more than a few 
millimetres thickness) and locked in place using the pressure arm. Spectra were then recorded 
from start 4000 cm-1 to 650 cm-1 with a resolution of 4 cm-1 and a minimum of 32 scans per 
sample. 
Transmission electron microscopy (TEM) 
Transmission electron microscopy (TEM) is a technique used to visualise the two-dimensional 
silhouette of a material obstructing a focused beam of electrons. TEM has a higher resolving 
power than optical microscopes permitting the visualisation of nanoscale features. 
Copper grids were first coated with pioloform. Pioloform was prepared to 0.5% solution in 
trichloromethane (TCM) (C2432). A glass slide was coated in Pioloform and allowed to dry for 
1 minute. The Pioloform was then lifted from the glass into a water tank. Copper grids were 
then positioned on top of the floating film and were collected using parafilm. Coated grids 
were then stored in a clean petri dish and plasma cleaned in a vacuum for 5 minutes using a 
Plasma Cleaner PDC 32G (HARRICK PLASMA ltd., Ithaca, New York, USA) prior to use. 
Powder samples were prepared by diluting particles in solvent (ethanol) to approximately 1-5 
mg/mL (or almost fully translucent, concentration not crucial). The sample solutions were 
then ultrasonically agitated for a minimum of 10 minutes using a USC 300TH Ultrasonic 
Cleaner (VWR International LLC., Radnor, Pennsylvania, USA). 
Material samples were embedded for sectioning in 100% epoxy resin (TAAB Labs, 
Aldermaston, Berks) at 60°C for 24 hours. Ultrathin sections of approximately 70 nm were cut 
using a diamond knife on a RMC MT-XL ultramicrotome (Boeckeler Instruments Inc., Tucson, 
Arizona, USA). Sections were then stretched using TCM to eliminate compression and 
mounted on Pioloform-filmed copper grids.  
Prepared grids were examined using a Phillips CM100 Compustage (FEI) transmission electron 
microscope (1000 kV). Digital images were collected using an AMT CCD camera (Deben, Ltd, 
Suffolk, UK) at the Electron Microscopy Research Services, Newcastle University, UK.  
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Scanning electron microscopy (SEM) & energy dispersive X-ray spectroscopy 
(EDX) 
All biological samples were prepared for scanning electron microscopy (SEM) by a chemical 
drying procedure and subsequent gold coating. Initially culture medium was aspirated and 
samples were washed three times in PBS (17-516F, Lonza, UK). Samples were then fixed using 
2.5% glutaldehyde for 30 minutes at 4°C. Samples were washed again with PBS and 
dehydrated using graded ethanol (25%, 50%, 75% and 100%) 5 minutes in each. Samples were 
then treated with hexamethyldisloxane (HMDS) diluted to graded concentrations using 100% 
ethanol. Samples were immersed in 25%, 50%, 75% and 100% HMDS for 10 minutes each and 
finally kept in 100% HMDS overnight to evaporate. The dry biological and non-biological 
samples were preserved in a desiccator with silica beads pending gold coating. 
All samples were mounted onto aluminium stubs with sticky carbon discs. Gold coating was 
performed when necessary using a polaron SEM coating unit (Quorum Technologies, Sussex, 
UK) to a thickness of 15nm least otherwise stated. 
Samples were examined using a Cambridge stereoscan 240 scanning electron microscope, 
housed within the Catherin Cookson building, Faculty of Medical Sciences, Electron 
Microscopy Research Services at Newcastle University. Digital images were collected using 
Orion6.60.6 software (1000 kV and Mode). 
Samples for EDX analysis were prepared by sticking powder to carbon tape (Elektron 
Technologies, AGG3939B). Samples were examined using either a Hitachi TM3030 analytical 
benchtop SEM. Calcium to phosphate ratios were measured using energy dispersive X-ray 
spectroscopy, values were processed by NEXUS services, School of Mechanical Systems 
Engineering, Stephenson building, Newcastle University. 
3.4  Ethics 
Donated tissue was collected via the Newcastle Bone and Joint Biobank 09/H0906/72. Ethical 
approval for the use of consented patient tissue was attained through the NHS National 
Research Ethics Service within the National Patient Safety Agency and Research Ethics 
Committees in England. Research numbers were designated to isolated cell samples to ensure 
patient anonymity. 
  
Chapter 3 
65 | P a g e  
 
3.5  Cell Culture 
Cell culture is the process by which isolated cell types are cultivated ex-vivo in controlled 
conditions outside of their natural environment. Specific cell types are adherent to certain 
substrates and can be propagated to form a monolayer which can be subcultured to expand 
the cell population. To achieve this the medium in which they are grown in should contain 
necessary components, these include specific osmolality, pH, essential minerals, vitamins and 
growth factors, glucose and oxygen dissolution. 
“Tissue culture treated” plastics have since replaced glass substrates as disposable cultivation 
surfaces for adherent tissue culture. The process involves corona discharge/gas-plasma to add 
oxygen containing chemical groups or to open benzene rings on the polymer surface to 
enhance protein interaction. Tissue culture substrates were purchased from coring plc. (New 
York, USA), unless otherwise stated. 
Dulbecco’s modified eagle medium (DMEM) developed by Harry Eagle during the 1970s 
contains a mixture of: amino acids, salts, calcium chloride, potassium chloride, magnesium 
sulphate, sodium chloride, monosodium phosphate, glucose, vitamins folic acid, nicotinamide, 
riboflavin, vitamin B-12 and phenol red. Medium is supplemented with fresh foetal bovine 
serum (FBS), L-glutamine/glutaMAX™ (Life Technologies) and penicillin/streptomycin. FBS 
contains essential growth factors and proteins for cell adhesion and proliferation. Glutamine 
is necessary for cell metabolism as well as protein and nucleic acid synthesis. 
Penicillin/streptomycin is added to help avoid unwanted bacterial and fungal contamination. 
Aseptic technique was used throughout any cell culture procedures using a class II 
microbiological safety cabinet (Contained Air Solutions Ltd, Manchester, UK). Solutions and 
reagents were either purchased sterile and endotoxin free or sterilised according to section 
3.5.2 . All liquids that came in contact with cells during cultivation were pre-warmed to 37oC 
using a Clifton unstirred thermostatic bath (NE1-8, Nickle – Electro Ltd., Western-super-Mare, 
UK) unless otherwise stated. 
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Medium and Supplements 
Medium name Medium 
Phosphate Buffered Saline (PBS) 
PBS without Ca++, Mg++ or phenol red (17-
516F, Lonza, UK) 
hMSC medium / Basal medium 
DMEM 1000 mg/mL glucose (D5523), 10% 
v/v FBS (F9665, batch 062M3397), 
penicillin/streptomycin 1,000 U/mL and 20 
mM GlutaMAX™ (15140 & 35050, Invitrogen-
Gibco, UK). 
Transportation buffer 
Hank’s buffered salt saline with phenol red 
without Ca and Mg (BE10-543F, Lonza Group 
Ltd, Basel, Switzerland), 
penicillin/streptomycin 1,000 U/mL and 
nystatin suspension 1,000 unit/mL (N1638). 
Osteogenic medium 
100 nm Dexamethasone, 10 mM /β 
Glycerophosphate disodium salt hydrate 
(G9422), 50 μg/mL L-Ascorbic acid (A4544). 
Chondrogenic medium 
hMSC media, 40 μg/mL Proline (P5607), 10 
ng/mL TGFβ-3 (PHG9305, Life-Technologies, 
UK) and 1X ITS™+ premix (Insulin, Transferrin 
and Selenous acid) (354352, BD Biosciences, 
New Jersey, USA). 
Adipogenic induction medium 
hMSC media, 25 ng/mL h-insulin (I2643), 0.5 
mM IBMX (3-isobutyl-1-methylxanthine) 
(I5879), 15 μM IGF-1 (insulin-like growth 
factor 1) (R&D Systems, Inc., USA), 40 nM 
Dexamethasone (D4902), 2 nM Rosiglitazone 
(R2408) and 60 μM Indomethacin (I7378). 
Table 3-1: Cell culture medium formulations. 
Table 3-1 outlines media used for tissue culture passaging and experimentation.   
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Sterilisation 
Liquids and equipment were sterilised prior to use in tissue culture using an Astell (UK) steam-
air autoclave with a sterilisation cycle including a peak temperature of 121oC with 1.037 
pressure bar for 30 minutes. 
Temperature sensitive liquids were sterilised by filtration. 1 mL – 50 mL volumes were filtered 
using an appropriate sterile syringe and a Millex-GP filter unit, 0.22 μm, polysulfone, 33mm, 
gamma-sterilised adapter (SLGP033RK, EMD Millipore™, MA, USA). Volumes exceeding 50 mL 
were filtered using a Steritop-GP® filter unit, 0.22 μm, polyethersulfone, 250 mL radio-
sterilised (SCGPU02RE, EMD Millipore™, MA, USA) attached to a vacuum pump. 
Materials were sterilised using a UV Steristorm 2537å (Coast-Air, London, UK) lamp for 30 
minutes in a class II safety cabinet. More complex three dimensional materials were first 
soaked in 70% ethanol for 1 hour and washed three times with PBS prior to cell seeding.  
Chapter 3 
68 | P a g e  
 
hMSC Isolation 
hMSC were isolated from donated femoral heads from arthroplastic surgery. Femoral heads 
from arthroplasty were stored at 4oC and collected twice daily, from the Freeman hospital, 
Newcastle, UK. The donated tissue was transported in sterile 500 mL containers containing 
transportation buffer. This was packaged with absorbent tissue, autoclavable polyethylene 
biohazard bag within a sealed plastic container with strap. 
       
Figure 3-1: Images of patient femoral head following hip arthroplasty. A) Femoral head 
showing exposed bone and remains of cartilaginous covering. B) Bone marrow cavity 
located within the neck of the femoral head. 
In a class II microbiological safety cabinet the femoral head was examined and held using a 
chainmail gloved hand. Debris of connective tissue was first removed from the cancellous 
bone region at the neck of the femoral head. A bone cutter was then used to mechanically 
homogenise and extract cancellous bone fragments into a universal tube containing 10 mL 
PBS. The bone and PBS was mixed to liberate free bone marrow; this solution was then filtered 
using a cell strainer to remove bone fragments. The washed bone marrow solution was then 
separated (figure 3-2A) using an equal volume of Ficoll-Paque PREMIUM (GE Healthcare Life 
Sciences, Buckinghamshire, UK) and centrifuged in a Sigma 2-6E centrifuge at 800g for 40 
minutes at 4oC figure 3-2. A P1000 pipette was used to carefully extract the buffy layer 
containing the mononuclear cells (MNC’s). This was washed twice using a 0.2% BSA, PBS, 
without Ca/Mg, 0.5 mM EDTA solution and centrifuged at 300 g for 10 minutes to remove any 
A B 
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contaminating Ficoll-Paque. The pellet was then suspended in hMSC media and transferred to 
adhere in a T-75 flask. After 2 days the remained non adherent cells were removed and fresh 
media was added. This process was repeated until the flask was confluent. If the cell density 
was too high in any specific regions throughout the flask, the cells were lifted via trypsinisation 
and seeded into the same flask. Cells were grown to ~70% confluence before passaging into 
P1. 
                 
Figure 3-2: Examples of washed bone marrow solution (top) separated using a ficol gradient 
(bottom). Before (A) and following centrifugation (B). 1 = lipids, 2 =less dense nucleated cells, 
3 = buffy coat, 4 = ficoll-Paque, 5 = pelleted non-nucleated cells.  
hMSC Culture 
The hMSC were subcultured upon reaching ~70% confluence. hMSC media was aspirated and 
the flask was washed using PBS 2.5 mL/25 cm2 to remove traces of serum. 0.5 mL/25 cm2 of 
0.05% trypsin-EDTA (1x) (Life-Technologies, UK) was added and the flask was incubated on a 
level surface at 37oC, in humidified atmosphere for 2-4 minutes (depending on cell 
morphology). hMSC media was used to inactivate the trypsin, an aliquot was obtained for a 
cell count and the remaining cell suspension was centrifuged at 200g for 5 minutes. Cells were 
counted within the 5-minute centrifugation period to minimise time spent outside incubation 
conditions. The supernatant was aspirated and the pellet suspended in a volume of hMSC 
media appropriate for seeding at a specific density or divided to subculture at one third (1/3) 
the density of confluence. Cells were fed with fresh hMSC media every 3-4 days with the 
addition of 10 ng/mL bFGF from passage one. 
Notes: Prolonged incubation with trypsin will damage cell membranes and induce cell death. 
  
1 
2 
3 
4 
5 
A B 
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Cell line 
number 
hTERT 
Immortalised 
Primary 
cell line 
Date of 
isolation 
Patient 
sex 
Patient 
age 
Source 
Y201 Yes Yes - ? ? THR 
Lonza No Yes - ? ? BM-Asp 
3070 No Yes 26/02/2013 F 70 THR 
3175 No Yes 25/06/2013 F 66 THR 
3286 No Yes 23/10/2013 F 79 THR 
3287 No Yes 23/10/2013 F 57 THR 
3303 No Yes 05/11/2013 F 61 THR 
3388 No Yes 05/02/2014 F 56 THR 
3502 No Yes 21/05/2014 F 73 THR 
3503 No Yes 21/05/2014 F 61 THR 
3505 No Yes 22/05/2014 F 60 THR 
Table 3-2: hMSC information and details of isolation and patient information. Total hip 
replacement (THR). Bone marrow aspirate (BM-Asp). Human telomerase reverse 
transcriptase (hTERT) modified immortalised cell line. 
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Cryopreservation and retrieval  
Cells were cultured to confluence in cell culture flasks 25, 75, 225 cm2. Upon ~70% confluence 
cells were detached from tissue culture plastic substrate using 0.05% trypsin-EDTA (Life-
Technologies, UK) centrifuged at 200g. Cells were suspended in freezing medium containing 
10% v/v DMSO in FBS and kept on ice. The cell suspension was then transferred into 
cryopreservation tubes (Coring) and transferred into an insulated container for initial freezing 
at -80oC for 5 days. Cryotubes were later relocated into a liquid-nitrogen storage unit -196oC 
for up to 5 years. 
Cells were retrieved from cryogenic storage by quickly thawing the cryotube in a 37oC water 
bath until it is half liquid. The liquid was then suspended in fresh media and seeded into a cell 
culture flash. After 24 hours the diluted cryopreservation media was replaced with fresh 
media and cells were cultured as described above. 
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3.6  Biological Analysis 
Analysis of biological material is necessary to determine the status of cells under a variety of 
parameters. In this thesis the influence of material surfaces and matrices were investigated 
in-vitro to determine their potential for tissue regeneration. 
Cell Counting 
Cells were counted using a Fuchs-Rosenthal haemocytometer (Marienfeld, Lauda-
Königshofen, Germany) with a depth of 0.200 mm. Cells collected from trypsinisation were 
homogenised using a pipette. A 20μl sample was taken from the cell suspension and applied 
to the haemocytometer to fill the viewing chamber via capillary action. 5 or more 1 mm2 areas 
were counted and the average is then divided by two and multiplied by the dilution volume 
to provide total cell number 𝒙 x 104. Cells were viewed using a Leica DMIL (Leica microsystems, 
Wetzlar, Germany) inverted light microscope with phase contrast filters. 
 
Figure 3-3: Dimensions and layout of a Fuchs-Rosenthal haemocytometer.  
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Biochemical assays 
Biochemical assays were employed for qualitative and quantitative assessment of cellular 
responses to materials. 
3.6.2.1 Alkaline Phosphatase Activity  
Alkaline phosphatase (ALP) of cells cultivated on material substrates was evaluated with 
methods similar to that of Jaiswal et al. (1997). Cells were seeded at ~100% confluence 
100,000 cells/well in a 24 well plate for 7, 14 and 21 days. 
At each time point media was removed from samples and incubated with 4% 
paraformaldehyde in PBS for 20 minutes at room temperature. Cells were then washed with 
PBS and incubated with PBS 0.1M TRIS buffer pH 8.3 for 10 minutes. Samples were incubated 
in the dark at room temperature with 300 μL p-nitrophenyl phosphate (pNPP) liquid substrate 
system (N7653) for 5-30 minutes (time was noted). The solution was then transferred into 96 
well plate and absorbance was measured at a wavelength of 405 nm using a Tecan plate 
reader. A calibration curve was used to determine pNPP concentration relative to absorbance 
(Appendix 8.6.3 ). Average pNPP conversion rate/well was presented when average cell 
number was not possible. 
3.6.2.2 Cell Viability 
The tetrazolium reduction assays were used to detect cellular viability of cells following 
cultivation on various substrates. The exact cellular mechanism of tetrazolium reduction is not 
fully understood, however it is thought to be involved with reducing molecules like 
nicotinamide adenosine dinucleotide (NADH) and potentially specific enzymes in the 
mitochondria capable of transferring electrons to MTT. 
Two fundamentally different tetrazolium compounds have been used; (1) MTT is positively 
charged and contains (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) which 
readily penetrates viable eukaryotic cells. (2) MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt; MTS] is negatively 
charged and requires an electron coupling reagent (Phenzein ethosulfate; PES) to transfer 
electrons from the cell cytoplasm to facilitate the reduction. The main divergence between 
these two compounds is that MTT forms an insoluble precipitate inside which requires 
solubilisation using prior to absorbance reading and whereas MTS forms a soluble formazan 
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coloured solution. Ergo the MTS assay can be used consecutively while the MTT assay is an 
end point assay. 
Prolonged exposure of cells to tetrazolium compounds results in cytotoxicity due to depletion 
of reducing equivalents such as NADH from the cell. Therefore, it is important to balance assay 
sensitivity and potential cytotoxicity with incubation time. Calibration of MTT was performed 
to quantify cell number however it is widely accepted that this assay assumes homogeneous 
cellular metabolism, which accounts for potential changes in cell phenotype from substrate 
interaction (Riss et al. 2013). 
For 2D proliferation experiments cells were seeded on 13 mm coverslips with various 
materials at 10,000 cells/well in a 24 well plate. MTT (M5655) solution was prepared to 0.5 
mg/mL in hMSC media and filter sterilised prior to use. Samples were incubated with 1 mL of 
MTT solution at 37oC, in a 5% CO2 and humidified atmosphere for 2 hours. Samples were 
washed using PBS and 300 μl of DMSO (D4540) applied to lyse the cells and dissolve formazan 
crystals. 200 μl of DMSO lysate was transferred into a flat bottomed 96-plate and absorbance 
was measured using a TECAN sunrise-basic plate reader (Austria, GmbH) at an absorbance of 
570 nm. 
Histology 
Samples were prepared for histology by first fixing in warmed (37oC) 4% w/v 
paraformaldehyde (P6148) or 10% formalin solution - neutral buffered (HT501128) for 20 
minutes or overnight at 4oC. Samples were then stored in 70% ethanol/water solution at 4oC 
before sectioning. 
Samples requiring sectioning were delivered to the Newcastle Centre Biobank (NCB) for 
embedding tissue in paraffin blocks. Blocks were sectioned by Mrs. Sharon Watson at the 
Musculoskeletal Research Group (MRG), Institute of Cellular Medicine (ICM), Newcastle 
University. 
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3.6.3.1 Trilineage differentiation of human mesenchymal stem cells 
Human hMSC were prepared for adipogenic and osteogenic differentiation with the same 
methodology. Cells were cultured to confluence in a 75 cm2 flask. Upon confluence cells were 
raised from tissue culture plastic substrate using 0.05% trypsin-EDTA (Life-Technologies, UK) 
centrifuged at 200g. The pellet was suspended into a volume to provide a confluent cell 
number in a 24 well plate (surface area = 1.9 cm2 (39.45 mL)). Supplements for each type of 
differentiation media is found in (table 3-1) 
Oil red O staining was performed on hMSC following 14 days cultivation with adipogenic 
medium. 13 mm slides were incubated with 60% isopropanol diluted in PBS for 5 minutes prior 
to staining. 200 μL working oil red O solution was added to each sample for 10 minutes. Excess 
oil red O solution was removed and samples washed in 60% isopropanol. Samples were then 
rinsed in distilled water before mounting on microscope slides using VECTASHIELD® mounting 
medium (Vector Laboratories Ltd., H-1000) and covered with a coverslip. Samples were 
imaged directly after staining. 
Von Kossa staining was performed on hMSC following 14-day incubation with osteogenic 
medium. Samples were first washed in dH2O three times. Samples were incubated with 1% 
silver nitrate solution (1g silver nitrate in 100 mL dH2O) in a 24 well plate under a UV Steristorm 
2537å (Coast-Air, London, UK) for 20 minutes. Samples were washed three times in dH2O. 
Unreacted silver was removed using 5% sodium thiosulphate (5g sodium thiosulphate in 100 
mL dH2O) for 5 minutes and washed in dH2O. Samples were mounted on microscope slides 
using VECTASHIELD® mounting medium (Vector Laboratories Ltd., H-1000) and covered with 
a coverslip. Samples were imaged directly after staining. 
Chondrogenic differentiation measured using hMSC pelleted in a V-well 96-well plate at a 
density of 200,000 cells/well. Following 14 days incubation with chondrogenic medium 
samples were removed and prepared for histology according to methods outlined in section 
3.6.3 Alcian blue staining was performed by first deparaffinising slides using xylene followed 
by rehydration in graded ethanol to dH2O. Samples were incubated with alcian blue solution 
(alcian blue 8GX 1g and 3% acetic acid solution 100 mL [pH 2.5 was attained using acetic acid]). 
Samples were washed in tap water and rinsed in dH2O. Samples were counterstained using 
0.1% nuclear fast red solution (0.1 g nuclear fast red, 5 g aluminium sulphate and 100 mL 
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dH2O). Samples were washed in tap water and dehydrated through grade ethanol. Samples 
were moved into xylene and a coverslip was mounted using DPX mounting medium (44581). 
Immunofluorescence 
For morphological evaluation cells were seeded 10,000 cells/well in a 24 well plate. Samples 
were incubated with the substrates for 24 hours at 37oC with a 5% CO2 atmosphere. Samples 
were prepared for immunofluorescent labelling by fixation in warmed (37oC) 4% w/v 
paraformaldehyde (P6148) for 20 minutes. Samples were then washed in 0.1% v/v Tween20® 
(P2287) PBS for 5 minutes and incubated with phalloidin–tetramethylrhodamine B 
isothiocyanate (P1951) (rhodamine phalloidin) 1:1000 dilution in 0.1% Tween20® PBS. 
Samples were then rinsed in PBS before mounting on microscope slides using VECTASHIELD® 
mounting medium (Vector Laboratories Ltd., H-1000) and covered with a coverslip. 
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RT-PCR Gene Expression 
3.6.5.1 TRIzol® RNA Isolation 
RNA isolation was performed in a chemical safety cabinet using TRIzol® reagent (15596-018, 
Life-Technologies, UK). For 2D cultures TRIzol® lysates were prepared by first removing growth 
medium and adding 1 mL of TRIzol®. Lysation was assisted using a p1000 pipette and 
transferred into a 1.5 mL Eppendorf. RNA was isolated from TRIzol® lysates by adding 200 μL 
TCM (C2432) and shaking for 15 seconds. Samples were centrifuged in a Fisher-Scientific 
micro-centrifuge AccuSpin Micro 17 (Fisher Scientific, UK) at 13,000 rpm (16,200g) for 15 
minutes. 
 
Figure 3-4: Trichloromethane separated TRIzol® lysate following centrifugation. Labels 
denote phases and contents. 
Eppendorf’s were carefully removed from the centrifuge and the aqueous phase was 
transferred into a fresh 1.5 mL Eppendorf. 500 μL of 100% isopropanol was added to the 
supernatant and incubated at room temperature for 10 minutes to precipitate the RNA. 
Samples were centrifuged for 15 minutes at 13,000 rpm with aligned hinges to pellet the RNA 
in the Eppendorf’s. Supernatant was removed and pellet was washed with 1 mL of 70% 
ethanol and centrifuged for 15 minutes at 13,000 rpm. Supernatant was removed and pellet 
was allowed to air dry upside down on a clean surface. Pellet was suspended in 15 μL RNase-
free water, Eppendorf’s were incubated in a water bath for 10 minutes at 65oC to aid pellet 
resuspension. Eppendorf’s were then cooled on ice for 5 minutes to condense the RNA-water 
suspension and ‘pulse’ centrifuged for 5 seconds to collect the sample at the bottom of the 
tube. RNA was stored at -80oC thereafter.  
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3.6.5.2 Complementary DNA synthesis 
Complementary DNA (cDNA) synthesis is a technique used to convert mRNA into cDNA using 
reverse transcriptase and DNA polymerase enzymes.  Sample RNA was first thawed and 1 μg 
added into a 0.2 mL RNase-free Eppendorf tube. 4 μL of mix 1 (table 3-3) was added to each 
sample and tubes were incubated at 70oC for 5 minutes using a PTC-200 Peltier thermal cycler 
with 96-well alpha unit block assembly (MJ Research, Minnesota, USA). Tubes were cooled on 
ice for 2 minutes and briefly centrifuged to pool the condensate. 8 μL of mix 2 (table 3-3) was 
added to each sample to make a final volume of 20 μL. The tubes were then incubated at 37oC 
for 50 minutes and at 70oC for 15 minutes. cDNA was stored at -20oC. cDNA samples were 
then diluted to 50 μL with DPEC-treated water. 
Mix 
number 
Reagent 
Volume/sample 
(μL) 
Mix 1 
20 ng/μL – Random 
hexamers 
1 
10 mM – dNTP mix 3 
Mix 2 
5X – First strand buffer 4 
0.1 M – DTT 0.125 
40 U/mL – RNaseOUT™ 0.1 
MMLV 0.5 
DPEC-treated water 1.375 
Table 3-3: Reagent mixtures for complementary DNA synthesis 
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3.6.5.3 Real Time – Polymer Chain Replication 
2 μL of sample cDNA was added to into a 96 well clear MicroAmp® Optical 96-well reaction 
plate (Applied Biosystems, Life Technologies, I02N4Q).  8μL of 3’ and 5’ primer mixtures 
reaction plate (containing 1 mM/μL in DPEC-treated H2O water) were added to the sample 
DNA for each gene. 10μL SYBR Green PCR Master Mix (Life-Technologies, 4309155) advantage 
reagent was added to every well and the plate was centrifuged using a Megafuge40 
(Heraeus™, Frankfurt, Germany) centrifuge to remove and bubbles from the liquid. The 
reaction plate was loaded into an Applied Biosystems Real-Time PCR instrument (model: 
7900HT, serial: 201456) and the appropriate method was selected on SDS2 (Applied 
Biosystems) software. 
The method consisted of 3 stages: 
1. Holding stage consisted of 50oC for 2 minutes and 95oC for 10 minutes.  
2. Cycling steps included 95oC for 15 seconds and 60oC for 1 minute for 40 cycles. 
3. Dissociation stage 95oC for 15 seconds, 60oC for 15 seconds and 95oC for 15 seconds. 
A dissociation stage was added following the cycling stage to determine that the correct 
amplicon was detected. SYBR green amplifies any double stranded DNA so it is important to 
assess the end products.  
Human gene Primer sequence sense/antisense Reference 
Internal control   
GAPDH 
CTCTGCTCCTCCTGTTCGACA 
(Yang et al. 2011)  
ACGACCAAATCCGTTGACTC 
Osteogenic markers 
T2 Runx2 
GGTTAATCTCCGCAGGTCAC 
(Yang et al. 2011)   
GTCACTGTGCTGAAGAGGCT 
OPN 
TTTTCTGGATCCTCCATTGC 
(Yang et al. 2011)   
CAAAAGCCATATGCTGCTCA 
COL 1A1 
ATGCCTGGTGAACGTGGT 
(Sarugaser et al. 2009) 
AGGAGAGCCATCAGCACCT 
Table 3-4: Human gene primer sequences  
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3.7  Microscopy 
Cell culture progression was assessed using a Leica DMIL inverted light microscope with phase 
contrast filters. The resolution of transmission optical microscopes is limited due to the 
wavelength of light (λ) used and the refractive properties of the objective lens and the 
numerical aperture. 
Cells were visualised using a Leica DM4000 B with a Leica EL6000 external light source for 
fluorescence excitation. Images were captured using a Leica DF310 FX camera and processed 
using the Leica application suite advanced fluorescence 3.1.0 build 8587 software (Leica 
microsystems, Wetzlar, Germany). 
3.8  Image Analysis 
ImageJ is a free software used for a variety of post-image processing applications. ImageJ was 
used to determine the shape factor circularity, a function of the perimeter P and the area A.  
𝑓𝑐𝑖𝑟𝑐 =
4𝜋. 𝐴
𝑃2
 
Equation 3-1: ImageJ shape factor calculation. 
TIFF images (A) were first colour stacked to separate RBG channels (imagecolorsplit 
channels). The red stack (stained actin) was used for morphological assessment (*B). The red 
image was first inverted (ctrl+shit+i) (C), cells at the periphery of the image were removed 
gating cells of interest and removing the outside (“clear outside”) (*D). Joined cells were then 
separated using the polygon tool to move cells to a free area (ctrl+x, ctrl+v) (*D). The cut cell 
area where cells were clearly overlapping was filled using the polygon tool (ctrl+f) (*D). A 
threshold (*E) was applied to each image to yield a solid black and white image (*F) for particle 
analysis. ROI manager was used to determine correct identification and analysis of single cells 
(*G) (*figure 3-5).  
Following data collection 60 cells were randomly selected from the data set using Microsoft 
Excel 2013. This was achieved by generating a random number from 0-1 using “=rand()” for 
each data point. The data set was then indexed and ranked to 60 according to the randomly 
assigned number using the formula “=index(“random number range”,rank(“data range”))”. 
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Figure 3-5: Example of image processing using ImageJ. A) RBG image, B) Red colour 
separated, C) B inverted, D) removal of peripheral cells and cell separation, E) thresholding, 
F) black and white image and G) analysis of particles and result output. 
A B 
C D 
E F 
G 
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3.9  Statistical analysis 
Data collected were first processed and formatted using Microsoft Excel 2013. Statistical data 
analysis was performed using both Minitab 16® and GraphPad Prism 5®. Anderson-Darling test 
was used to assess normality prior to statistical evaluation. One-way analysis of variance 
(ANOVA) were performed using a Tukey’s HSD post-hoc test, two-way ANOVAs were 
performed when possible to determine variation between data sets.  For missing values in a 
two and one-way ANOVA GraphPad Prism5® calculates the type III sum-of-squares using three 
times multiple regression (Glantz & Slinker 1990).  
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Chapter 4 – Sol-gel Synthesis and Characterisation of 
Hydroxyapatite Nanoparticles 
4.1  Introduction 
This chapter first aims to investigate key parameters influencing HAp crystal characteristics 
using a low temperature sol-gel synthesis technique. Key parameters include titration addition 
methodology, component addition rate and reaction vessel pH. Using the identified 
parameters, the aim is to tailor the sol-gel method to produce HAp crystals with specific 
characteristics. A variety of material characterisation techniques will be used to help 
characterise the physical properties of the HAp nanoparticles. The cytotoxicity of the HAp will 
be evaluated using an in-vitro viability assay with patient derived hMSC. 
The aforementioned parameters were investigated due to the variation that exists throughout 
the literature without pinpointing an optimised procedure for fabricating reliably reproducible 
HAp particles by investigating the interaction on the multiple parameters that could potential 
influence the process. The pH of the reaction system is arguably one of the most critical factors 
governing crystal formation by influencing the organisation of the HAp at the atomic level. The 
availability of Ca2+ and PO43- within the reaction vessel is equally as important as the pH which 
will be influenced by both the method of titration and also the addition rate. 
There are a number of other variables which were not included, of which some have been 
investigated. The mixing of the components by sonication (Utara & Klinkaewnarong 2015), 
temperature (Bouyer et al. 2000), surfactants to govern crystal growth (Iyyappan et al. 2016; 
Wang et al. 2006) and addition of proteins to act as templates for HAp formation (Semino 
2008; Uskoković et al. 2011; Jahromi et al. 2013). 
The aspect ratio of nanoparticles has been linked to a number of important influences on 
optical properties in gold nanoparticles (Link et al. 1999) nanocomposite mechanical 
properties (Fu et al. 2008), cytotoxicity (Murphy et al. 2008) and cellular uptake (Qiu et al. 
2010). 
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4.2  Materials and Methods 
Preparation of Hydroxyapatite 
HAp was prepared using a modified sol-gel similar to those described by other authors (Bakan 
et al. 2013; Jadalannagari et al. 2011; Marković et al. 2011; Yubao et al. 1994; Wang et al. 
2010; Iyyappan et al. 2016; Wang et al. 2007; Kumar et al. 2004; Ramesh et al. 2015; Vázquez-
Hernández et al. 2010; Ha et al. 2015; Huang et al. 2012). Aqueous solutions of CaCl2 200 mM 
(calcium chloride), Na2HPO4 120 mM (sodium phosphate dibasic) and NaOH 50mM (sodium 
hydroxide) were prepared using deionised water. These solutions were stored and used for 
up to 1 week. The precipitation reaction between the calcium and phosphate precursor 
solutions produces acid by-products and pH was controlled by the automated addition of the 
sodium hydroxide solution. Precursor components were titrated at a specific addition rate and 
pH was regulated with the use of the 907 Titrando Metrohm dual burette 800 DOSINO system 
and Tiamo 2.0 software. The order of precursor component additions was also modified to 
investigate method differences in resulting HAp powders. 
 
Figure 4-1: Schematic representation of titration methodologies A, B and C. Method A) 
calcium is titrated into an excess of phosphate. Method B) Phosphate is titrated into an 
excess of calcium. Method C) calcium and phosphate are titrated simultaneously into a 
medium of water.  
A variety of methodologies were generated within the Tiamo 2.0 to investigate differences in 
precipitation parameters on crystal morphology, crystallinity, composition and chemical 
interactions (section Error! Reference source not found.). 
The following is an example procedure for the control HAp titration method (method A, 0.1 
mL/min addition rate and stabilised at pH 10). 50 mL of Na2HPO4 120 mM was loaded into a 
500 mL Pyrex beaker with magnetic stirrer bar. The beaker with solution and magnetic stirrer 
bar was placed on a IKA® C-MAG HS7 hot plate (Staufen, Germany) at stirred at ‘3’. The 800 
Chapter 4 
85 | P a g e  
 
DOSINO burettes and pH meter were fastened in place in the beaker using a retort clamp and 
clamp stand. The Tiamo2.0 software method was then started with following program.  
Set pH 10: pH of the Na2HPO4 120 mM solution was monitored for 30 seconds before NaOH is 
added incrementally with a maximum addition rate of 2.5 mL/min to achieve pH 9.8. Upon 
attainment of pH 9.8 the method waited for 30 seconds to allow for pH drift. The software 
then initiated two protocols 1: maintain pH 10 and 2: dose component. The maintain pH 
protocol aimed to keep the pH of the reaction to pH 10 ± 0.05 for the duration of the titration. 
The dose component was set up to titrate 50 mL of the CaCl2 200 mM solution into the 
Na2HPO4 120 mM reservoir at an addition rate of 0.1 mL/min. The total time taken for the 
titration was 500 minutes or 8 hours 20 minutes. 
Titration parameters 
Calcium phosphates generated using method outlined in section 4.2.1 were titrated using 
different parameters defined in Error! Reference source not found.. The default- control set 
of parameters are described as method A and the other methods contain small alteration in 
one parameter at a time. 
 Titration parameter 
 Method pH 
Rate 
(ml/min) 
Volume 
(mL) 
Time 
(minutes) 
Temperature 
(°C) 
Control A 10 0.1 50 500 25 
4.3.2 Addition Method 
B 10 0.1 50 500 25 
C 10 0.1 50 500 25 
4.3.3 Addition Rate 
A 10 1.0 50 50 25 
A 10 10.0 50 5 25 
4.3.4 Addition pH 
A 9 0.1 50 500 25 
A 8 0.1 50 500 25 
4.3.5 “Tailored HA” A 8 1.0 50 50 25 
Table 4-1: Hydroxyapatite reaction vessel and titration parameters. 
  
Chapter 4 
86 | P a g e  
 
Post-titration processing 
The reaction fluid was dialysed using cellulose dialysis tubing in >1 L dH2O for 72 hours and 
water was replaced every 24 hours. The precipitate was then autoclaved using an Astell (UK) 
steam-air autoclave at 121oC temp and 1.037 bar pressure for 30 minutes. Following the 
precipitate was frozen at -80oC for 24 hours and freeze dried in an ALPHA 1-2 LDplus (Martin 
Christ Freeze Dryers GmbH, UK) for 24 hours at -52oC <0.0005 mbar. The resultant powder 
was stored in a desiccator for subsequent materials analysis and scaffold fabrication. 
X-Ray Diffraction (XRD) 
X-Ray diffraction spectra of hydroxyapatite powders were measured using a PANalytical X’Pert 
Pro MPD and powered by a Phillips PW3040/60 X-ray generator. X-rays were filtered using a 
real time multiple strip technology X’Celerator detector. Diffraction data was acquired by 
exposing powder samples to Cu-Kα X-ray radiation with a characteristic wavelength (λ) of 
1.5418 Ǻ. X-rays were generated using a Cu anode supplied with 40 kV and a current of 40 
mA. 
Data was collected over a ranged of 2 – 80 °2θ with a step size of 0.0334225 °2θ and a nominal 
time per step of 200.025 milliseconds, using the scanning X’Celerator detector. Fixed anti-
scatter and divergence slits of 0.38 mm were used together with a beam mask of 10 mm and 
all scans were carried out in ‘continuous’ mode. 
Phase identification was carried out by means of X’Pert accompanying software program 
PANalyical High Score Plus in conjunction with the ICDD Powder Diffraction File 2 Database 
(1999), ICDD Powder Diffraction File 4 – Minerals (2012), the American Mineralogist Crystal 
Structure Database (March 2010) and the Crystallography Open Database (February 2013; 
www.crysallography.net).  
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Figure 4-2: Highly crystalline hydroxyapatite characteristic XRD line pattern (Rusu et al. 
2005). 
Crystals are regular arrays of atoms and elastic scattering of X-ray from atoms can be used to 
determine crystal planes. These crystal planes lie orthogonal to the reflective angle denoted 
by the miller indices with curved brackets (hkl). These crystal planes lie parallel along an axis 
called the crystal direction and has the same hkl nomenclature as the planes, however is 
denoted by square brackets [hkl]. 
With nanoscale materials the size of a specific direction forming a crystal plane can be 
estimated by using the Scherrer formula. However XRD is sensitive to the size of coherent 
scattering domains which can significantly differ from particle size, with lattice defects or 
amorphous surface layers (Borchert et al. 2005). 
Crystallite size was calculated using Scherrer formula (equation 4-1). The full width at half 
maximum (FWHM) of Si (111) at position 2.8443 °2θ was used to calibrate FWHM peak values 
of hydroxyapatite at (002) (~29.91°2θ) and (110) (~16.84°2θ). 
𝜏 =
𝛫𝜆
𝛽 cos 𝜃
 
Equation 4-1: τ, refers to the mean size of the ordered crystalline domains. Κ, is the shape 
factor, which varies with the actual shape of the crystallite. λ, is the X-Ray wavelength. β, is 
the distance in °2θ at the full width at half maximum (FWHM) of a unique peak. θ, is the 
Bragg angle. 
The crystallite direction at [002] was chosen to allow characterisation of the c-axis length and 
perpendicular ab-axis at [110] of the crystallite direction (Jevtic et al. 2008).  
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Fourier Transformed Infrared Spectroscopy 
FTIR was performed according to materials and methods section 0. Similar to literature 
published by Marković et al. (2011) carbonate vibrational modes have been labelled according 
to their crystal position. A-type carbonate ions refer to CO32- occupying the OH- sites and B-
type, where CO32- ions occupy PO43- sites. 
Cell viability assay (MTT) 
Osteoarthritic patient derived hMSC were isolated from donated femoral heads subsequent 
to total hip replacement surgery (methods section 3.5.3 ). hMSC were seeded into a 48 – well 
plate at 20,000 cells/well and allowed to attach for 24 hours. 
HAp was weighed, washed with 100% ethanol and ultrasonically agitated for 1 hour. The HAp 
ethanol solution was centrifuged at 400g for 5 minutes (to pellet the HAp) and washed with 
PBS, this was repeated three times for each HAp powder to remove any ethanol from the 
solution. hMSC medium was added the HAp pellet to make a 500 mg/mL stock solution, this 
was then serially diluted in hMSC to make the media for the experiment. hMSC media ranging 
from 0 – 500 mg/mL were ultrasonically agitated for 10 minutes prior to their application to 
the pre-seeded 48 well hMSC seeded monolayers. 
Following 24 hours incubation the media was removed and replaced with 0.5 mg/mL MTT 
working solution (see section 3.6  ) for 2 hours. The MTT solution was carefully removed and 
the monolayer washed with PBS. 300 μL of DMSO was added to each well and the plate was 
agitated at room temperature wrapped in aluminium foil for 10 minutes. 200 μL of the 
DMSO/dye was added to a 96 well plate and absorbance was read at 570nm. Results were 
displayed as percentage cell viability relative to control (0 mg/mL HAp = 100%). 
4.3  Results 
HAp synthesised from the parameters shown in table 4-1 were first characterised using a 
variety of techniques to assess the size, morphology, chemical composition and crystallinity 
of the synthesise nanocrystals. As a reference, HAp powder synthesised with method A, at pH 
10, with 0.1 mL/min rate of component addition with standard post processing procedures 
was used as a control. 
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Transmission electron microscopy 
TEM was used throughout the course of this study to observe the morphology of fabricated 
calcium phosphate crystals. Figure 4-3 shows images of the same cluster of HAp with minimal 
and prolonged exposure to electron bombardment at 1000 kV. 
     
Figure 4-3: TEM images of control hydroxyapatite degradation with exposure to electron 
bombardment. A) First image B) 2 minutes, 5 seconds post image A. Images were collected 
on 30/07/2013. A) [13:25:16] & B) [13:27:21]. 
The TEM imaging of HAp particles yielded the loss of graphical definition of individual crystals 
with prolonged observation (figure 4-3). 
  
100 nm 100 nm 
A B 
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Influence of component addition methodology 
This section investigates the influence of component addition method on the variation in 
resultant HAp crystal morphology, crystal size and Ca/P ratio. The influence of section 4.2.1 
methods A, B and C were observed whilst maintaining control pH, and titration rate. Variables 
examined throughout this section are summarised below in table 4-2). 
KEY Method pH 
Rate 
(ml/min) 
Volume 
(mL) 
Time 
(minutes) 
Temperature 
(°C) 
Addition method 
A – Calcium 
↓ 
Phosphate 
10 0.1 50 500 25 
B – Phosphate 
↓ 
Calcium 
10 0.1 50 500 25 
C – Calcium 
+ 
Phosphate 
10 0.1 50 500 25 
Table 4-2: Section key for titration parameters investigating addition methodology.  
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4.3.2.1 Energy-Dispersive X-Ray Spectroscopy 
EDX analysis was used to determine elemental composition and extrapolate 
calcium/phosphate ratio. 
 
Figure 4-4: EDX analysis of titrated hydroxyapatite powders Calcium to Phosphate ratio. (n 
= 3) 
EDX analysis of titration rates shown in figure 4-4 revealed a Ca/P ratio of ~2.0 with no 
significant variation found between HAp synthesised at all titration rates.  
4.3.2.2 Transmission Electron Microscopy  
TEM was used to provide information on HAp crystal morphology to provide an insight into 
how the various methodologies are influencing crystal synthesis. 
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Figure 4-5: Representative TEM images of HAp synthesised with different precipitation rates. 
A) Method A, B) Method B, C) Method C. Images were collected on A) 18/12/12, B & C) 
30/07/13. 
A A1 
B B1 
C1 C 
100 nm 500 nm 
100 nm 500 nm 
100 nm 500 nm 
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Observations from figure 4-5 show subtle variations in crystal morphology throughout the 
different methodologies. The reference nanocrystals (figure 4-5 A) titrated at pH 10, 0.1 
mL/min with titration method A appears to have a rod-like morphology with lengths of 
approximately 50 nm. Crystals formed via method B and C (figure 4-5 B & C) seem to form a 
similar morphology to reference HAp, with apparent heterogeneity in size. 
4.3.2.3 X-Ray Diffraction  
XRD analysis was used to characterise phase composition and crystallinity of the titrated 
calcium phosphate powder.  
 
Figure 4-6: Representative XRD spectra for hydroxyapatite powders synthesised with various 
titration methodologies.  
The XRD patterns (figure 4-6) of the powders synthesised using various addition 
methodologies are labelled with notable crystal planes. The powders demonstrated broad X-
Ray diffraction peaks. No significant diffraction peak was observed at 2θ = 45.5o 
demonstrating removal of NaCl by the wash process. Using Scherer’s formula (equation 4-1) 
from section 4.2.3 average crystal dimensions were calculated to provide quantitative 
information on HAp precipitated with different titration methodologies. 
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Figure 4-7: XRD derived crystallite size calculated using equation 4-1). A & B) Bars show the 
mean ± SEM [002] & [110] crystal direction of HAp synthesised with various titration 
methodologies (n=3). C) Average aspect ratio of the HAp nanoparticles D) 1 x 106 scale 
graphical representation of HAp crystal dimensions.  
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Figure 4-7A displays increased crystal length [002] with dual titration methodology in 
comparison to the alternative single reservoir addition methods with significant differences 
observed in between control. Figure 4-7B shows a significant increase in crystal width in HAp 
titrated with both phosphates into excess calcium and dual titration methodologies in 
comparison with control. HAp aspect ratios demonstrated a range from 1.92 (P  Ca) to 2.8 
(Ca  P), however no significant differences were observed between the groups (figure 4-7 
C).  
Fourier Transformed Infrared Spectroscopy  
FTIR analysis was used to determine influences to molecular groups included in the unit cells 
of the HAp structure. The three HAp powders from the different component addition 
methodologies are shown in figure 4-8.  
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Figure 4-8: FTIR spectrum of dry hydroxyapatite powder. Each line represents the mean of 
three titration samples. Ca  P, P  Ca and Ca + P refer to addition methodologies (A-C 
respectively). A) Full 500-4000 cm-1 stacked spectrums B) narrow scan 1750-1350 cm-1of A. 
B1) spectra from B stacked. C) Narrow scan 1300-750 cm-1 of A, C1) Spectra from C stacked.  
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Figure 4-8(A) shows the FTIR spectrum of the three synthesised HAp powders using various 
titration methodologies. All powders show strong absorption bands that can be attributed to 
HAp: ν3PO43- at 1045 -1092 cm-1 and ν2PO4 at 474 cm-1, ν1PO4 symmetric stretch at 963 cm-1, 
ν4PO4 from 602- 572 cm-1. Absorption peaks at 1415 cm-1 and 1455 cm-1  appeared lower in 
HAp titrated using the dual addition methodology relative to HAp titrated using reservoir 
addition methods.  
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Influence of component addition rate 
Changing the addition rate of titration components is one of the key variables in 
manufacturing large quantities of HAp for biomedical uses. Controlling the component 
addition rate and the reaction pH during the titration is the main advantage of using this 
system, this section characterises HAp synthesised using three titration rates (table 4-3). The 
hypothesis for this section is that titration rate will significantly alter final HAp crystal 
characteristics. Variables examined throughout this section are summarised below in (table 
4-3). 
KEY Method pH 
Rate 
(ml/min) 
Volume 
(mL) 
Time 
(minutes) 
Temperature 
(°C) 
Addition rate 
A – Calcium 
↓ 
Phosphate 
10 0.1 50 5 25 
A – Calcium 
↓ 
Phosphate 
10 1.0 50 50 25 
A – Calcium 
↓ 
Phosphate 
10 10.0 50 500 25 
Table 4-3: Section key for titration parameters investigating component addition rate. 
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4.3.3.1 Energy-Dispersive X-Ray Spectroscopy 
EDX analysis was used to determine elemental composition and extrapolate 
calcium/phosphate ratio. 
 
Figure 4-9: EDX analysis of titrated hydroxyapatite powders Calcium to Phosphate ratio. (n 
= 3). 
EDX analysis of titration rates shown in figure 4-9 revealed a Ca/P ratio of ~2.0 with no 
significant variation found between HAp synthesised at all titration rates.  
4.3.3.2 Transmission Electron Microscopy  
The morphology of HAp titrated at different titration rates was investigated using TEM. A 
summary of the titration parameters for the HAp discussed in this section are outlined in table 
4-3.  
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Figure 4-10: Representative TEM images of HAp synthesised with different precipitation 
rates. A) 0.1 mL/min, B) 1.0 mL/min, C) 10 mL/min. Images were collected on A) 18/12/12, 
B & C) 30/07/13. 
A A1 
B B1 
C1 C 
100 nm 500 nm 
100 nm 500 nm 
100 nm 500 nm 
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Images from figure 4-10 revealed similar rod-like morphologies with HAp titrated at 1 mL/min 
and 10 mL/min compared with control HAp 0.1 mL/min. HAp crystal sizes appear to be larger 
with increased titration rates evident in figure 4-10 B1 and C1. 
4.3.3.3 X-Ray Diffraction  
 
Figure 4-11: Representative XRD spectra for hydroxyapatite powders synthesised with 
various titration rates. 
XRD patterns of HAp synthesised using various component titration rates are displayed with 
labelled notable crystal planes (figure 4-11). The powders demonstrated broad X-Ray 
diffraction peaks. No significant diffraction peak was observed at 2θ = 45.5o demonstrating 
removal of NaCl by the wash process. Using Scherer’s formula (equation 4-1) from section 
4.2.3 average crystal dimensions were calculated to provide quantitative information on HAp 
precipitated with different titration methodologies. 
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Figure 4-12: XRD derived crystallite size calculated using equation 4-1). A & B) Bars show the 
mean ± SEM [002] & [110] crystal direction of hydroxyapatite powder synthesised with 
various titration rates (n=3). C) Average aspect ratio of the HAp nanoparticles D) 1 x 106 
scale graphical representation of HAp crystal dimensions. 
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Average crystallite planes shown in figure 4-12 A & B show variation in HAp dimensions with 
synthesis at different titration rates. Figure 4-12 A shows a significant increase the particle size 
in [002] crystal direction of HAp with 1.0 mL/min titration rate in comparison to control (0.1 
mL/min). No significance was observed in [002] crystal direction of HAp titrated at 10 mL/min 
compared with both 0.1 and 1 mL/min addition rates. Figure 4-12 B shows a significant 
increase in crystal [110] direction in HAp titrated at 1.0 and 10 mL/min compared with control 
(0.1mL/min). HAp aspect ratios demonstrated a range from 2.67 (10 mL/min) to 3.36 (1 
mL/min), however no significant differences were observed between the groups (figure 4-12 
C). 
4.3.3.4 Fourier Transformed Infrared Spectroscopy 
FTIR analysis was used to determine influences to molecular groups included in the unit cells 
of the HAp structure. The three HAp powders from the different titration rates are shown in 
figure 4-13.  
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Figure 4-13: FTIR spectrum of dry hydroxyapatite powder. Each line represents the mean of 
three titration samples. 0.1, 1 and 10 refer to component addition rate in mL/min. [A] Full 
650-4000 cm-1 stacked spectrums [B] narrow scan 1750-1350 cm-1of A. [B1] spectra from [B] 
stacked. [C] Narrow scan 1300-750 cm-1 of [A], [C1] Spectra from [C] stacked. 
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Figure 4-13 A shows the FTIR spectrum of three HAp powders synthesised at different titration 
rates. All powders show similar phosphate absorption bands vibrational bonds ν3PO43- at 
1045-1092 cm-1 and ν2PO4 at 474 cm-1, ν1PO4 symmetric stretch at 963 cm-1, ν4PO4 from 602-
572 cm-1. Broad absorption peaks were observed in HAp titrated at 10 mL/min from ~3100 
cm-1 – ~3600 cm-1 and at ~1650 cm-1 with higher absorption peaks relative to HAp titrated at 
0.1 and 1.0 mL/min. Absorption peaks at 1415 and 1455 cm-1 appeared lower in HAp titrated 
at 1.0 and 10.0 mL/min compared with control.  
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Influence of reaction pH 
The reaction pH of HAp particle synthesis is a fundamental parameter governing HAp 
morphology, ergo reaction pH was varied using methods outlined in section 4.2.1 The 
hypothesis for this section is that titration pH will significantly alter final HAp crystal 
characteristics. A summary of the titration parameters for the HAp discussed in this section 
are outlined in table 4-4. 
KEY 
Method 
pH 
Rate 
(ml/min) 
Volume 
(mL) 
Time 
(minutes) 
Temperature 
(°C) 
Reaction pH 
A – Calcium 
↓ 
Phosphate 
10 0.1 50 500 25 
A – Calcium 
↓ 
Phosphate 
9 0.1 50 500 25 
A – Calcium 
↓ 
Phosphate 
8 0.1 50 500 25 
 
Table 4-4: Section Key of reaction pH variables. 
4.3.4.1 Energy-Dispersive X-Ray Spectroscopy 
EDX analysis was used to determine elemental composition and extrapolate 
calcium/phosphate ratio.  
 
Figure 4-14: EDX analysis of titrated hydroxyapatite powders Calcium to Phosphate ratio. (n 
= 3) 
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EDX analysis of titration rates shown in figure 4-14 revealed a Ca/P ratio of ~2.0 with no 
significant variation found between HAp synthesised at all titration rates.  
4.3.4.2 Transmission Electron Microscopy  
The morphology of HAp titrated at different reaction vessel pH was investigated using TEM.  
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Figure 4-15: Representative TEM images of HAp synthesised with different reaction vessel 
pH. A) pH 10, B) pH 9, C) pH 8. Images were collected on A) 18/12/12, B & C) 30/07/13.  
100 nm 500 nm 
100 nm 500 nm 
100 nm 500 nm 
A A1 
B B1 
C1 C 
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Figure 4-15 illustrates representative images of HAp crystals synthesised under various 
reaction vessel pH. The rod-like morphology of the HAp appears more plate-like with the 
reduction in titration pH from figure 4-15 A-C. Crystal sizes appeared to become more 
heterogeneous in nature with decreased pH titration environments. 
4.3.4.3 X-Ray Diffraction  
 
Figure 4-16: Representative XRD spectra for hydroxyapatite powders synthesised with 
various titration methodologies.  
XRD patterns of HAp synthesised using various component titration rates are displayed with 
labelled notable crystal planes (figure 4-16). The powders demonstrated board X-Ray 
diffraction peaks. No significant diffraction peak was observed at 2θ = 45.5o demonstrating 
removal of NaCl by the wash process. Using Scherer’s formula (equation 4-1) from section 
4.2.3 average crystal dimensions were calculated to provide quantitative information on HAp 
precipitated at different pH. 
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Figure 4-17: XRD derived crystallite size calculated using equation 4-1). A & B) Bars show the 
mean ± SEM [002] & [110] crystal direction of hydroxyapatite powder synthesised with 
various titration pH (n=3). C) Average aspect ratio of the HAp nanoparticles D) 1 x 106 scale 
graphical representation of HAp crystal dimensions.  
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Figure 4-17A shows no significant differences in average [002] crystal direction size in HAp 
titrated at all three pH ranges. [002] crystal direction of HAp titrated at pH 10 was the lowest 
at 45.42 ± 1.46 nm, the largest being HAp titrated at pH 8 at 66.04 ± 7.77 nm. Figure 4-17B 
illustrates a significant increase in HAp [110] crystal direction with decreased titration pH. HAp 
titrated at pH 10 has the smallest [110] crystal direction size of 16.34 ± 1.18 nm with pH 8 
having the largest at 34.05 ± 5.33 nm. HAp aspect ratios demonstrated a range from 2.20 (pH 
8) to 2.80 (pH 10), however no significant differences were observed between the groups 
(figure 4-17 C). 
4.3.4.4 Fourier Transformed Infrared Spectroscopy  
FTIR analysis was used to determine influences to molecular groups included in the unit cells 
of the HAp structure. The three HAp powders synthesised with different reaction pH are 
shown in figure 4-18. 
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Figure 4-18: FTIR spectrum of dry hydroxyapatite powder. Each line represents the mean of 
three titration samples. 8, 9 and 10 refer to the titration pH of the reaction. [A] Full 500-4000 
cm-1 stacked spectrums [B] narrow scan 1750-1350 cm-1of A. [B1] spectra from [B] stacked. 
[C] Narrow scan 1300-750 cm-1 of [A], [C1] Spectra from [C] stacked.  
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Figure 4-18A shows the FTIR spectrum of three HAp powders synthesised with different pH 
conditions. All powders show similar phosphate absorption bands vibrational bonds ν3PO43- 
at 1045-1092 cm-1 and ν2PO4 at 474 cm-1, ν1PO4 symmetric stretch at 963 cm-1, ν4PO4 from 
602-572 cm-1. No significant differences were observed in absorption peaks between the HAp 
synthesised at the three pH conditions.  
Tailoring hydroxyapatite morphology and composition 
To investigate the influence of two parameters on HAp formation, titration conditions were 
specifically combined with an aim to vary in shape and carbonate content. 
The influence of the combination of two factors were investigated to provide insights into any 
interaction between the titration variables. The titration 1 mL/min was selected based on the 
observed increase in [002] crystal direction length relative to the 0.1 mL/min titration rate. pH 
8 was selected as the second variable due to the observed increase in the [002] crystal 
direction length relative the pH 10 control. 
HAp key Rod-Like Plate-Like 
Carbonated A) pH 10 – 0.1 ml/min B) pH 8 – 0.1 ml/min 
Non-carbonated C) pH 10 – 1.0 ml/min D) pH 8 – 1.0 ml/min 
Table 4-5: Hydroxyapatite titration parameters and designated nomenclature.  
4.3.5.1 Energy-Dispersive X-Ray Spectroscopy 
EDX analysis was used to determine elemental composition and extrapolate 
calcium/phosphate ratio.  
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Figure 4-19: EDX analysis of A) rod-like carbonated, B) plate-like carbonated, C) rod-like non-
carbonated and D) plate-like non-carbonated HAp titrated hydroxyapatite powders Calcium 
to Phosphate ratio. (n = 3) 
Figure 4-19 shows a decrease in calcium content incorporated into the HAp lattice when 
synthesised at lower pH with a faster titration rate. HAp A has a Ca/P ratio of 2.01 ± 0.36 
whereas D has a Ca/P ratio of 1.75 ± 0.01. 
4.3.5.2 Transmission Electron Microscopy 
TEM was used to compare qualitative differences in HAp morphology in relation to their 
respective titration methodology.  
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Figure 4-20 shows TEM images form HAp titrated using methodologies outlined in table 4-5. 
Figure 4-20 A-C illustrates HAp discussed in previous sections, figure 4-20 D shows HAp 
synthesised with a combination of two previously investigated parameters. The HAp crystals 
D appear to have a similar morphology to that of A and C.  
4.3.5.3 X-Ray Diffraction  
 
 
Figure 4-21: XRD spectrum of dry hydroxyapatite powder. Each series is a representative 
spectrum from a triplicate titration.  
XRD patterns of HAp synthesised using various component titration rates are displayed with 
labelled notable crystal planes (figure 4-21). The powders demonstrated board X-Ray 
diffraction peaks. No significant diffraction peak was observed at 2θ = 45.5o demonstrating 
removal of NaCl by the wash process. 
Using Scherer’s formula (equation 4-1) from section 4.2.3 average crystal dimensions were 
calculated to provide quantitative information on HAp precipitated at different pH. 
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Figure 4-22: XRD derived crystallite size calculated using equation 4-1). A & B) Bars show the 
mean ± SEM [002] & [110] crystal direction of hydroxyapatite powder synthesised with 
various titration methodologies (n=3). C) Average aspect ratio of the HAp nanoparticles D) 
1 x 106 scale graphical representation of HAp crystal dimensions. 
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Figure 4-22 shows average crystallite size calculated from the XRD data from powders A-D. 
There is a significant difference in average crystallite size between A 45.42 ± 1.46 nm and both 
C & D 88.39 ± 6.81 nm and 88.39 ± 6.80 nm respectively. Both C and D were synthesised using 
1 mL titration rate, which appears to significantly influence the crystal size irrespective of 
titration pH. HAp aspect ratios demonstrated a range from 2.20 (HAp B) to 3.36 (HAp C), 
however no significant differences were observed between the groups. 
4.3.5.4 Fourier Transformed Infrared Spectroscopy  
FTIR analysis was used to determine influences to molecular groups included in the unit cells 
of the HAp structure. The four HAp powders synthesised with various titration methods are 
displayed in figure 4-23. 
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Figure 4-23: FTIR spectrum of dry hydroxyapatite powder. Each line represents the mean of 
three titration samples. A) pH 10, 0.1 mL/min, B) pH 8, 0.1 mL/min, C) pH 10, 1 mL/min and 
D) pH 8, 1 mL/min. [A] Full 500-4000 cm-1 stacked spectrums [B] narrow scan 1750-1350 cm-
1of A. [B1] spectra from [B] stacked. [C] Narrow can 1300-750 cm-1 of [A], [C1] Spectra from 
[C] stacked. 
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Figure 4-23A shows the FTIR spectrum of four HAp powders synthesised using various titration 
parameters. All powders display comparable phosphate vibrational bonds ν3PO43- at 1045-
1092 cm-1 and ν2 PO43-  at 474 cm-1, ν1 PO43-  symmetric stretch at 963 cm-1, ν4 PO43-  from 
602-572 cm-1. 
Carbonate bonds associated with ν3 vibrational mode were noticibly different between HAp 
titration at different titration rates irrespective of reaction pH. Specifically absorption linked 
to carbonate ion ν3a 1455 and 1415 cm-1 were increased in HAp titrated with 1.0 mL/min 
titration rate relative to HAp from 0.1 mL/min (figure 4-23B). CO32- absorption peaks present 
at 1645 and 1655 cm-1 were similar in HAp titrated using the aforementioned titration 
parameters. 
4.3.5.5 Cytotoxicity 
Using HAp fabricated according to 4.3.5 table 4-5 cytotoxicity was assessed using patient 
derived hMSC. MTT, a cell viability assay was used to determine hMSC viability following 24 
hours incubation with a series of HAp nanoparticle dilutions comparable to Müller et al. 
(2014). 
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Figure 4-24: Cytotoxicity of HAp to patient derived hMSC (patient number 3286, 3303, 3175 
and Y201 with corresponding passage number: denoted as PX). Cells were incubated with a 
serial dilution from 500 μg/mL to 31.25 μg/mL concentrations of A) rod-like carbonated, B) 
plate-like carbonated, C) rod-like non-carbonated and D) plate-like non-carbonated HAp for 
24 h prior to measuring cell viability using MTT assay. Values represent the mean ± SEM of 
5 technical replicates.  
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Figure 4-24 shows average cellular viability in response to the different nanoparticles pools 
data from a number of experiments investigating hMSC cytotoxicity to HAp concentrations. 
From the “[average] graph” cell viability to HAp shows an average 17.42 ± 2.76% reduction in 
cellular viability in response to all types and concentrations of HAp. The largest reduction in 
hMSC viability was observed in response to ‘HAp B’ 36.81 ± 1.08% which was found to be 
significantly different than hMSC responses to other forms of HAp (10.95 ± 1.33%). 
Looking at individual hMSC responses to different concentrations and types of HAp we can 
see an array of varied reactions. Figure 4-24 ‘HAp A, B, C & D’ shows the response of 4 cell 
types to different concentrations and types of HAp. Similar responses were observed in A, C 
and D throughout cell type and passage with an apparent downward trend in cellular viability 
with increase HAp concentration.  
Figure 4-24 ‘HAp B’ showed a marked decrease in cell viability in response to all concentrations 
of HAp in all cell types except 3303 P5. The 3303 cell type investigated at P4 was repeated 
with cells from P5 due to the observed reduction in viability in response to HAp titrated at pH 
8 (D). When this experiment was repeated with the latter passage, this cytotoxic effect was 
not observed. It was observed that the DMEM based hMSC media containing HAp D did not 
sediment over time like the other HAp groups in the initial experiment. Additionally, it was 
observed that upon repeating this experiment with the 3303 P5 cells that the stock solution 
containing the HAp D began to sediment, unlike the previous experiment. 
The HAp synthesised at a lower pH with a slower titration rate i.e. HAp D appeared to form a 
more uniform suspension of nanoparticles in the DMEM based medium, however this 
property appeared altered when the stock solutions were stored at -20oC.  
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4.4  Discussion 
The sol-gel method developed in this thesis resulted in nanocrystalline forms of non-
stoichiometric HAp nanocrystals fabricated at room temperature with a variety of addition 
methodologies, titration rates and pH conditions. Initial TEM investigation demonstrated 
sensitivity of HAp to electron microscopic observation. Final HAp crystal dimensions varied 
significantly with various titration parameters, with an increase observed in [002] and [110] 
crystal directions. Aspect ratios of the HAp produced in this chapter demonstrated a range 
from 3.36 – 1.92, however there were no significant differences between any of the variables 
investigated. Carbonate content was found to decrease with increased titration rates and the 
titration addition order. 
‘Tailored’ HAp D synthesised with the aim to increase particle [110] direction and decrease 
carbonate content was successful, however XRD information demonstrated a significant 
increase in [002] crystal direction. Ca/P ratios of HAp did not vary with single factor variation, 
however two factor variation revealed a significant decrease in Ca/P ratio still within the 
stoichiometric remit of HAp (≥1.67). Investigations into HAp cytotoxicity showed good cell 
viability (~75% +), with a slight reduction in viability in response to HAp synthesised at lower 
pH with carbonate incorporation (~60%). 
EDX is not the ideal method for the measurement of calcium and phosphorous elements, 
inductively coupled plasma atomic emission spectroscopy (ICP-AES) is a more accurate 
method, however the machine was not operation at the time of this work. EDX analysis 
revealed an approximate Ca/P value of 2.0 for single factor synthesised HAp powders, 
synonymous with non-stoichiometric HAp (≥ 1.667) (figure 4-4, figure 4-9 and figure 4-14). 
Although the components were added in a molar ratio of 1.667 Ca/P, the Ca/P ratio was 
higher, indicating phosphate exclusion or greater calcium inclusion in the final HAp crystal 
lattice. Assuming this measurement is accurate, this evidence conflicts with previous 
observations by Lazić (1995), whom demonstrated calcium phosphate titrated at lower pH 
yielded calcium deficient apatite’s. 
XRD spectral analysis allows us to determine that the resultant powder contains 
nanocrystalline crystal peaks similar to that illustrated by characteristic hydroxyapatite 
diffraction library spectra (figure 4-2) and to crystals synthesised by Jevtic et al. (2008). The 
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absence of a significant diffraction peak at 2θ = 45.5o in the XRD spectra demonstrates removal 
of NaCl from the resultant HAp product via the dialysis washing method outlined in section 0. 
TEM images (figure 4-3) show loss of particle definition with prolonged observation with 
electron microscopy. Material degradation by electron bombardment is a known 
consequence of electron microscopy on non-gold coated samples using TEM. This observation 
demonstrates the delicate nature of observing nanoscale materials and illustrates the 
limitations of this technique for morphological analysis without a cryogenically cooled sample 
stage (Bouyer et al. 2000). This indication also alludes to the thermal instability of the material 
in observation, which is confirmed by XRD analysis and supported by previous studies in low 
temperatures sol-gel HAp production (Monmaturapoj 2008). 
Influence of titration parameters on HAp crystal dimensions 
A number of methodologies have been used to measure HAp crystal size including XRD, 
dynamic light scattering (DLS), atomic force microscopy (AFM) and TEM quantification 
(Munarin et al. 2015; Marković et al. 2011; Cunniffe et al. 2010). 
Cunniffe et al. (2010) used DLS and AFM to quantify HAp size. Data demonstrated large HAp 
agglomeration using a similar titration method to the one presented in this thesis. DLS 
measurement is a useful tool for the assessment of dispersity of a solid in a fluid, however is 
a poor tool for the quantification of HAp crystal size without a homogeneous dispersion. 
Furthermore, AFM measurement of HAp crystals can be misleading as intercalation of 
individual HAp particles can mask single crystal measurements and provides low-throughput 
qualitative information. Agglomeration of the HAp was observed throughout the work 
conducted in this thesis and is supported by observations and TEM. 
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4.4.1.1 Literature comparison 
The following publications were selected as they produced HAp with similar morphological 
and crystallographic characteristics with the HAp produced in this chapter. The sol-gel 
methodologies varied by the addition order, type of precursor solutions and not all specify the 
rate at which the components were combined. 
Bakan et al. (2013) produced HAp by titrating the Ca(NO3)2 solution at 3 mL/min into a 
NH4H2PO4 reservoir at pH 9. The Hap was then aged for 24 hours prior to assessment. This 
method produced carbonated HAp with an average crystallite size of 26.46 nm [002] XRD. HAp 
produced by Bakan et al. (2013) contradicts evidence presented in this work as the crystallite 
size is much smaller in relation to HAp produced in this chapter using similar parameters 
(figure 4-7, figure 4-12 and figure 4-17). The main differences between the methodologies 
include the precursor solutions, titration rate and lack of pH regulation. Results from this 
thesis demonstrate that HAp nanoparticles produced at greater than 0.1 mL/min titration 
rates have significantly increased crystallite size (figure 4-12). However, the specific factor that 
is influencing HAp crystal size is likely masked by the number of deviating variables. 
Jadalannagari et al. (2011) synthesised HAp through the titration of the H3PO4 precursor 
dropwise into a CaCl2 reservoir at pH 10. The HAp was then dialysed for 12 hours prior to 
assessment. The reported HAp crystal size ranged from 110 – 115 nm with TEM observation 
according to the assumed [002] c-axis direction. The main differences between the 
methodologies include the phosphate precursor solution and lack of definitive titration 
rate/pH regulation.  Results from this thesis have demonstrated HAp synthesised using a 
similar methodology to Jadalannagari et al (2011). Titration of phosphate into a calcium 
reservoir (method B: figure 4-5) demonstrated morphologically similar HAp to that produced 
by Jadalannagari et al. (2011), however the average crystallite size was 54.39 nm with respect 
to the assumed [002] direction.  This difference in HAp [002] size could potentially be caused 
by the differences in titration addition rate, as results from this chapter demonstrated a similar 
increase in [002] crystal direction with increased titration rates (figure 4-12). However, lack of 
addition rate quantification makes it difficult to determine underlying causes for the 
differences observed in HAp crystal sizes.  
Marković et al. (2011) fabricated carbonated HAp through the titration of the Ca(NO3)2 
solution dropwise into a H3PO4 reservoir with a Na2CO3 carbonate precursor at 50oC with pH 
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11. The HAp was then aged at 90oC for 1 hour. The carbonated HAp was reported to have an 
average crystallite size of 11.1 nm [002] XRD.  The key differences between methods used by 
Markovic et al. (2011) and those used in this chapter include the addition of a carbonate 
precursor, the calcium and phosphate precursors, the pH and the ‘dropwise’ addition. Results 
from this chapter yielded HAp with a larger crystallite size this is likely due to the differences 
in precursor solutions, particularly the carbonate incorporation and the elevated titration 
temperature. It is likely that the deliberate incorporation of carbonate into the HAp crystal 
lattice retards the growth and overall size of the resulting nanoparticle (Kanno et al. 1999). 
This is supported by results from this thesis, which demonstrates reduced crystal dimensions 
with increased carbonate incorporation (see discussion section 4.4.2 ). 
Yubao et al. (1994) fabricated HAp by titrating a NH4H2PO4 solution dropwise into Ca(NO3)2 
reservoir at pH 10-12. The HAp was hydrothermally treated at 140oC 0.3 MPa for 2 hours prior 
to analysis. The average crystal size of HAp synthesised using this method was 23.7 nm by 90 
nm giving an aspect ratio of 3.8. The most similar HAp produced in this chapter was produced 
at pH 10 adding calcium into a phosphate reservoir with an addition rate of 1 mL/min. The 
resulting HAp had an aspect ratio of 3.36 with dimensions of 26.69 nm by 88.39 nm which are 
very similar to that reported by Yubao et al. (1994). The differences in hydrothermal treatment 
(121oC vs 140oC), precursor solutions and addition rate could explain the differences observed 
between the HAp presented by Yubao et al. (1994) and the control HAp produced in this 
chapter. 
The aspect ratio of HAp produced in this chapter appears to vary similar to other studies 
utilising a simple sol-gel methodology (Motskin et al. 2009; Müller et al. 2014; Motskin et al. 
2011). Others have utilised surfactants to retard crystal growth and promote elongation to 
produce HAp with different aspect ratios but did not investigating their influence on cell 
uptake (Zhang et al. 2009). This method could be used to significantly vary the aspect ratio, 
however some have reported difficulties concerning residual surfactant cytotoxicity (Motskin 
et al. 2009; Müller et al. 2014; Motskin et al. 2011). 
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4.4.1.2 Component addition methodology 
The influences of component addition methods were previously investigated by Cunniffe, M 
et al., (2010), they reported differences in resulting HAp particle sizes using a reservoir 
titration method. The addition of either calcium or phosphate component into an excess of 
the other will influence the ion availability within the reaction fluid, this will alter nucleation 
and growth kinetics of crystals formed at different stages of titration. 
Average crystallite dimensions represented in figure 4-7 A & B show variation in HAp crystal 
directions [002] and [110] as a consequence of the titration methodology.  
Calcium is also known to expand the [110] (a-axis) direction of HAp over the c-axis as they are 
not coordinated by the phosphate ions in the [002] (c-axis) direction (Elliott et al. 2002). This 
would explain how titration of phosphate into an excess of calcium led to favoured a-axis 
crystal growth with method B (figure 4-7). The differences in molarity of the precursor 
solutions CaCl2 200 mM and Na2HPO4 120 mM, would also result in greater calcium availability 
during crystal growth and the subsequent increase in 110 direction with method C (figure 4-7). 
Addition of both components simultaneously (method C) may have also been influenced by a 
diminishing saturation effect, where by the availability of ions is depleted over the period of 
titration. Dual addition will also be influenced by ever increasing concentrations of HAp, which 
may result in growth promotion of existing HAp particles over new nucleation.  
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4.4.1.3 Component addition rate 
TEM and XRD analysis of HAp synthesised using titration rates of 0.1, 1 and 10 mL/min 
demonstrated increased growth of HAp crystals in the [110] direction and increased [002] 
direction with the 1 mL/min and 10 mL/min titration rates (figure 4-12). The component 
addition rate is the key rate limiting factor in the synthesis of HAp using a sol-gel methodology, 
influencing scalability. The parameters investigated are 10 and 100-fold increase in HAp 
production rate relative to the control (0.1 mL/min).  With these large differences in titration 
rate, one would expect a similar fold influence on the resulting HAp crystal structure and 
composition. Results demonstrated a very limited shift in HAp crystal size from 45.42 nm to 
88.39 nm [002] direction and 16.34 nm to 26.69 nm [110] direction (figure 4-12). The key 
alteration in HAp characteristic appeared to be with the decreased carbonate content in the 
resulting HAp from the 1.0 and 10 mL/min titration rates (figure 4-13). 
As previously discussed, increased availability of calcium within the reaction vessel with higher 
titration rates would encourage preferential growth of the [110] crystal plane in HAp crystals. 
This helps explain differences observed with the faster titration rates 1.0 and 10.0 mL/min. 
The increase in HAp [002] direction growth is less straightforward and could be due to 
carbonate substitution (see section 4.4.2 ). 
The heterogeneity in [002] crystal direction size of HAp titrated at 10 mL/min (figure 4-12) 
could be caused by the limitations of the pH control system used in this setup. The pH 
regulatory system of the Titrando unit attempts to equilibrate the pH within the boundary of 
the set pH (±0.05) as quickly as possible using an alkaline solution (NaOH) with a maximal 
addition rate of 100 mL/min. Upon attainment of the lower pH threshold the unit begins to 
titrate increasing volumes of NaOH until the rate of pH drift is sufficient to regain the set pH 
value. There is an exacerbated time lag period between the activation of the equilibration 
system and change in pH with increased titration rates. This could potentially lead to increased 
fluctuations in reaction vessel pH with the increased titration rates, ultimately influencing HAp 
characteristics. This theoretically could be overcome by calculating the rate of acid production 
by the precipitation and introducing an equal alkaline to balance the pH. Nevertheless, there 
does appear to be an increase [002] axis growth with increased availability of reaction 
components as observed in figure 4-12 A between 0.1 mL/min and 1.0 mL/min. 
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Cunniffe, M et al., (2010) also investigated the reactive component addition rate of using a 
sol-gel reservoir titration method (method A), results showed little variation in HAp crystal 
size using dynamic light scattering analysis. Results observed by Cunniffe et al., (2010) 
investigated titration rates of 0.083, 0.166, 5, 300 mL/min and found no significant differences 
in particle size using a dynamic light scattering technique. This could have been caused by 
particulate agglomeration following sonication resulting in particle agglomerates regardless 
of physical crystal sizes. Alternatively, these results were obtained titrating phosphate into a 
calcium reservoir method which is the inverse of the method applied in this section. 
The majority of published articles do not directly state a titration rate and those that do not 
supply a rationale behind the rates which are used. Results from this thesis illustrates the 
impact titration rate has on resulting HAp crystal size and could potentially be used to regulate 
HAp crystal dimensions. 
4.4.1.4 Reaction vessel pH 
TEM and XRD analysis of HAp synthesised at pH in the range 8-10 demonstrated a significant 
increase in HAp crystal width [110] plane with decrease in pH environments with no significant 
changes in HAp crystal length [002] axis. This is likely due to OH- facilitated organisation of the 
[110] crystal plane with preferential axis growth of the [110] crystal plane in lower pH 
environments. 
HAp carbonate incorporation 
FTIR analysis of titrated HAp powders revealed differences in carbonate vibrational modes 
correlating with differences in titration parameters including: addition methodology and 
titration rate. 
Two carbonate ion vibrational modes can be observed in the FTIR spectra of control HAp ν2 
and ν3 (figure 4-8, figure 4-13, figure 4-18). Carbonate ions with vibrational mode ν2 can be 
observed at 873 cm-1 and are associated with OH- at the interface of the growing crystal (A 
type). Vibrational mode ν3 from 1300-1650 cm-1 is assigned to surface carbonate ions and 
related to carbonate ions in the lattice occupying PO43- sites. Vibrational mode ν3 also has a 
peak split centred at 1645 and 1550 cm-1 with distribution of carbonate sites depending on 
the maturation and formation of the HAp (Rehman & Bonfield 1997; Marković et al. 2011). 
There are some discrepancies in the literature concerning interpretation of FTIR peaks from 
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1655-1640 cm-1 relating to either surface water absorption or ν3 carbonate vibrational bonds 
(Shi et al. 2009; Rehman & Bonfield 1997; Ugarte et al. 2005). 
It has been reported that atmospheric carbon dioxide absorption into reaction vessel liquid 
during titration is responsible for the incorporation of carbonate groups into the apatite’s 
crystal lattice (Shi et al. 2009). More recently increase carbonate content was observed in HAp 
synthesised under increasing ultra-sonication (25kHz) times which was again linked to 
entrapment of atmospheric carbon dioxide (Utara & Klinkaewnarong 2015). Indeed 
carbonation of the HAp lattice is a noted characteristic of in-vivo formed HAp found in 
mammalian bone (Delgado-López & Rodríguez et al; Ślósarczyk et al. 2005; Marković et al. 
2011). 
FTIR analysis of HAp titrated using a dual addition method revealed a decrease in carbonate 
vibration modes at 873, 1415 and 1455 cm-1 relative to reservoir addition methods (figure 4-8). 
A similar decrease in carbonate content was observed in HAp titrated at 1.0 and 10 mL/min 
relative to 0.1 mL/min HAp control (figure 4-13). This decrease in carbonate content correlates 
with increased crystal dimensions compared with carbonated control HAp. The data from this 
thesis corroborates previous reports that carbonation retards HAp crystal growth (Marković 
et al. 2011; Kanno et al. 1999).There is limited understanding of why the dual titration method 
yields lower carbonate content relative to reservoir titration methodologies, however it is 
likely be due to dissociation differences of atmospheric CO2 in solvents and solutions. 
The observed differences in carbonate content associated with titration rate are possibly due 
to reduced maturation time with the increased titration rates, leading to decreased 
atmospheric exposure time. Alternatively, the observed reduction in carbonate content could 
be caused by the speed in which the crystals were formed reducing available carbonate 
incorporation. 
The carbonate vibrational modes present from HAp titrated at all three pH values were similar 
(figure 4-18B). It was observed by Kumta et al., (2005) more carbonate incorporation into the 
calcium phosphate crystal with increased pH conditions and this is most likely due to the 
increased dissolution rates of atmospheric CO32- into alkaline solutions. However, this 
observation was seen when fabricating brushite at pH <6, the pH ranges investigated in this 
section were all alkaline >pH 8 and would explain the absence of this result. 
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Future work may investigate exclusion of atmospheric carbonate absorption, perhaps via 
vacuum or by bubbling nitrogen through the sol-gel reaction during titration (Lazić 1995). 
Tailored HAp 
EDX analysis of HAp D synthesised using pH 8 and 1 mL/min titration rate revealed a significant 
decrease in Ca/P ratio (1.75) compared with HAp A, B and C (Ca/P = ~2.0). The ratios fall within 
the accepted stoichiometry for HAp mineral. This alludes to a potential interaction effect 
between reaction pH, titration rate and/or maturation time that directly influences resultant 
HAp Ca/P ratio.  
In a study by Lazić et al., (1995), time dependent depletion of free calcium and phosphate ions 
during HAp crystal formation were found to increase dramatically following >250 minutes 
maturation time (0.1 mL/min = 500 min and 1.0 mL/min = 50 min. Lazić also noted differences 
in the conversion kinetics of OPC into the HAp conformation in response to pH, with lower pH 
coverting more slowly than higher pH conditions. This observation might explain the observed 
differences in Ca/P ratio in D as it was produced with a faster titration rate and pH conditions. 
One theory could be that at lower pH calcium has a reduced affinity for crystal binding 
domains, this could explain why there is a significant difference between HAp titrated at the 
same rate; calcium ions have a greater affinity to integrate with the crystal lattice. 
FTIR analysis indicated reduced carbonation ion inclusion into the HAp crystal lattice with 
increase titration rate regardless of the titration pH (figure 4-18). This evidence supports the 
hypothesis that addition rate/maturation time influences carbonate content. Further 
investigation could explore the influence of maturation time on resultant HAp carbonate 
content. 
HAp D (titrated at 1 mL/min at pH 8) demonstrated that the rate of component addition had 
a more profound impact on final crystal dimensions than pH. Evidence for this is demonstrated 
by extrapolated XRD data (figure 4-22) showing HAp D showed no significant differences in 
morphology when titrated at pH 8 or 10 (HAp C). This reinforces the argument that 
morphology is strongly governed by the availability of free calcium and phosphate in the 
reaction system and that pH plays a less significant role than anticipated. 
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The cytotoxicity of HAp A, B, C and D is demonstrated by the MTT viability assay of hMSC 
(figure 4-24). Results were largely homogeneous, however HAp B showed increased 
cytotoxicity relative to other forms of HAp. It was observed that HAp B was the only HAp to 
form a stable colloid suspension within the hMSC growth medium, this characteristic was lost 
during sample freeze – thawing. Coincidently, subsequent experimentation with HAp B 
revealed a loss of hMSC – HAp B cytotoxicity. The aspect ratio of HAp B was lower than the 
other forms of HAp, however this was not statistically significant. Future experiments could 
aim to produce HAp with statistically different aspect ratios and investigate their influence on 
cytotoxicity and dispersion characterises using dynamic light scattering (DLS). 
A recent study by Müller et al. (2014) found that agglomerates of HAp induce higher levels of 
cytotoxicity than dispersed, this conflicts with the aforementioned preliminary finding. 
Further research is required to investigate this phenomenon.  
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4.5  Conclusion 
A nanocrystalline non-stoichiometric form of HAp was successfully synthesised and isolated 
using a room temperature sol-gel methodology. Within the confines of a titration rate of 0.1 
mL/min using a reservoir addition methodology Ca2+  PO3-, we can conclude that a decrease 
in reaction pH yields HAp with increased a-axis width. This is itself limited to pH ≥ 8 as < pH 8 
results in other calcium phosphate derivatives (Bouyer et al. 2000). I also conclude that it is 
the availability of calcium within the reaction vessel that governs HAp morphology, as 
modification to titration order and rate influenced both length and width of resultant HAp. 
These result supports the hypothesis of preferential a-axis expansion of Ca2+ during apatite 
formation described by Elliott et al. (2002). Carbonate content can be directly influenced by 
the titration rate of reaction components and there is evidence that this in turn may influence 
HAp crystal [002] direction length. The combination of lowered reaction vessel pH and 
increased component addition rate, demonstrated that either addition rate or maturation has 
a more significant impact on final HAp morphology than reaction vessel pH, this observation 
has yet to be explored. Increase titration rate and dual addition of reaction components 
yielded a decrease in carbonate content. The hMSC demonstrated low cytotoxicity (~75% 
viability) to various forms and concentrations of synthesised HAp. 
The HAp produced at pH 10, 0.1 mL/min with method A (control) appeared to be most similar 
to naturally occurring bone mineral nanoparticles in morphology, size and carbonate 
substitution (Marković et al. 2011). This HAp was therefore used in subsequent experiments 
in chapter 5, chapter 6 and chapter 7. 
  
Chapter 5 
134 | P a g e  
 
Chapter 5 – Poly (Lactic Acid)/Hydroxyapatite Surface 
Fabrication and Characterisation 
5.1  Introduction 
The aim for this chapter was to characterise material fabrication processes and investigate 
substrate influence on hMSC behaviour. Initial work focused on developing routes to produce 
a HAp PLA composites and characterise final HAp dispersal. A series of in-vitro assays were 
performed on these materials to assess changes to hMSC adherence, morphology, growth 
kinetics, functionality and gene expression. 
The integration of nanoparticles with polymeric materials offers the potential to produce 
composite materials with enhanced mechanical and bioactive properties. The mechanical 
properties of these materials is not only dependent on the properties of the polymer and 
nanoparticle but also the distribution and interfacial bonding of the two. The fabrication of 
monodisperse polymer – nanoparticles still remains a significant challenge for material 
scientists (Tjong 2006; Deng et al. 2007; Stankovich et al. 2006; Sinha Ray & Okamoto 2003; 
Althues et al. 2007).This chapter presents two methods for the production of HAp filled PLA 
composites using physico-chemical methods. The two approaches attempt to disperse HAp 
within solvents with differing properties, both capable of dissolving PLA. 
The first approach presented utilises a solvent capable of dispersing both polymer and 
nanoparticle. N,N-dimethyl formamide (DMF) has previously been used to disperse both PLA 
and HAp (Deng et al. 2007; Patlolla et al. 2010). DMF is a polar-aprotic solvent. This family of 
solvents are known to have both high dielectric constants and high dipole moments. They are 
also capable for accepting hydrogen bonds which make them an ideal candidate for stabilising 
HAp in suspension. The disadvantages of DMF are that it can often be difficult to remove from 
the resulting material and the solvent does not readily evaporate making it unsuitable for 
solvent casting (Patlolla et al. 2010). 
The second approach presented in this chapter applies a commonly used non-polar volatile 
solvent trichloromethane (TCM) to dissolve the PLA. The method of dispersing a HAp 
(hydrophilic) within a hydrophobic medium presents a number of complications. Firstly, dry 
addition of HAp into a non-polar solvent results in large scale agglomeration by overwhelming 
repulsion of the medium. This repulsion requires a huge amount of energy to disperse the 
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solid. The rationale behind the work presented in this chapter is to overcome this initial HAp 
agglomeration prior to introduction within the non-polar solvent utilising a surfactant. 
Cetyltrimethyl ammonium bromide (CTAB) is a cationic surfactant used in the synthesis of 
nanoparticles and has been investigated as a dispersion agent for HAp (Zhou & Lee 2011). 
Cationic surfactants readily form micelles within an aqueous environment with the hydrophilic 
head exposed to the aqueous environment (figure 5-1). In the case of a reverse micelle, the 
hydrophilic head of the surfactant associates with the exposed OH- groups on the exterior of 
the negatively charged nanoparticle (figure 5-1). 
 
Figure 5-1: Chemical structure of A) CTAB molecule, B) CTAB micelle in H2O and illustration 
of HAp – CTAB reverse-micelle. 
The affinity of the HAp-CTAB complex is hydrophobic providing stability of the particle within 
an aqueous medium. The work in this thesis investigates the potential application of this 
hydrophobicity to facilitate movement of dispersed HAp from an aqueous phase into a non-
polar phase for composite fabrication.  
The modification of nanoparticles by surfactants to facilitate transfer from one phase to 
another is not a novel process. Previous research has demonstrated the transfer of gold 
nanoparticles from an aqueous solution into organic hydrophobic solvent. Underwood & 
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Mulvaney (1994) showed the transfer of aqueous gold nanoparticles by complexation with 
‘comb stabilizers’ (surfactant) present in an organic phase facilitated by gentle agitation. The 
methods presented in this chapter are based on a similar principle. 
To investigate how hMSC interaction with PLA, the material requires processing into a film. 
There are a number of techniques for producing flat thin films of materials including solvent 
casting summarised in an excellent review by (Granqvist 2012) (table 5-1). In this thesis a bulk 
coating wetting process of spin coating was used to quickly evaporate a polymeric solvent 
solution with the aim to reduce particle sedimentation within PLA HAp composite solution 
preparations. 
 
Table 5-1: Thin film deposition technologies (Granqvist 2012). 
To investigate the influence of direct HAp – cell contact on PLA spin coated substrates, HAp 
was first stabilised in solution using a pH dispersion technique. The PLA spin coated substrates 
were then coated using a wetting process of dip coating to adsorb the HAp particles to the 
surface of the PLA films.  
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5.2  Materials and Methods 
Dynamic Light Scattering (DLS) 
DLS data was collected using a Zetasizer Nano ZSP Malvern Instruments Ltd (Worcestershire, 
UK). The poly dispersive index (PDI) is a measure of the distribution and homogeneity of the 
sample. PDI was recorded by the instrument and samples with value greater than 0.4 omitted 
from data analysis due to their heterogeneity. 
A concentration of 0.1 mg/mL HAp was found to be appropriate for DLS measurement. 
Samples were prepared by ultrasonic agitation for a minimum of 10 minutes prior to 
measurement. For water dispersed solutions samples, 1 mL of solvent was added into a 
disposable PMMA cuvette. For TCM and DMF solvent dispersed solutions a quartz cuvette was 
used to hold the sample. The quartz cuvette was washed between measurements with dH2O 
and acetone. 
Samples were loaded into a measurement cuvette and three measurements were 
immediately recorded for each sample. The reflective index and viscosity of the various 
solvents and HAp were added into the Malvern database.  
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Spin casting 
Polymer solutions for spin coating were fabricated to a concentration of 2.5% v/v. Poly (lactic 
acid) (PLA) has a density of approximately 1.21 g/cm3, this was used to calculate the weight of 
PLA required to fabricate the polymer solution (equation 5-1).  
𝑊𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑃𝐿𝐴 (𝑔) = (𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑝𝑜𝑙𝑦𝑚𝑒𝑟 𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛 (𝑚𝐿) ×  2.5%) ×  1.21 𝑔/𝑐𝑚2 
Equation 5-1: Weight of PLA required for 2.5% v/v solvent mixture. 
A bench top rotary spin coater (MTI tech Ltd.) with a vacuum pump (Charles Austin pumps ltd. 
Model 8100) was use to coat 13 mm glass coverslips with a PLA film. Spin coating parameters 
such as polymeric temperature, concentration, volume and speed were optimised. The 13 mm 
glass cover slip was secured on the vacuum holder rotor and 60 μL of polymer TCM solution 
was applied evenly to the slide. The spin casting chamber was then flooded with/without 
nitrogen and spun with a two phase spin cycle; Stage 1) 3 seconds at 1000 rpm and stage 2) 
10 seconds at 3000 rpm.  
Substrate abbreviation Description 
PLA- PLA surface cast without N2 
PLA PLA surface cast with N2 
PLA HAp HAp 10% v/v within a PLA matrix 
PLA HAp CTAB HAp ~10% v/v dispersed with CTAB within a PLA matrix 
PLA+ Plasma treated PLA surface 
PLA+ HAp Coated Plasma treated PLA surface with HAp functionalisation. 
Table 5-2: PLA substrate key  
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Inductively Coupled Plasma Atomic Emission Spectroscopy (ICP-AES) 
Samples were prepared for ICP-AES by digesting approximately 0.1g of HAp powder in a 100ml 
Erlenmeyer flask. The digestion was used according to (Guzm 2005) with a solution containing 
58% HNO3, 35% H2O2 and 7% HCl at room temperature for 1 hour. The solution was then 
diluted using ultrapure distilled H2O to 20% its original concentration. Elemental composition 
was then found using a Unicam 701 emission spectrometer. Results given in PPM were then 
converted into mg/ml using equation 5-2 below. The following two assumptions were used: 
1 mg/1 L= 1PPM 
Ca + P = 97.55% Mw of HAp 
Equation 5-2: ICP-AES HAp quantity calculation 
Ca PPM + P PPM/0.9755 = HAp PPM 
HAp PPM x dilution factor = Total HAp PPM 
Total HAp PPM/1000 = HAp mg/ml 
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Crystal Violet 
The methodology for crystal violet dye-binding method was used similar to that used by 
Bruder et al. (1997). Samples were washed with PBS and incubated for 10 minutes with 0.01% 
w/v crystal violet solution (0.25% methanol with dH2O). Samples were then washed 
repeatedly with PBS to remove any excess dye form the surfaces. 300μL of 0.01% SDS in dH2O 
was used lyse the cells and dissolve retained crystal violet, absorbance was measured at λ 
570nm. Calibration curve was used to determine cell number relative to retained dye from 
the samples (appendix 8.6.3 ). 
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5.3  Results 
The results presented in this section were divided into two areas, dispersal processes for HAp 
PLA nanocomposite fabrication and biological characterisation of PLA and HAp materials.  
Hydroxyapatite Polymer Dispersal, Coating and Characterisation 
The measurements shown in this section are focused on dispersal processing of previously 
fabricated HAp filled in and coated on PLA material.  
5.3.1.1 DMF based dispersal  
This section addresses the use of DMF as a potential solvent for the dispersal of HAp and the 
processing of PLA HAp composites.  
The dispersion of HAp in DMF was assessed using DLS. HAp was weighed and diluted to 0.1 
mg/ml in either H2O with CTAB 10 mM or DMF. Samples were then ultrasonically agitated for 
and pipetted into a cuvette for measurement according to section 5.2.1 . 
 
Figure 5-2: Dynamic light scattering graph showing average hydroxyapatite agglomerate 
size in water, water – 10 mM CTAB and DMF at 0.1 mg/ml concentration. (d.nm = diameter 
in nanometres) 
No significant differences were observed in the dispersion of HAp in CTAB H2O and DMF media 
groups. DMF dispersed HAp had an average particle size of 210.13 ± 24.80 nm. DMF dispersed 
PLA/HAp composites were fabricated using a developed procedure outlined in figure 5-3.  
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Figure 5-3: DMF processing route for monodispersed HAp/PLA composite granules. 
PLA HAp composites were produced by dispersing the desired quantity of HAp in DMF and 
mixed by ultrasonic agitation for 1 hour. The desired quantity of PLA was then introduced in 
pelleted form into the HAp DMF solution and ultrasonically agitated for 4 hours until complete 
polymer dissolution. The PLA HAp DMF solution was then allowed to gel over night at 4oC. The 
resultant gel was then extracted from the preparation bottle and washed repeatedly with 
100% ethanol with the use of a vacuum filter to remove the DMF. The resulting composite 
powder was then frozen at -20oC overnight and freeze dried using an ALPHA 1-2 LDplus 
(Martin Christ Freeze Dryers GmbH, UK) for 24 hours at -52oC <0.0005 mbar. The dry 
composite powder was then stored in a nitrogen filled desiccator. 
Compression moulding was performed on the DMF dispersed PLA HAp powder to investigate 
composite processing technique. Composite bars were fabricated using an in house PTFE - 
stainless steel mould with linear compression guide bars designed and made by Dr Matt 
Benning at the school of mechanical systems engineering, Newcastle University figure 5-4. 
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Figure 5-4: PTFE mould with linear bearing guided compression for level bar fabrication.   
Composite powder was first weighed and carefully distributed into the PTFE mould channels. 
The powder was then loaded using a spring to exert force on the linear bar to evenly compress 
the powder. The assembled mould complex was then placed in an oven with 10oC/min ramp 
to 200oC and held for 2 hours before cooling at 10oC/min. 
  
Figure 5-5: Compression moulded 10% w/w HAp/PLA composite bar with flash.  
Observation of the bars fabricated using the compression moulding technique revealed some 
trapped air bubbles within the bar itself. No visible agglomerations were observed in the flash 
or within the bar. 
The influence of compression moulding on the final dispersion of HAp throughout the PLA HAp 
material was assessed using TEM. The bar was cut into smaller pieces, resin embedded and 
sectioned on an ultramicrotome for TEM analysis method outlined in section 3.3.3 . 
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Figure 5-6: TEM images of DMF processed composite powder following compression 
moulding procedure. A) 800x, B) 10500x and C) 130000x magnification. A-C) Core end 1 and 
A1-C1) core end 2. Agglomerates of HAp (red arrow) and ‘star-like region’ (blue arrows). 
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The DMF dispersed PLA HAp composite bar sections revealed ~ 5 – 15 μm agglomerate of HAp 
at low magnification (figure 5-6 A & A1) indicated by the red arrows. Emanating star-like 
regions were observed within the material cross-section (blue arrows). Images B-C show HAp 
monodispersion with smaller agglomerates of HAp ranging from ~ 100 – 200 nm in size (red 
arrows). 
FTIR was used to characterise molecular vibrational changes in PLA HAp composite compared 
with non-DMF processed PLA and HAp powder. FTIR analysis was performed on HAp powder, 
flattened PLA filament and PLA HAp composite bar sections. Sample preparation for HAp 
powder is outlined in methods section 0, PLA filament and PLA HAp composite bar sections 
were flattened using a press prior to measurement. 
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Figure 5-7: FTIR spectra of PLA, PLA/HAp and HAp powder. A) Vertically stacked spectra and 
B) Overlay spectra of PLA and PLA/HAp composite (650 cm-1 to 2000 cm-1-). Arrows indicate 
peak changes within PLA in the presence of HAp. (n=1) 
FTIR analysis of the composite material revealed differences in specific peak domains (figure 
5-7).  Peak differences between PLA and PLA/HAp composite were observed at (1) 958 cm-1, 
(2) 1033 cm-1, (3) 1266 cm-1 and (4) 1672 cm-1. Generic broadening in some absorption bands 
was observed in the overlaid FTIR spectra (figure 5-7B). 
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5.3.1.1 CTAB aided TCM dispersal  
This section addresses the use of a surfactant as a potential route for the dispersal of HAp and 
the processing of PLA HAp composites.  
Spin coated PLA and PLA HAp substrates were evaluated using SEM to view surface 
topography. All PLA substrates were cast with parameters outlined in section 5.2.2 Substrates 
spin coated with and without nitrogen are denoted PLA and PLA- respectively. PLA HAp 
solutions were prepared to a concentration of 10% v/v HAp of the final solid volume. HAp was 
weighed into a glass tube and ultrasonically agitated with TCM in an ultrasonic water bath for 
10 minutes. Weighed PLA pellets were then added into the TCM HAp solution and 
ultrasonically agitated until the pellets fully dissolved (2 hours minimum). 
  
   
Figure 5-8: Scanning electron microscope image of TCM spin cast PLA/PLA HAp surfaces. A) 
PLA- cast under standard laboratory conditions, B) PLA, C & D) PLA HAp (1% v/v) surface.  
Results from figure 5-8 demonstrated differences in PLA surface topography under different 
atmospheric conditions. A porous film was observed in image A with a uniform smooth 
topography in image B. SEM of PLA HAp spin cast surfaces (figure 5-8 C & D) show ~10 μm size 
subsurface aggregates beneath the PLA (red arrows).  
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The influence of CTAB surfactant on HAp particle dispersion was examined in H2O using DLS 
measurement (figure 5-9). Samples were prepared for DLS by mixing a serially diluted range 
of CTAB dH2O concentrations with 0.2 mg/mL HAp dH2O solution in a 1:1 ratio. Samples were 
then ultrasonically agitated for and pipetted into a cuvette for measurement according to 
section 5.2.1 .  
 
Figure 5-9: Dynamic light scattering graph showing average particle size in dH2O, 0.1 mg/mL 
HAp with serial dilutions of CTAB (mM). (n=3) Average particle size ± SEM.  
DLS shows particle sizes ranging from 186.37 – 1943.50 nm. Dispersion characteristics of HAp 
demonstrated in figure 5-9 shows the average particle size was largest in CTAB concentrations 
less than 2.5 mM. CTAB concentrations 5, 10 and 20 mM appeared to decrease average 
particle size with 10 mM being the lowest with an average size of 186.37 ± 6.41 nm. A blue 
hue was also observed in the mixture containing HAp with 10 mM CTAB. An increase in sample 
mixture viscosity was also noted in samples containing ≥ 20 mM concentrations of CTAB. 
The nature of the H2O CTAB dispersed HAp suspensions were characterised to provide 
information on the stability of the colloid particle suspension during the DLS measurement 
process.  
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Figure 5-10: Representative DLS data of 0.1 mg/mL HAp dispersed in dH2O with CTAB, lines 
represent the calculated particle size (radius nm) population in three serial measurements 
of sample. 1st measurement = Red, 2nd = Green and 3rd = Blue. A) HAp in dH2O & 2.5 mM 
CTAB. B) HAp in dH2O & 10 mM CTAB.  
Figure 5-10 illustrates representative DLS data collected from 0.1 mg/ml HAp dispersed in 
dH2O and 10 mM CTAB. The lines presented in these graphs show three consecutive 
measurements of ‘size distribution’. Figure 5-10A shows size distribution by intensity peaks 
shift with each measurement and show a new smaller peak in the final measurement. Figure 
5-10B shows a large intensity peak at ~80 nm radius (190 nm diameter) with a smaller peak at 
the micron range.  
A 
B 
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Particle agglomeration was observed with HAp directly mixed in TCM with CTAB. Prolonged 
utlrasonication was also insufficent to disperse the HAp within TCM CTAB solutions. Since HAp 
could disperse within an aqueous medium, efforts were made to first disperse HAp within 
water, then to transfer  the proposed micelle complexes (figure 5-1) into a polymer solution 
with TCM similar to approaches used by Underwood & Mulvaney (1994).  
CTAB dispersed HAp PLA TCM solutions were fabricated for spin casting using the procedure 
outlined in figure 5-11. 
 
Figure 5-11: Process of reverse micelle transfer. CTAB dispersed HAp particle transfer from 
water to TCM and composite solution fabrication process 1-5. 
10 mM CTAB was first used to disperse HAp and transfer CTAB-HAp micelles form the 
hydrophilic to the hydrophobic phase. Various concentrations of HAp were dispersed in dH2O, 
10 mM CTAB and separated with TCM in a 1:1 ratio. The solution was vigorously agitated to 
shear the interface and the HAp-CTAB TCM collected for composite fabrication and 
characterisation. Information from the ICP-AES analysis the required HAp quantity was 
calculated to form an approximate 10% v/v solid content of the final CTAB dispersed PLA/HAp 
product.  
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ICP-AES was performed to assess the quantity of HAp transferred from the H2O to the TCM 
phase during the reverse micelle transfer process (section 5.3.1.1 ). The TCM phase following 
the transfer process (figure 5-11 step 3) was evaporated in a 100ml Erlenmeyer flask in a 
chemical fume cabinet overnight. The resultant powder was digested and analysed according 
to the method outlined in section 5.2.3 . 
 
Figure 5-12: Percentage of HAp transferred into the TCM phase from 10 mM CTAB dispersed 
HAp of various concentrations. Data obtained through ICP-AES analysis of the TCM phase 
following micelle processing (n=1). Error bars = SEM of technical repeats. 
During the reverse micelle transfer process, it was found that some of the material was 
trapped at the interface between the TCM and H2O solvents. Results demonstrated in figure 
5-12 A show the percentage of HAp in the TCM phase following reverse micelle transfer using 
different concentrations of HAp in the aqueous phase. The percentage of HAp transferred 
appeared reduced with 10% wt./v HAp concentration, however remains higher with 
concentrations of ≤ 7.5 wt.% Hap at ~90% - ~80%. 7.5% HAp concentration was therefore used 
for the reverse micelle process to make a TCM HAp solution of approximately 6.75 wt. % HAp 
(90% of 7.5 wt. %) – (figure 5-11, step 3).  
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The influence of reverse micelle transfer on resultant HAp dispersal (figure 5-11 step 3) was 
assessed using DLS. Both H2O 10mM CTAB and TCM phase HAp samples were diluted to ~ 0.1 
mg/mL and ultrasonically agitated for 10 minutes. 1 mL of the samples were transferred into 
a respective cuvettes and measured according to the method outlined in 5.2.1  
 
Figure 5-13: Dynamic light scattering data showing average particle size of 0.1 mg/mL HAp 
in 10 mM CTAB H2O and following reverse micelle transfer. (n= 3) Average particle size ± 
SEM. 
Figure 5-13 B shows the influence of the reverse micelle processes on the size of the CTAB – 
HAp agglomerates. A significant 3.30-fold increase in particle size was observed in 
agglomerate size following phase transfer.  
The effect of adding PLA and spin cast processing on final PLA HAp CTAB composites HAp 
dispersal was determined using TEM. HAp at a concentration of 6.75 wt. % was diluted with 
TCM PLA solution to form a composite solution of 2.5% w/v solid fraction containing 90% PLA 
and 10% HAp (figure 5-11, step 5). This solution was used to spin cast PLA HAp CTAB surfaces 
later used for the biological characterisation of the material using parameters outlined in 
section 5.2.2  
To evaluate final PLA HAp dispersion, the PLA HAp CTAB solution was spin cast onto copper 
grids for TEM analysis. Copper grids were first fixed to the glass coverslips prior to spin coating 
using a small volume of PLA TCM solution. The PLA HAp CTAB solution was then added to the 
glass coverslip and spin cast using parameters outlined in section 5.2.2 The grid was then 
peeled from the supporting glass coverslip and visualised using TEM. 
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Figure 5-14: Transmission electron microscope image of spin cast PLA HAp CTAB composite 
film. A) 13500x, B) 46000x, C) 640000x and D) 130000x magnification. Red arrow = HAp, blue 
arrow = PLA matrix and green = artefact. 
TEM images from figure 5-14 show relatively uniform dispersal of HAp observed through a 
PLA matrix (blue arrow), small aggregates of HAp were observed ranging from 200 – 1000 nm 
(red arrows). At higher magnification artefacts can be observed throughout the PLA matrix 
(green arrows). 
  
200 nm 
1000 nm 
B A 
500 nm 
100 nm 
C D 
Chapter 5 
154 | P a g e  
 
5.3.1.2 Hydroxyapatite Polymer Surface Coating 
The pH of the HAp H2O suspension was investigated as a potential aqueous dispersal route a 
dip coating process. 
 
Figure 5-15: DLS data showing 0.1 mg/ml HAp dispersion in dH2O at pH 8 – 10 (dH2O with 
NaOH). 
The DLS data indicated average HAp particle size was lowest in a pH 10 environment with an 
average particle size of 689.20 ± 44.46 nm with the largest at pH 7 with a size of 8.96 ± 1.14 
μm. The zeta potential of HAp at room temperature (25oC) pH 7 was found to be -14.63 ± 1.20 
mV.  
Plasma treatment of PLA surfaces was performed to enhance HAp – PLA interaction during 
the dip coating process. PLA spin cast samples were plasma treated using a compact plasma 
cleaner PDC-32G (EQ-PDC-32G) (MTI Corporation, US) with an 8CFM double step rotary 
vacuum pump (2TW-4C) (MTI Corporation, US). Samples were loaded onto a glass microscope 
slides and inserted into the PT chamber. The chamber was sealed and a vacuum pump was 
activated and allowed to warm-up for 10 minutes before the PT procedure. PT was performed 
for 3 minutes on the ‘medium’ setting of the compact plasma cleaner PDC-32G. The chamber 
was then slowly brought to atmospheric pressure and samples removed directly into a 24 well 
plate. 
HAp suspension was made by diluting NaOH in dH2O to 50mM and ultrasonically agitated for 
1 hour prior to dip coating. Spin coated PLA+ coverslips were immersed in HAp suspension for 
~10 seconds and washed by dipping immediately in dH2O three times blotting on absorbent 
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paper roll in between each dip. PLA+ HAp coated coverslips were then placed and covered on 
a hot plate at 70oC for 15 minutes to dry before placing in a 24 well plate. All samples were 
then sterilised by UV irradiation for 30 minutes and stored in PBS for seeding.  
  
Figure 5-16: A) Diagram of PLA surface treatment and dip-coating procedure. B) PLA+ spin 
cast, plasma treated 13mm glass coverslip image. C) PLA+ HAp coated 13mm glass coverslip.  
The image of the PLA+ HAp coated glass coverslip (C) shows a thin non-uniform white coating 
across the PLA surface in comparison to non-coated PLA+ substrate (B) (figure 5-16). 
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Biological Characterisation 
This section evaluates the effects of the processed material substrates shown in section 5.3.1 
on hMSC adherence, morphology, growth kinetics, and gene expression in-vitro. 
5.3.1.1 Scanning Electron Microscopy 
The influence of TCM dispersed HAp PLA substrates was assessed for basic cell adherence and 
substrate interaction. Cells were seeded at a density of 10,000 cells/well in a 24 well plate 
(approximately 5.3 cells/mm2) using methods outlined in methods section 3.3.4 . 
   
Figure 5-17: SEM image of spin cast (A) PLA & (B) PLA HAp (10% v/v) surfaces with hMSC 
cultivated for 24 hours. Blue arrows = cells and red arrows = subsurface particles. 
From figure 5-17 cells can be observed on both PLA and PLA HAp surfaces (blue arrows) 
adhering and spreading. Large subsurface particles can be seen throughout the PLA coating 
(red arrows) in figure 5-17B. 
The influence of the PLA HAp CTAB substrates were assessed for surface topography and cell 
adherence in figure 5-18. 
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Figure 5-18: SEM images of spin cast PLA (A-B) and PLA HAp CTAB (C-H) surfaces with hMSC 
cultivated for 24 hours. A&C) 100x, B, E & F) 600x, D) 300x, G) 2000x, H) 10,000x 
200 μm 20 μm 
A B 
200 μm 
20 μm 20 μm 
2 μm 
C D 
E F 
20 μm 
50 μm 
G H 
Chapter 5 
158 | P a g e  
 
magnification. Red arrows = subsurface aberrations and green = pseudopodia. Red outline 
= cell perimeter.  
Figure 5-18A shows a relatively smooth homogeneous PLA surface topography from low 
magnification. Cells can be observed adhering on both substrates (image A – F). PLA HAp CTAB 
substrates show subsurface aberrations ranging from 0.5 – 1 μm can be observed in images C 
– H (red arrows). Extended cell pseudopodia can be seen in images G and H interacting directly 
with aforementioned irregularity in surface topography (green arrows).  
The influence of plasma treatment and HAp dip coating on spin coated PLA+ surfaces were 
investigated to assess both surface coating efficacy and basic cell adherence. 
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Figure 5-19: SEM images of spin coated PLA+, hMSC 3286 incubated with surfaces for 24 
hours. A) PLA, B) PLA+ and C-D) PLA HAp Coating. A-D) 100x magnification and A1-D1) 600x 
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magnification. Blue arrow = ‘lines of contraction’, red arrow = HAp surface coating and green 
= pseudopodia. Red outline = cell perimeter. 
The influence on cell adherence to PLA+ substrates can be observed in figure 5-19 B & B1 
compared with PLA control A & A1. In figure 5-19 B & B1 cells on PLA+ appear to be well spread 
and have what appears to be lines of contraction (blue arrow), this effect is not evident the 
PLA+ HAp coated surface image C1, D or D1. Further examination of the PLA+ HAp coated 
substrates revealed a similar coating of HAp across the PLA surface with islands of HAp ranging 
from <1 – ~10 μm. Cells could be observed adhering to the PLA HAp coated surface, illustrated 
by the red dotted outline (figure 5-19 C1, D & D1). 
5.3.1.1 Morphological Analysis 
Images of hMSC stained with crystal violet (CV) were imaged to provide information on 
morphological changes of hMSC cultivated on PLA HAp CTAB surfaces following 21 days of 
culture in both basal and osteogenic media (figure 5-20).  
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Figure 5-20: Crystal violet stained hMSC (3070) P5 cultivated on various 2D substrates for 21 
days. A) Glass, B) PLA, C) PLA HAp and D) PLA HAp CTAB. A-D = basal medium and A1-D1 = 
osteogenic medium. Arrow indicates subsurface aberrations. 40X magnification. 
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Long term culture of hMSC on CTAB dispersed HAp within PLA matrices revealed differences 
in cellular morphology following 21 days’ incubation in various media (figure 5-20). Cells 
cultivated on glass substrates (A & A1) appear to have a variance in morphology from a striated 
form in A to a cobblestone-like form in A1.  
Cells cultivated on PLA substrates not containing CTAB appear to have a rounded phenotype 
in both media groups. Large agglomerates can be observed in PLA HAp substrates, as can be 
observed in C & C1 black arrows. The density of cells cultivated on PLA HAp CTAB surfaces 
appeared to be substantially reduced (D & D1) in comparison to other substrate groups. It was 
also observed that density varied between media groups with less cells in the osteogenic 
medium grouped substrates (D1).  
Immunofluorescence was used to quantify differences in cell morphology to assess cell – cell 
and cell – material differences between glass, PLA+ and PLA+ HAp coated surfaces. Phenotypic 
observations of hMSC cultivated on glass, PLA+ and PLA+ HAp coated are present in images 
figure 5-21 & figure 5-22, quantification of these images are displayed in figure 5-23 and figure 
5-24.  
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Figure 5-21: Immunofluorescence images of hMSC cultured for 24 hours on A) glass, B) PLA+ 
and C) PLA+ HAp coated. A-C) Y201 A1-C1) 3388. 200X magnification. Red = rhodamine 
phalloidin & Blue = DAPI. 
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Figure 5-22: Immunofluorescence images of hMSC cultured for 24 hours on A) glass, B) PLA+ 
and C) PLA+ HAp coated for 24 hours. A-C) 3286 A1-C1) 3287. 200X magnification. Red = 
rhodamine phalloidin & Blue = DAPI.  
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Figure 5-23: Donor-to-donor morphological analysis of hMSC cultured on a variety of 
surfaces for 24 hours. (A) Average cell surface area, (B) perimeter and circularity (C). 
(Number of cells assessed n = 60) 
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Figure 5-24: Cell-to-material morphological analysis of hMSC cultured on a variety of 
surfaces for 24 hours. (A) Average cell surface area, (B) perimeter and circularity (C). 
(Number of cells assessed n = 60)  
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Immunofluorescent images demonstrate sparsely adhered hMSC to various substrates, the 
rhodamine phalloidin highlights the cellular f-actin cytoskeleton and DAPI the cell nucleus 
(figure 5-23 & figure 5-24). From these representative images it was difficult to determine 
variances between these donor cell types and surfaces. 
Inter-patient variance in hMSC morphology was assessed to provide an insight into phenotypic 
differences on various substrates. Figure 5-23 illustrates variances between donor cell types 
on different surfaces. Figure 5-23A demonstrates significant differences in donor cell surface 
area on the various substrates. Patient derived 3286 hMSC have the largest surface area on 
all substrate surfaces, these differences were significant when compared with 3388 and the 
Y201 cell line which had the smallest surface area on all substrate surfaces. Patient derived 
3287 had the second highest surface area on all surfaces which was also significantly larger 
than Y201 only in the PLA+ HAp coated surface group.  
Cellular perimeter results coincided with surface area in all hMSC cell types across all surfaces, 
except for patient derived 3388 which had a similar perimeter with 3287 but a reduced surface 
area when cultured on glass. 
Cell circularity was similar in all patient derived hMSC with an average circularity of 0.191 ± 
0.009 on glass, 0.207 ± 0.020 PLA+ and 0.178 ± 0.008 on PLA HAp C. Circularity of Y201 was 
not significantly different when compared with patient derived cell types when cultured on 
glass.  
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Cell – substrate interaction was examined to provide an insight into any trends in hMSC 
morphology to the different substrates. 
hMSC cell surface area revealed no significant differences in 3286 between all substrate 
groups. Patient hMSC 3388 showed a significant reduction in surface area between glass and 
PLA+ substrate, however there was a significant increase reported between PLA+ and PLA+ 
HAp coated surfaces. Patient hMSC 3287 revealed a statistical increase in cell surface area 
between glass the PLA+ surface group. Y201 indicated a reduction in surface area in HAp 
coated PLA+ groups when compared with both glass and PLA+ surfaces. 
hMSC cell Perimeter measurements revealed no significant differences in 3286 and 3287 cell 
perimeter between all substrate groups. Significant reduction in patient hMSC 3388 cell 
perimeter was noted between glass and PLA surface groups. Y201 cell perimeter was 
significantly reduced on PLA+ and PLA+ HAp coated substrates relative to glass. Y201 cell 
perimeter on HAp coated PLA+ was also found to be significantly lower than cells cultured on 
PLA+ alone. 
hMSC circularity showed no significant differences in 3286 and 3287 cell circularity between 
all substrate groups. Patient derived hMSC 3388 demonstrated a significant increase in cell 
circularity between glass and PLA+ substrate group. Similar results were found in Y201 with a 
significant increase in both PLA+ and PLA+ HAp coated substrate groups  
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5.3.1.1 Cell Viability (CV/MTT) 
The influence of matrix filled PLA HAp and PLA HAp CTAB composite substrates were 
investigated for long term cell viability using the methods outlined in section 5.2.4 (figure 
5-25).  
 
Figure 5-25: Crystal violet derived cell number of hMSC A) ‘Lonza’ and B) 3070 on various 
surfaces over 21 days. A & B hMSC cultured in basal medium and A1 & B1 in osteogenic 
medium. (n = 4) 
Similar cell densities were observed on Lonza hMSC cultivated on glass, PLA and PLA HAp 
substrates with no significant differences at any time point in both media groups. A significant 
reduction in cell number was seen in Lonza hMSC cultivated on PLA HAp CTAB groups 
compared with all other substrates at every time point in all media groups. This reduction in 
cell number was mirrored in the patient derived 3070 except at day 21 in the osteogenic 
medium group where there was no significant difference between glass and the PLA HAp CTAB 
group. A statistical reduction in glass substrate cell number was observed in the 3070 group 
at day 14 and 21 in the osteogenic medium group. 
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It was observed that patient derived 3070 hMSC monolayer in the glass osteogenic medium 
formed a dense cell cluster after day 7 and began to condense removing the monolayer from 
the glass coverslip.  
The cellular viability of hMSC cultivated on HAp coated PLA+ substrates was investigated for 
7 days to assess in-vitro material adhesion, biocompatibility and proliferation. 
 
Figure 5-26: MTT derived cell number of hMSC cultured over 7 days on glass, PLA+ and PLA+ 
HAp coated substrates. (n=5) 
Patient derived 3505 cells had a notable increase in cell number at day 3 in all substrate groups 
in comparison with all other donor cells from the same time point.  
Some notable reduction in cell number was observed on PLA substrates in comparison to glass 
in 3505, 3502 and 3503 at day 7. PLA+ HAp coated substrates had some increases in cell 
number relative to PLA+ at day 7 in patient derived 3502 and 3503 hMSC, but no variance in 
Y201 or 3505. 
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5.3.1.2 Alkaline Phosphatase 
ALP was measured to determine the influence of the material substrates on hMSC 
differentiation along the osteoblastic lineage. The sensitivity of the assay was assessed 
through the cultivation of hMSC on substrates in both basal and osteogenic media over 7 days. 
 
Figure 5-27: Average pNPP conversion rate from Y201 cultured on various surfaces from 1 – 
7 days. (n = 4) 
A significant decreased in ALP activity at day 7, in hMSC cultivated in osteogenic medium, on 
HAp coated PLA compared with PLA+. Two-way ANOVA analysis revealed a significant increase 
in ALP activity from day 1, 3 and 7 on all substrates, in both media groups. Two-way ANOVA 
of hMSC ALP activity in the osteogenic medium group indicated a significant difference 
between substrates.  One-way ANOVA revealed no significant differences in ALP activity of 
hMSC cultured in basal media between all surface substrates. No statistical differences 
observed between substrate ALP activities of hMSC cultured in osteogenic medium group day 
1 – 3.  
The influence of the substrates shown in section 5.3.1 were assessed for long term in-vitro 
ALP activity on patient derived hMSC.  
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Figure 5-28: Average pNPP conversion rate μM/well/minute. A) Lonza, B) 3070, C) 3174 and 
D) 3288 cultured on various surfaces from 7 – 21 days. A-D cultured in basal medium and A1-
D1 in osteogenic medium. A & B glass, PLA, PLA HAp and PLA HAp CTAB surface groups. C & 
D glass, PLA+ and PLA+ HAp coated surface groups. (n = 4). 
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A large reduction in pNPP conversion rate was found in all PLA HAp CTAB substrate groups 
with significant differences compared with all surface groups, at each measurement in both 
media groups (figure 5-28 A, A1, B & B1). No significant differences in pNPP conversion rate 
were found between glass, PLA and PLA HAp surfaces in both Lonza and 3070 at any time point 
and in both media groups. One-way ANOVA revealed a significant increase in the conversion 
rate of Lonza hMSC over 7 – 21 days in both basal and osteogenic media groups in glass control 
surfaces (A & A1). 
Some statistical reduction pNPP conversion rate was observed in 3174 & 3288 hMSC 
cultivated in basal medium, at day 7 in PLA+ and PLA+ HAp coated surface groups compared 
with glass control.  3288 hMSC cultured in basal medium on PLA+ HAp coated substrates had 
significantly lower pNPP conversion rate at each time point. A statistical increase in pNPP 
conversion rate was found in 3174 cultured in osteogenic on PLA+ HAp coated surfaces 
compared with glass, and PLA+ at day 7 and PLA+ at day 21. 
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5.3.1.3 Gene Expression 
Reverse transcriptase – polymer chain reaction (RT-PCR) was used to quantify osteogenic 
differentiation at a transcriptional level, messenger ribonucleic acid (mRNA) expression of 
lineage-specific markers were analysed to assess influences of different material substrates 
on hMSC differentiation. 
 
Figure 5-29: mRNA expression of T2 Runx 2 relative to GAPDH. Bars show average gene 
expression of Y201, 3505, 3503 and 3502 hMSC cells cultivated on glass, PLA and PLA HAp C 
surfaces in basal and osteogenic media groups for 7 days. (n=5) 
Analysis of T2 Runx 2 mRNA expression revealed levels at ~0.005 2-ΔCt in all patient derived 
hMSC cultivated in basal medium on glass controls (figure 5-29). These mRNA levels were 
upregulated by two orders of magnitude when cultivated in osteogenic medium (figure 5-29). 
Similar levels of T2 Runx 2 expression were observed in glass, osteogenic media groups in 
patient derived hMSC from ~0.010 – 0.014 2-ΔCt (figure 5-29). Runx2 expression was lower in 
hTERT Y201 cell line osteogenic, glass control surface, in relation to patient derived cells at 
~0.010 – 0.014 2-ΔCt (figure 5-29). 
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A significant increase was observed between basal media groups, HAp coated PLA surfaces 
compared with glass and PLA controls in patient derived sampled ‘3505’ and ‘3502’ (figure 
5-29).  
A significant reduction in T2 Runx 2 expression was found in PLA HAp coated surface groups 
in osteogenic medium of ‘3505’ and ‘3502’ compared with PLA and glass surfaces respectively 
(figure 5-29). Interestingly there was no statistical difference observed in the HAp coated PLA 
surfaces and glass control surfaces in the same groups (figure 5-29).  
Patient derived ‘3503’ cells revealed a significant reduction in T2 Runx 2 gene expression in 
HAp coated surfaces in comparison to glass and PLA surfaces in osteogenic medium (figure 
5-29). 
 
Figure 5-30: mRNA expression of osteopontin relative to GAPDH. Bars show average gene 
expression of Y201, 3505, 3503 and 3502 hMSC cells cultivated on glass, PLA and PLA HAp C 
surfaces in basal and osteogenic media groups for 7 days. (n=5) 
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A significant increase in OPN mRNA levels was found in ‘3505’ hMSC cultured in basal medium, 
on PLA HAp coated surfaces compared with glass and PLA surfaces (figure 5-30).  
Data from ‘3503’ revealed a significant reduction in mRNA OPN levels in cells cultivated on 
HAp coated PLA surfaces in both basal (figure 5-30).  
Both ‘3503’ and ‘3502’ showed a significant reduction in OPN levels between glass and HAp 
coated PLA surfaces in osteogenic medium compared with glass control (figure 5-30). Patient 
derived ‘3502’ also revealed a significant decrease in OPN mRNA levels in cells cultured in 
osteogenic medium, on PLA surfaces in contrast to glass control (figure 5-30).  
OPN mRNA levels were low with no significant variation between substrate groups in the basal 
group of ‘3502’ and the osteogenic groups of Y201 and ‘3505’ (figure 5-30). 
 
Figure 5-31: mRNA expression of COL1A1 relative to GAPDH. Bars show average gene 
expression of Y201, 3505, 3503 and 3502 hMSC cultivated on glass, PLA and PLA HAp C 
surfaces in basal and osteogenic media groups for 7 days. (n=5) 
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Basal medium glass control surface COL1A1 mRNA expression revealed some inter-patient 
variability ranging from ~ 0.5 – 2.0 2-ΔCt (figure 5-31). COL1A1 expression appeared elevated 
in osteogenic medium treatment groups on glass substrates and again varied from patient to 
patient (figure 5-31). A significant reduction in COL1A1 mRNA expression was found in both 
‘3505’ and ‘3503’ hMSC cultured in basal media between HAp coated PLA and PLA control 
substrate (figure 5-31). 
No significant differences were observed in COL1A1 expression in ‘3505’ hMSC cultured in 
osteogenic medium between all substrate groups. COL1A1 mRNA levels were significantly 
lower in ‘3503’ hMSC cultured in osteogenic medium, on HAp coated surfaces compared with 
both glass and PLA substrates (figure 5-31). This was similar in ‘3502’ hMSC with a significant 
reduction in both PLA and HAp coated PLA COL1A1 expression relative to glass in osteogenic 
medium (figure 5-31).  
A statistical increase in COL1A1 expression observed in Y201 cells cultured in osteogenic 
medium on HAp coated PLA compared with both glass and PLA substrates (figure 5-31). 
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5.4  Discussion 
This chapter demonstrates routes to disperse HAp produced from chapter 4 in various 
solvents and to produce polymeric nanocomposite materials with a monodisperse HAp filling. 
Results demonstrate that HAp dispersed in PLA with CTAB are cytotoxic to hMSC. Biological 
characterisation of HAp filled and coated PLA matrices are non-toxic, however they do not 
show any significant variation in hMSC adherence, morphology, growth kinetics and 
osteogenic stimulation compared with control surfaces at the intervals investigated. 
Dispersion of HAp 
5.4.1.1 DMF 
Data from DLS analysis allows us to determine that HAp is dispersed to the nanoscale in DMF 
solvent and TCM solvent following CTAB aided reverse micelle transfer (figure 5-2 and figure 
5-13). Physical evidence form TEM images show nanoscale HAp dispersal following composite 
fabrication (figure 5-6 and figure 5-14). 
DMF processing has previously been used to fabricate disperse HAp filled polymer composite 
materials (Deng et al. 2001; Deng et al. 2007; Patlolla et al. 2010). TEM data revealed some 
particle agglomeration in the PLA HAp composite bar which was not reported by Deng et al. 
(2001). This could potentially be due to water contamination within the composite solution 
prior to gelation. 
DMF dispersal has its limitations and it is reportedly difficult to completely remove all of the 
residual toxic solvent (Hong et al. 2004). FTIR data of the nanocomposite PLA/HAp bar (figure 
5-7) revealed some polymer – DMF interaction at ~1266 cm-1 (3) associated with C-N and/or 
C-H bonds and reduction in peak absorption at ~1675 cm-1 (4) (Jacob & Arof 2000; Olejnik et 
al. 1971). The DMF contamination could potentially influence this materials biocompatible 
properties, however Patlolla and colleges (2010) colleagues showed no detrimental effects on 
cells cultivated on their electrospun materials. Future work could include flexile strength 
testing of the composite bars, in-vitro assays and NMR analysis to assess the degree of DMF 
contamination. 
TEM observation demonstrated good dispersion of HAP within the PLA HAp composite with 
some regions of HAp agglomeration (figure 5-5). The agglomeration could potentially be 
caused by the relatively high loading of HAp within the composite, alternatively it could be 
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caused by lack of ultrasonic dispersion or contamination with adsorbed water. Different 
loading densities, ultrasonic dispersion duration and dehydration of the HAp could be tested 
to investigate these speculations. Furthermore, TEM EDAX could be used to confirm the 
presence of the HAp. 
5.4.1.2 CTAB 
Data form DLS analysis demonstrated optimal dispersion of HAp within deionised H2O medium 
with 10 mM to 186.37 ± 6.41 nm (figure 5-9). Stability of the HAp suspension illustrated in 
figure 5-10 shows characteristic sedimentation of HAp particles in a water medium, whereas 
the dispersion of HAp in the CTAB 10 mM water solution appears to remain consistent 
throughout the measurements. The transfer of the theorised HAp – CTAB complexes 
demonstrated an increase in average particle size following transit to the TCM phase (figure 
5-13). TEM through the spin cast CTAB dispersed PLA HAp composite demonstrated dispersion 
of nanoparticles with some areas of agglomeration and some unknown artefacts (figure 5-14). 
The dispersion and stability of HAp in the H2O medium with 10 mM CTAB concentration is 
likely due to the attainment of the CMC (Cai et al. 2007b). The measured increase in average 
particle size following phase transfer could potentially be caused by dissociation of some of 
the CTAB from the HAp to the non-polar phase. This CTAB dissolution would likely lead to 
rearrangement of the HAp – CTAB complex, favouring stability of a larger complex. 
The dispersion of the HAp observed in the TEM of the spin cast CTAB dispersed PLA HAp 
composite correlates with 2D SEM cell studies showing subsurface agglomerates (figure 5-14 
and figure 5-18). The artefacts observed in figure 5-14 could potentially be caused by 
crystallisation of dissociated CTAB through the casting process. Further work is required to 
characterise this material. For example, TEM EDAX could be used to confirm the presence of 
the HAp and XPS could be used to determine the presence of CTAB crystals within the PLA 
structure. 
As previously introduced, the process of transferring nanoparticles from an aqueous 
environment into an organic hydrophobic phase is not a new approach. However, the work 
presented in this chapter demonstrates a novelty in overcoming dispersion challenges 
associated specifically with suspension of HAp in organic hydrophobic solvents. 
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5.4.1.3 pH 
Results from DLS analysis of HAp in water with various pH demonstrated improved dispersal 
in pH 10 to an average size of 689.20 ± 44.46 nm (figure 5-15). The coating of the PLA+ by HAp 
shown by SEM demonstrates agglomeration of the particles on the surface of the material 
(figure 5-16). 
Balancing the electrostatic interaction of the solid and liquid phases improves dispersion of 
solids through alteration of the entropic threshold. Altering the pH of the dispersant medium 
appeared to be an effective way to balance electrostatic differences and disperse the HAp 
within the water. The HAp crystals were synthesised at pH 10, they would therefore order to 
minimise potential differences with the surrounding environment in comparison to crystals 
prepared at lower pH (section 4.3.4 . This would explain the improved dispersion potential at 
higher pH conditions (figure 5-15). 
The coating of the PLA+ by HAp shown by SEM demonstrates adsorption of the HAp to the 
PLA surface (figure 5-19C, C1, D and D1). This interaction is likely caused by hydrogen bonding 
of hydrogen bond acceptors (O=C) on the surface of the plasma treated PLA and hydrogen 
bond donators (O-H) groups from the hydroxyapatite forming hydrogen bonds.  
CTAB aided HAp dispersed PLA composite cytotoxicity 
The cytotoxicity of CTAB dispersed HAp PLA substrates is evident from the stressed 
morphology and sparse density of the hMSC in (figure 5-20 D & D1). Cell assays also 
demonstrated CTAB cytotoxicity with significantly reduced cell viability (figure 5-25) and ALP 
(figure 5-28 A & B) at day 7-21. 
CTAB has a number of uses including the control over production of gold and silver 
nanoparticles. Indeed some concern over nanoparticle cytotoxicity is in part due to CTAB 
release from these nanoparticles and has been widely reported (Alkilany et al. 2009; Qiu et al. 
2010) 
The mechanism of CTAB cell cytotoxicity is a disputed subject although two mechanisms have 
recently been postulated. The first is CTAB – cell membrane phospholipid substitution, at high 
concentration leads to cell death, but at low concentrations allows for rearrangement of the 
cell membrane. Secondly, dissociated CTAB (CTA+) has an affinity of ATP synthase interfering 
with ATP production, leading to cessation of cell metabolism. Cell viability analysis using CV 
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dye extraction assay shows some cell survival, however ALP activity is drastically reduced 
which corroborates with the second suggested mechanism of CTAB induced cytotoxicity. 
(Vieira & Carmona-Ribeiro 2006; Ito et al. 2009). 
The CV dye extraction assay only provides information on the approximate number of cells 
cultivated on the CTAB dispersed HAp PLA materials, an MTT assay could have been used to 
determine the effect on cellular metabolism. Replacement of the surfactant with one which is 
more biocompatible would be the focus of future research. Research by Maurin et al. (2002) 
has also demonstrated the inhibitory effects of polyunsaturated fatty acids. This would also 
need to be taken into account when selecting a potential surfactant candidate. 
PLA HAp biocompatibility and differentiation 
Evidence that the combination of PLA and HAp materials are non-toxic and have no influence 
on hMSC behaviour is demonstrated by the lack of significant variation between hMSC from 
morphological, cellular viability, ALP and gene expression analysis (figure 5-21, figure 5-22, 
figure 5-23, figure 5-24, figure 5-26, figure 5-27, figure 5-28, figure 5-29, figure 5-30 and figure 
5-31). 
Polymer HAp filled materials have previously demonstrated increased cell surface spreading 
with PLGA and carbonated HAp with “rice-like” (Hong et al. 2007). However, results from the 
morphological assessment of hMSC cultivated on PLA+ HAp coated and HAp filled PLA 
materials had no significant influence on cell surface area (figure 5-21 and figure 5-22).  This 
is potentially due to differences in surface topography which was not measured in work 
presented in this chapter. Stylist profilometry or laser interferometry could have been used to 
measure surface topography. 
Müller et al. (2014) investigated the effect of agglomerated hydroxyapatite nanoparticles with 
different morphology on mature human macrophages. Results demonstrated reduced HAp 
uptake in cells exposed to disperse HAp concluding that cell toxicity is correlated with the 
degree of HAp uptake into the cell.  Although HAp uptake was not evaluated in this chapter, 
the form of HAp exposure to the cells differs from Müller et al. (2014) in that the HAp was 
agglomerated on the polymer surface. The morphology of the HAp on the PLA+ surfaces, show 
approximate 1 µm agglomerates on the surface (figure 5-19) and viability of cells on these 
substrates appears to be unaffected over 7 days (figure 5-26). This could be due to differences 
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in cellular uptake of the HAp when bound to the surface of a material. Further investigation 
could look at the uptake of HAp into cells on these substrates using sectioning/TEM and a 
parallel study similar to that used by Müller et al. (2014). 
The ALP enzyme activity of hMSC cultured on the HAp coated PLA+ substrates had a highly 
variable response at day 7 between all hMSC groups (figure 5-28). ALP activity of patient 
derived hMSC in basal medium indicated at reduction compared with control at day 7. 
Evidence for the reduction in ALP activity is supported by work from Ha et al. (2015) using 
morphologically similar HAp. Results from Ha et al. (2015) showed a significant reduction in 
ALP mRNA expression in MSCs at 3 and 7 days culture with increasing concentrations of 
“needle-like” HAp (5-50 µg/mL). Published literature has also demonstrated the ability of 
“needle-like” HAp coatings to enhance ALP and osteogenic gene differentiation in human 
osteoblast cells. Roohani-Esfahani et al. (2010) demonstrated a significant increase in ALP 
activity, Runx2 and collagen type I gene expression in human osteoblasts on biphasic calcium 
phosphate (BCP) scaffolds coated with polycaprolactone and needle-like HAp coated scaffolds 
at day 7 compared with BCP coated PCL alone. 
The mRNA gene expression results from hMSC to HAp coated PLA substrates in this chapter 
are highly variable. Some trends were observed in OPN and collagen type I mRNA expression, 
with a significant reduction observed in patient derived hMSC 3503 and 3502 in osteogenic 
medium. Contradicting this data Ha et al. (2015) demonstrated a significant increase in OPN 
from MSCs in response to similar HAp following 7 days culture. 
Previous literature has established the enhanced proliferative and osteogenic effects of HAp 
nanoparticles on bone cells and hMSC over conventional ceramic substrates (Webster et al. 
2000). Results from this chapter do not reflect the reported observations of hMSC to HAp 
nanoparticles. 
There are a number of possible explanations for this observation. Primarily differences in HAp 
crystallite dimensions and surface area have been suggested to play a role in hMSC behaviour 
modification (Cai et al. 2007b). As discussed in the previous chapter, the HAp synthesised and 
used for this chapter has specific crystallite dimensions and crystallinity, which may influence 
its effect on hMSC behaviour. The quantity of HAp coated on the PLA substrate is unknown 
and may not be sufficient to elicit an effect on hMSC behaviour. The quantity of HAp on the 
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PLA substrate could have been determined using ICP-AES, however this equipment was 
unavailable at the time of this work. 
Functional heterogeneity in discrete hMSC populations are known to vary from donor to 
donor and knowledge regarding these populations is not fully understood (Phinney 2012). 
Expression of transcriptional mRNA for specific osteogenic markers is often transient 
throughout the differentiation process. Heterogeneity within the hMSC population would 
influence the osteogenic gene expression profiles and therefore the data collected at a single 
time point (figure 5-29, figure 5-30 and figure 5-31). 
The hMSC isolated in this thesis are derived from female donors with OA ranging from 56 – 80 
years of age. The reparative and destructive processes associated with OA have been linked 
to functional alteration in hMSC populations (Luyten 2004). This chapter has demonstrated 
various responses to HAp which might allude to differences in hMSC sensitivity to HAp, 
however a more targeted study would be required to investigate this hypothesis. 
5.5  Conclusion 
In this chapter I have presented novel processing techniques to produce monodisperse 
PLA/HAp materials. The influence of PLA and HAp coated/filled materials on hMSC cell 
behaviour has been assessed in 2D in-vitro experiments. The biological data presented in this 
chapter shows that PLA/HAp material incorporation and surface functionalisation had no 
significant effect on the behaviour of hMSC. The CTAB dispersed PLA/HAp substrates however, 
were found to induce cytotoxicity with prolonged in-vitro cell culture.  
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Chapter 6 – Influence of 2D fibrin/HAp substrates on hMSC 
Behaviour 
6.1  Introduction 
In this chapter, the fabrication and characterisation of two-dimensional fibrin hydrogels 
containing HAp synthesised from chapter 4 will be described. 2D fibrin surface coatings on 13 
mm glass coverslips were fabricated for in-vitro assays using hMSC to assess the influence of 
HAp in combination with fibrin. The aim of this chapter is to evaluate the adhesion, 
morphology, viability and osteogenic behaviour of hMSC to HAp in the presence of a 2D fibrin 
surface coating. 
There are some number difficulties with the in-vitro investigation of cells on 2D fibrin hydrogel 
substrates. Gel formation within a well plate leads to the formation of a meniscus, of which 
may influence the cell-substrate interaction. To overcome this issue, this chapter presents a 
method to produce flat scaffolds by sandwiching the fibrinogen thrombin solution within 13 
mm glass coverslips. Synthetic amino acid chains such as poly-L-lysine have been used to 
enhance substrate interactions with ECM proteins (Tsuchiya et al. 2001). Poly-L-lysine was 
therefore coated on one of the glass coverslips to encourage preferential adhesion of the 
fibrin hydrogel. 
The fibrinogen and thrombin concentrations were based on published research with fibrin 
scaffolds. A fibrinogen solution concentration of 20 mg/mL was selected based on work by 
Dikovsky et al. (2006). In this study Dikovsky et al. (2006) investigated the effect of a PEG 
modified fibrinogen peptide on smooth muscle cells in-vitro, results demonstrated good cell 
proliferation and migration using a spheroid outgrowth model. In addition Bensaıd̈ et al. 
(2003) investigated optimal fibrinogen and thrombin concentrations for hMSC spreading and 
proliferation. A concentration of 18 mg/mL fibrinogen concentration and 100 U/mL resulted 
in good proliferation, migration and osteogenic potential in-vitro and vivo. The thrombin 
concentration used in this thesis was 13.25 U/mL based on research by Linnes et al. (2007). 
The formulation of the two fibrinogen and thrombin solutions were also based on research by 
Linnes et al. (2007). 
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6.2  Experimental procedures 
2D fibrin hydrogel fabrication 
Fibrin surfaces were fabricated through the polymerisation of plasma derived Bovine 
fibrinogen (Merck Millipore - 341573) 20 mg/mL in 0.9% NaCl dH2O by the addition of an equal 
volume of plasma derived Bovine thrombin (T4648) 13.25 U/L in low glucose DMEM (similar 
to Thomson et al. 2013).  
Solution Concentration Solvent HAp 
Bovine thrombin (T4648) 13.25 U/L DMEM ± 10 mg/mL 
Bovine fibrinogen 
(Millipore, 341573) 
20 mg/mL 0.9% w/v NaCl 
in dH2O 
0 
 
Table 6-1: Fibrin precursor solutions and their constituents. 
The Bovine thrombin solution was first made to 13.25 U/L concentration in DMEM and filter 
sterilised. Thrombin solutions containing 10 mg/mL HAp were made by first weighing out the 
desired quantity of HAp into a centrifuge tube. HAp was sterilised by incubating with 70% 
ethanol for 30 minutes, samples were then centrifuged to pellet the HAp at 1000g for 5 
minutes. Supernatant was carefully aspirated and HAp was then washed three times with 
sterile PBS. Finally, HAp was suspended in the thrombin solution to a concentration of 10 
mg/mL. Thrombin ± HAp solutions were first sonicated for a minimum of 10 minutes prior to 
experimentation. 
13mm glass coverslips were immersed in 0.01% poly-L-lysine dH2O solution for 24 hours prior 
the fabrication of fibrin surfaces. Before use, the poly-L-Lysine coated surfaces were first dried 
in a class II safety cabinet and UV treated for 30 minutes.  
30 μL of fibrinogen and 30 μL thrombin solution (± HAp) were mixed using a pipette on the 
poly-L-lysine coated coverslip and a clean sterile 13mm glass coverslip was placed on top to 
distribute the fibrinogen/thrombin mix and incubated for 24 hours at 37oC in a 5% CO2 humid 
atmosphere. The clean cover slip was then removed using a needle point to wedge and lever 
the coverslip away from the fibrin/poly-L-lysine covered surface (figure 6-1). 
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Fibrin/HAp coated substrates were fabricated by dip coating fibrin substrates in a sterile 
solution of 0.05 M NaOH in dH2O with 10 mg/mL HAp. Samples were then washed three times 
in PBS and UV treated for 30 minutes. 
 
Figure 6-1: Schematic representation of 2D fibrin surface fabrication. 
Substrates were washed three times with PBS and incubated with hMSC medium for 1 hour 
prior to cell seeding. Cells were then seeded on these surfaces and analysed as described in 
chapter 2. 
  
 
Glass 
Fibrinogen/thrombin 
Poly-L-Lysine coated glass 
Fibrinogen/thrombin 
Fibrin surface 
 
24 hours 
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6.3  Results  
The results presented in this section show the development of 2D fibrin/HAp substrates and 
their evaluation in-vitro. 
Surface characterisation 
6.3.1.1 Scanning Electron Microscopy 
Samples were prepared according to processes outlined in methods section 3.3.4 . SEM was 
performed to provide information on fibrin and fibrin/HAp surface topography.  
   
   
Figure 6-2: SEM images of fibrin (A & C) and fibrin/HAp filled (B & D) surfaces with hMSC 
cultivated for 24 hours. A – D) 13x magnification. 
SEM images of fibrin substrates show a relatively flat morphology covering the 13mm glass 
coverslip. Figure 6-2B shows fibrin/HAp with central blister region that has lifted form the glass 
coverslip during processing for SEM analysis. The fibrin/HAp surfaces show differences from 
the centre to the edges of glass coverslip, with a bulging topography in the centre and a flatter 
region around the edges (figure 6-2D). The bulging region blister appears to correlate with the 
location of the fibrinogen and thrombin components mixing site prior to capillary spreading.  
2 mm 2 mm 
2 mm 2 mm 
A B 
C D 
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Biological characterisation 
The effects of fibrin/HAp substrates on hMSC adherence, morphology, growth kinetics, and 
gene expression in-vitro was investigated. 
6.3.2.1 Cell adhesion and morphology on fibrin and fibrin/HAp surfaces 
The effect of fibrin alone and fibrin/HAp substrates was assessed for their role in supporting 
cell adherence. 
   
    
   
Figure 6-3: SEM images of fibrin (A-C) and fibrin/HAp filled (A1-C1) surfaces with hMSC 
cultivated for 24 hours. A & A1) 100x, B & B1) 300x and C & C1) 6000x magnification. Red 
arrows = subsurface aberrations and green = pseudopodia. Red outline = cell perimeter. 
200 μm 200 μm 
100 μm 100 μm 
50 μm 50 μm 
A 
B 
C 
A1 
B1 
C1 
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figure 6-3 A-C shows a relatively smooth homogeneous fibrin hydrogel substrate with cells 
adhering and spreading. Images from A1-C1 demonstrate cells adhering and spreading across 
a fibrin/HAp surface with subsurface aberrations (red arrow). Figure 6-3C1 shows a cell 
adhering, with pseudopodia extending over the fibrin surface, subsurface aberrations can be 
observed through the cell membrane. The black arrow in image A1 shows the morphological 
separation between the bulging region and the non-bulging region of the fibrin/HAp substrate, 
which appears to wrap around aforementioned subsurface aberrations. 
 
  
Figure 6-4: Immunofluorescence images of hMSC cultured for 24 hours on A) fibrin B) 
fibrin/HAp. 400X magnification. Red = rhodamine phalloidin & Blue = DAPI. 
Immunofluorescence images of hMSC demonstrate the cytoskeletal structure of hMSC 
cultivated on fibrin and fibrin/HAp substrates (figure 6-4). 
Immunofluorescence was used to assess cell morphology of cells cultured on glass, fibrin and 
fibrin/HAp filled substrates. Observations of hMSC cultivated on glass, fibrin and fibrin/HAp 
are present in figure 6-5 and figure 6-6, quantification of cells in these experiments are 
displayed in figure 6-7 and figure 6-8.  
50 μm  50 μm  
 
50 μm  
 
50 μm  
 
A A1 
B B1 
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Figure 6-5: Immunofluorescence images of hMSC cultured for 24 hours on A) glass, B) fibrin 
and C) fibrin/HAp filled. A-C) Y201 A1-C1) 3388. 200X magnification. Red = rhodamine 
phalloidin & Blue = DAPI. 
A A1 
B B1 
C C1 
100 μm  100 μm  
100 μm  100 μm  
100 μm  100 μm  
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Figure 6-6: Immunofluorescence images of hMSC cultured for 24 hours on A) glass, B) fibrin 
and C) fibrin/HAp filled. A-C) 3286 A1-C1) 3287. 200X magnification. Red = rhodamine 
phalloidin & Blue = DAPI. 
The quantification methodology for hMSC morphology is described in the methods section 3.8  
. Results are presented analysing variation based upon donors (figure 6-7) and cell-material 
influence (figure 6-8).  
A A1 
B B1 
C C1 
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Figure 6-7: Donor-to-donor morphological analysis of hMSC cultured on glass, fibrin and 
fibrin/HAp filled surfaces for 24 hours. (A) Average cell surface area, (B) perimeter and 
circularity (C).  
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Figure 6-8: Cell-to-material morphological analysis of hMSC cultured on glass, fibrin and 
fibrin/HAp filled surfaces for 24 hours. (A) Average cell surface area, (B) perimeter and 
circularity (C).  
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Investigating cell populations from different donors showed that on glass substrates patient 
derived 3286 cells appeared to be spread the most over the largest area, patient derived 3287 
showing no significant variation. Patient derived 3388 and Y201 cells displayed the smallest 
area with no significant differences between them covering approximately half the area of 
3286 cells (figure 6-7). 
Both fibrin and fibrin/HAp substrates had a similar influence on cell area with 3286 and 3388 
cells having the largest area. 3287 cells had a significant reduction in cell area in comparison 
to 3286, however Y201 cells had the smallest cell area with statistical significance recorded 
between all patient cells on most substrates (figure 6-7). 
The cell perimeter analysis indicated patient derived 3286 cells had the largest perimeter on 
all substrate groups in comparison to other patient’s cells and the Y201 cell line. 3287 and 
3388 cells tended to have a similar cell perimeter on all substrates with a slight reduction in 
comparison with 3286. Y201 had the smallest cell perimeters in comparison to all patient cells 
on most surfaces (figure 6-7). 
Cell circularity of hMSC cultivated on glass substrates yielded no significant variation between 
all hMSC sources. Fibrin and fibrin/HAp substrates had a similar effect on cell morphology with 
no significant variation between all but one of the hMSC sources. Patient derived 3388 
demonstrated significantly higher circularity showing a rounder cell morphology (figure 6-7). 
Assessing the influence of substrates on cell morphology showed that the cell area of Y201 
has no statistical variation between all surfaces. In contrast to that all of the patient derived 
hMSC showed a significant increase in cell surface area when cultivated on fibrin substrates in 
comparison to glass control. A reduction in cell surface area between fibrin and fibrin/HAp 
substrates was found in all patient derived cell types with significance recorded in 2 out of 3 
(figure 6-8). 
No significance in cell perimeter was found in the Y201 cells between all substrate groups. A 
significant increase in cell perimeter was found in all patient cells cultured on fibrin substrates 
in comparison to glass control (figure 6-8). 
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Cell circularity showed mixed results with no significance recorded in 3286, an increase in 
3388, some decrease in 3287 and Y201 with fibrin/HAp substrates compared with glass (figure 
6-8) 
6.3.2.2 Cell viability (MTT) 
The influence of fibrin/HAp encapsulated and fibrin/HAp coated surfaces on hMSC adhesion, 
biocompatibility and proliferation was assessed using an in-vitro cellular viability assay over a 
7-day period. 
 
Figure 6-9: Cell viability of hMSC cultured on various substrates over 7 days. Substrate 
groups include glass, fibrin, fibrin/HAp coated and fibrin/HAp filled surfaces. (n=5) 
Similar cell densities of all hMSC populations were observed on all substrate groups at day 1 
indicating good cell adhesion to fibrin and HAp associated fibrin surfaces (figure 6-9). Growth 
kinetics of patient derived 3505 hMSC appeared to be greater in all substrate groups at day 3 
in comparison to other patient and Y201 hMSC groups. A significant increase in hMSC number 
was observed in glass and fibrin/HAp substrates in comparison to HAp coated fibrin surfaces 
at day 7.  
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6.3.2.3 Alkaline phosphatase 
ALP was measured to determine the influence of the fibrin/HAp material substrates on hMSC 
differentiation along the osteoblastic lineage. The in-vitro sensitivity of the assay was assessed 
through the cultivation of hMSC on substrates in both basal and osteogenic media over 7 days. 
 
Figure 6-10: Average pNPP conversion rate from Y201 cultured on various surfaces from 1 – 
7 days. A cultured in basal medium and A1 in osteogenic medium. Substrate groups include 
glass, PLA, fibrin, fibrin/HAp coated and fibrin/HAp filled surfaces. (n = 4) 
Increased ALP activity was found in hMSC cultured in osteogenic medium at day 7 on glass, 
fibrin and fibrin/HAp surfaces in comparison to basal medium groups. A significant decrease 
in ALP activity was observed in all fibrin contain surfaces groups in osteogenic medium at day 
7 compared with glass control. hMSC cultivated on fibrin surfaces showed increased ALP 
activity at day 7 compared with both filled and coated HAp fibrin surfaces in both media 
groups. ALP activity of hMSC grown for 7 days on fibrin/HAp filled substrates was increased 
relative to fibrin/HAp coated surfaces in both media groups.  
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The influence of fibrin/HAp filled and coated substrates on ALP activity were assessed over a 
21-day period in patient derived hMSC cultivated in both basal and osteogenic media.  
 
Figure 6-11: Average pNPP conversion rate. A) 3174 and B) 3288 cultured on various surfaces 
from 7 – 21 days. A & B cultured in basal medium and A1 & B1 in osteogenic medium. A & B 
glass, PLA, fibrin, fibrin/HAp coated and fibrin/HAp filled surface groups. (n = 4). 
The pNPP conversion rate was lowest in hMSC cultured in basal medium compared with 
osteogenic medium groups. Patient derived 3174 cells showed a significant reduction in ALP 
activity when cultivated in osteogenic medium on the fibrin/HAp coated compared with fibrin 
filled substrates at day 7 and 14. Significant reduction in pNPP conversion rate was found in 
both hMSC cultivated on fibrin/HAp filled substrates compared with fibrin/HAp coated surface 
groups at day 7 in all media groups.  
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6.3.2.4 Gene Expression 
RT-PCR was used to quantify osteogenic differentiation at a transcriptional level, through the 
analysis of messenger ribonucleic acid (mRNA) expression of lineage-specific markers to assess 
the influence of different material substrates on hMSC differentiation. 
 
Figure 6-12: mRNA expression of T2 Runx 2 relative to GAPDH. Bars show average gene 
expression of Y201, 3505, 3503 and 3502 hMSC cells cultivated on glass, fibrin and fibrin/HAp 
coated and fibrin/HAp filled surfaces in basal and osteogenic media groups for 7 days. (n=5). 
No significant differences in T2 Runx2 mRNA expression was observed in patient derived 3503 
cells in both media groups on all substrates (figure 6-12). A significant increase in T2 Runx 2 
expression was observed in 3505 cells cultivated on fibrin/HAp filled substrates in basal 
medium compared with both glass and fibrin surfaces. A statistical increase in T2 Runx 2 mRNA 
expression was found in Y201, 3505 and 3502 hMSC cultivated on fibrin filled substrates 
relative to glass in osteogenic medium (figure 6-12). 
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Figure 6-13: mRNA expression of OPN relative to GAPDH. Bars show average gene 
expression of Y201, 3505, 3503 and 3502 hMSC cells cultivated on glass, fibrin and fibrin/HAp 
coated and fibrin/HAp filled surfaces in basal and osteogenic media groups for 7 days. (n=5). 
No significant differences in OPN mRNA expression was observed in patient derived 3503 and 
3502 cells in both media groups on all substrates (figure 6-13). Y201 cells cultured on 
fibrin/HAp substrates had a significantly increased OPN mRNA expression relative to glass 
control (figure 6-13). 
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Figure 6-14: mRNA expression of T2 Runx 2 relative to GAPDH. Bars show average gene 
expression of Y201, 3505, 3503 and 3502 hMSC cells cultivated on glass, fibrin and fibrin/HAp 
coated and fibrin/HAp filled surfaces in basal and osteogenic media groups for 7 days. (n=5). 
Significantly reduced collagen type 1 mRNA expression was found in 3503 hMSC cultivated on 
fibrin substrates in comparison to glass in both basal and osteogenic medium (figure 6-14). 
Y201 and 3505 cells demonstrated a significantly increased collagen type 1 mRNA expression 
when cultivated on fibrin compared with glass control (figure 6-14). Y201 and 3505 showed a 
significantly increased mRNA expression in fibrin substrates relative to glass and fibrin/HAp 
filled groups, in osteogenic medium (figure 6-14).  
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6.4  Discussion  
This chapter describes the synthesis of 2D fibrin hydrogel materials with HAp produced from 
chapter 4 and subsequent in-vitro assessment. The processing approach resulted in relatively 
flat fibrin substrates and fibrin/HAp filled materials with some evidence of fibrin/HAp 
interaction. Morphological differences in patient derived hMSC were observed with an 
increase in surface area on fibrin based materials. Biological characterisation revealed good, 
but variable patient to patient hMSC growth kinetics on fibrin and HAp filled/coated materials. 
Results from hMSC cultivated on fibrin/HAp materials also demonstrated some differences in 
osteogenic gene expression. 
Fibrin/HAp substrates 
SEM characterisation of the fibrin/HAp surfaces revealed a uniform fibrin coating across the 
glass coverslip, however fibrin/HAp filled surfaces appeared to have subsurface irregularities. 
An area of bulge in the central region was observed in fibrin/HAp substrates, co-located with 
the initial droplet deposition (figure 6-2). 
The irregularities are likely due to agglomeration of HAp within the fibrin matrix. There are a 
number of suggestions for the observed central bulge. 1. The fibrin formed within the droplet 
is large enough not to be sheared from the droplet location through the addition of the clean 
coverslip. 2. The inherent large surface area of the HAp could lead to adsorption of thrombin 
and/or, fibrinogen molecules creating a fibrinogen conversion region localised to deposits of 
HAp agglomerates (Nakamura et al. 2007; Hu et al. 2002). This would influence the 
crosslinking density in proximity to the HAp particles and agglomerates, however there is no 
direct evidence of increased fibrin fibril density. 
The information drawn from the SEM observations is limited, further work to physically 
characterise these surfaces could include TEM observation to assess HAp particle dispersion 
within the fibrin/HAp matrix, AFM to measure substrate stiffness/profile and equilibrium 
water content to measure crosslinking density.  
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Fibrin/HAp hMSC adherence and morphology 
SEM and immunofluorescent images of hMSC cultivated on fibrin and fibrin/HAp substrates 
revealed physical cell adherence and spreading across the materials (figure 6-3, figure 6-5 and 
figure 6-6 respectively). The images show hMSC extending pseudopodia and associated actin 
fibre stress filaments on the glass, fibrin and HAp filled fibrin substrates. Quantitative 
morphological assessment of patient derived hMSC showed increased spreading on fibrin 
compared with glass controls. It was also evident that a patient derived hMSC on fibrin/HAp 
filled surface spread to a lesser extent than on fibrin alone. Remarkably no large differences 
were observed in Y201 cell morphology on all material substrate groups. 
Literature has previously demonstrated adherence and characteristic fibroblastic morphology 
of hMSC on 2D fibrin hydrogels with fibrinogen concentrations less than 18 mg/mL (Bensaıd̈ 
et al. 2003). Increase in hMSC surface area on fibrin substrates relative to glass is likely due to 
differences in anchorage points for cell adhesion which is known to directly influence cell 
morphology (Yeung et al. 2005). Differences in crosslink density might explain why hMSC 
cultivated on fibrin/HAp filled materials had a higher surface area relative to glass control yet 
lower than the fibrin alone. In addition to the observed morphological changes, an increase in 
cell area and alteration of shape has been linked to lineage commitment of hMSC as reported 
by McBeath et al. (2004). Lack of morphological differences in Y201’s to the various substrates 
could be a result of hTERT modification, leading to a loss in cell sensing characteristics. 
The morphological quantification of hMSC immunofluorescence using a simple actin filament 
stain has its limitations. Actin staining allows for basic shape quantification, however it is not 
a measurement of cytoskeletal tension, which is known to be a determining factor in stem cell 
fate. Immunohistochemical staining for vinculin could have been used to quantify focal 
adhesion plaques which provides information on the level of cytoskeletal tension (Mcnamara 
et al. 2012).  
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Fibrin/HAp hMSC growth kinetics 
The MTT assay allows us to determine that hMSC adhere to fibrin and fibrin/HAp substrates 
in densities similar to, or greater than glass control. 
Relative cell number of all cell populations were statistically lower on fibrin/HAp coated 
surfaces relative to glass and fibrin/HAp filled substrates at day 7. The MTT assay also indicates 
cell proliferation and viability over a 7-day period with high variability observed across the 
different cell sources on the different material substrates (figure 6-9). 
The data presented in this chapter is supported by literature showing hMSC proliferation on 
fibrin substrates (Catelas et al. 2006). The differences observed at day 7 between HAp filled 
and coated substrates could be due to a number of factors associated with the material and/or 
biological response. 1. The HAp organisation (dispersed vs agglomerated), quantity and 
presentation (covered in fibrin or exposed) in the two substrates is uncharacterised, but most 
likely different. 2. hMSC growth kinetics are known to alter with osteogenic lineage 
commitment and it could be an indication of early differentiation in the HAp coated materials 
(McBeath et al. 2004). 
Differences observed in cell numbers between cell sources suggest donor cell heterogeneity 
which is highlighted by the relative cell number of 3505 cells at day 3 relative to other cell 
sources (figure 6-9). Likewise, inconsistencies in data across donor sources supports this 
presumption. Heterogeneity of hMSC populations reflect a variety of differentiated cells 
including progenitor osteoblast primed precursor cells, however knowledge regarding these 
populations is not fully understood (Phinney 2012). Therefore, differences in cell number are 
varied as different donor cell populations proliferate at different rates. 
The limitations of using the MTT assay to quantitate relative cell number is well known, and is 
based upon the reduction capability of the cells mitochondria. The metabolism of hMSC at 
various stages of cell density, differentiation and donor age is known to vary and this could 
also explain variations in patient to patient ‘relative cell number’ (McBeath et al. 2004). Future 
work to assess the growth kinetics of hMSC cultivated on fibrin materials could include 
comparison of metabolic activity as discerned by MTT, to DNA quantity which could be 
measured using a fluorescence assay such as the PicoGreen assay (Singer et al. 1997). 
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Fibrin/HAp – hMSC osteogenesis 
No obvious data trends were observed in hMSC ALP activity on fibrin/HAp substrates, however 
substrates were not inhibitory and ALP activity was increased in osteogenic media groups. 
Small differences were observed in hMSC osteogenesis with an increase in T2 Runx 2 mRNA 
levels at day 7 on fibrin/HAp filled substrates relative to control. 
Results from the ALP assay with hMSC demonstrate high substrate variability, however cells 
demonstrated a response to osteogenic medium with higher ALP activity at day 7 compared 
with basal control. The ALP data gathered was not standardised to cell number thus limiting 
the inference from these experiments. 
An increase in hMSC T2 Runx2 mRNA expression at day 7 was found in (figure 6-12) was found 
in two patient derived and the Y201 cells cultured on fibrin/HAp filled substrates relative to 
glass control in osteogenic medium. Previous studies have found that fibrin materials support 
hMSC growth and do not inhibit osteogenesis, with some evidence suggesting enhanced 
osteogenesis with increased fibrinogen concentrations (Catelas et al. 2006). An increase in 
fibrinogen (and crosslinking density) would increase the stiffness of fibrin and, as previously 
outlined is a major regulator for cell behaviour and differentiation (Park et al. 2011). The 
inclusion of HAp into this material could potentially lead to an increase in substrate stiffness, 
by acting either as a simple filler or through direct fibrin chain bonding as previously discussed 
(Nakamura et al. 2007; Hu et al. 2002). 
6.5  Conclusion 
This chapter has demonstrated the fabrication of relatively flat fibrin substrates, with and 
without HAp coating on the surface or filled within the matrix. Results have shown that hMSC 
cultivated on the surface of these materials adhere, proliferate and maintain their capacity to 
differentiate towards the osteogenic lineage. Experimental evidence also reveals variation in 
hMSC morphology and osteogenesis when cultured on fibrin/HAp filled substrates. This is 
possibly linked to substrate stiffness and organisation with the inclusion of HAp and/or fibrin 
crosslinking density, however further studies are required to elucidate the underlying 
mechanism for this observation. 
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Chapter 7 – Influence of 3D fibrin/HAp filled PLA constructs on 
hMSC behaviour in-vitro 
7.1  Introduction 
This chapter aims to investigate the combination of HAp synthesised using the approach 
discussed in chapter 4 with fibrin hydrogel as a delivery vehicle for hMSC into 3D printed PLA 
constructs. The seeding of the 3D printed PLA scaffolds was investigated using two different 
static seeding techniques. The next aim was to develop a viable cell delivery methodology 
using fibrinogen/thrombin system outlined in the chapter 5 and to investigate the influence 
of these HAp nanoparticles on hMSC within a 3D environment. Finally, the outcome of 
prolonged in-vitro culture was examined on hMSC gene expression and matrix deposition via 
histology. 
The method of seeding of 3D scaffolds with cells can be split into two main approaches static 
and dynamic. Static seeding techniques include surface seeding and direct injection 
(Vitacolonna et al. 2015). Dynamic approaches involve the movement of cells in medium 
around and through the scaffolds to encourage better cell coverage than static seeding 
techniques (Thevenot et al. 2008). In this chapter two static seeding techniques were 
investigated for 3D printed PLA constructs. 
The work presented in this chapter is similar to a study by Shao et al. (2006) which investigated 
the delivery of MSC using commercially available fibrin glue into a 3D printed PCL TCP 
composite scaffold. Localised delivery of hMSC laden hydrogels has a number of advantages 
over direct implantation of porous scaffold materials. Firstly, the immunomodulatory function 
of hMSC may help regulate host immune response to the implant and secondly hMSC are 
capable of differentiating into bone forming osteoblasts. To encourage these actions, the 
fibrin hydrogel can temporarily localise the hMSC within the implant site, allowing them to 
interact with the host’s extracellular fluid. HAp fillings have been widely used to encourage 
osteogenesis in hMSC and is also reported to encourage angiogenesis, therefore HAp filled 
hydrogels have the potential to enhance bone regeneration (Rao et al. 2014). Cell laden fibrin 
hydrogel delivery methods also offer greater control over seeding processes and more 
uniform distribution, which in turn would be expected to produce a more uniform and 
complete osteogenesis (Schantz et al. 2005). 
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Hydrogels are not only limited to the delivery of cells. In a less related proof of concept in-vivo 
study, Lee et al. (2010) used TGFβ3 infused collagen type 1 hydrogel within a custom 3D 
printed PCL hydroxyapatite scaffold in a rabbit condyle model. The 3D printed scaffold had 
varied pore dimensions to specifically target various regions of the replaced tissue. Results 
demonstrated 130% more recruitment of cells in the TGFβ3 infused regenerated cartilage 
compared with control with no TGFβ3 using 5 mg/mL collagen type 1. This study demonstrates 
the versatility of using hydrogel delivery, which can be adapted to include growth factor 
release to enhance regional regeneration of tissues. 
Similar to work by Shao et al. (2006) a biodegradable polymeric scaffold was fabricated using 
the additive manufacturing approach fused filament fabrication (FFF). Unlike the work 
presented in Shao et al. (2006), PLA was used as the biodegradable material for the scaffold. 
The scaffold was designed for the regeneration of cancellous subchondral bone region with a 
defect size of 8mm in diameter and 2 mm in depth. The hydrogel was investigated in an 
unconstrained (free floating) form and within the PLA scaffold. HAp produced from chapter 4 
was also incorporated within the fibrin component to investigate its influence on hMSC in a 
3D environment. 
In the past decade nanotechnology has received a great deal of interest for a number of 
different applications. To date the number of nanoparticle-related publications have focus 
exclusively on the synthesis and physical characterisation of these nanomaterials. Previous 
literature has demonstrated the toxicity of some nanomaterials, which consequently has led 
to a focus on their mode of action in biology. An excellent review by Mahmoudi et al. (2011) 
describes in detail various processes for the internalisation of nanoparticles and their 
influence on the cell cycle. 
Cells are known to internalise their surrounding extracellular molecules via a process of 
endocytosis. Typically, endocytosis can be divided into two categories phagocytosis and 
pinocytosis. All eukaryotic cells except erythrocytes perform pinocytosis, which is often called 
fluid-phase endocytosis when it does not involve specific receptors. This involves the 
internalisation of fluids, soluble material, or nanoparticles in the order of 100 nm 
(micropinocytosis) (Mahmoudi et al. 2011). 
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Figure 7-1: TEM image examples of A) of clathrin-dependent endocytosis and B) clathrin-
independent endocytosis (Mahmoudi et al. 2011). 
Clathrin dependent pinocytosis as the name suggests, involves the formation of a clathrin 
protein complex at the surface of the cell membrane. This complex is subsequently 
internalised, encapsulating the extracellular molecules into a cage-like structures figure 7-1A. 
This process is well known for its selective uptake of specific molecules through interaction 
with membrane receptors (Mahmoudi et al. 2011). Clathrin independent endocytosis is a 
poorly uncharacterised process, in which non-specific invagination and internalisation of 
surrounding bulk extracellular fluid leading to uncoated pinocytic vessels (figure 
7-1B)(Mahmoudi et al. 2011). 
A HAp concentration of 10 mg/mL was selected to give a 5 mg/mL final concentration, this 
was based on previous research by Rao et al. (2014) showing it gives better hydrogel 
mechanical properties than 0 – 2.5 mg/ml HAp fillers. When this material was studied using 
endothelial cells the 5 mg/mL appeared to have better capillary network formation than the 
10 mg/mL hydrogel concentration. 
The fibrin alone, has insufficient mechanical properties for load bearing applications. For this 
reason, a solid free form fabrication using FFF was used to process PLA into a cage with large 
pores. This was done to improve implant mechanical properties, whilst allowing nutrient 
diffusion and cell migration. The PLA construct would also promote osteogenesis based on its 
mechanical properties (Engler et al. 2006). FFF was selected as it allows for control over 
specific geometries of the scaffold material using a computer aided design (CAD) program.  
  
A B 
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7.2  Materials and Methods 
The methods outlined in this section focus specifically on fused deposition modelling, 
histological staining and the live/dead assay. 
Fused filament fabrication (FFF) 
PLA constructs were fabricated with translucent PLA using a RapMan 3D Touch printer (Bits 
from Bytes, UK). The information for the parts to be printed using RapMan was contained in 
a G code file on an SD card. The G code was generated using Axon 2 (Axon 2.0 beta 2, Bits from 
Bytes, UK). Autodesk Inventor 2012 was used to CAD the PLA constructs used in 
experimentation. 
Histology 
Samples were prepared for histology by incubation in 10% formalin solution for 24 hours at 
4oC. Samples were then incubated with 70% ethanol for 24 hours before paraffin embedding. 
Dehydrated fibrin gels were transferred into fenestrated cassettes, smaller samples were 
wrapped in tissue prior to processing. Paraffin embedding was performed by Mrs Xin Xu – 
research technician at the Newcastle Biomedicine Biobank tissue processing services. 
Microtome sectioning of paraffin blocks and histological staining were processed by Sharon 
Watson - technician from Newcastle University, Institute of Cellular Medicine, 
Musculoskeletal Research Group. Specific protocols can be found in the materials and 
methods chapter 3.6.3 . 
TEM cell staining 
Samples were prepared for TEM staining by fixation in 2% glutaldehyde in cacodylate buffer 
<1h. Samples were rinsed cacodylate buffer twice for 10 minutes. Samples were rinsed in 
dH2O twice for 120 minutes and fixed in 1% osmium tetroxide (diluted in dH2O) for 30 minutes. 
Samples were then rinsed in dH2O twice for 10 minutes each. 
Samples were dehydrated in 20%, 50%, 75%, 100% and 100% acetone in dH2O for 15 minutes 
each. TAAB epoxy resin kit was used to impregnate epoxy into the samples using 25%, 50% 
75% resin in acetone for 30 minutes each. Samples were then incubated in 100% resin for 1 
hour three times each. Samples were left on a rotator overnight and polymerised at 60oC in 
an oven overnight before sectioning. 
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Sections were cut to 0.5 μm and stained with toluidine blue in 1% borax to visualise cells. 
Ultrathin sections ~70nm were cut using a diamond knife on a RMC MT-XL ultramicrotome or 
a Leica EM UC7 ultramicrotome. The sections were stretched using TCM to eliminate 
compression and mounted on Pioloform-filmed copper grids. 
Live dead staining 
A Live/Dead® Viability/Cytotoxicity kit (Molecular Probes, UK) was used to visualise cell 
viability. Calcein acetoxmethyl (Calcein, 0.05%) and Ethidium homodimer-1 (EthD-1, 0.2%) 
were diluted in PBS and incubated with samples for 20 minutes similar to (Catelas et al. 2006). 
Samples were viewed using the Leica DM4000B described in the materials and methods 
chapter, section 1.8. 
The percentage of live cells within L/D images was calculated using ImageJ in a similar fashion 
to methods section 3.8  (figure 3-5). Images were split into RGB and green and red images 
were analysed. The image was first inverted and a threshold was set to include the fluorescent 
cells of the focal plane. Cells out of the focal plane were excluded by using this threshold. The 
particles were analysed using the “analyse particles option”. Particles with and area of <140 
μm2 were excluded from analysis. Instances of cells in both green (live) and red (dead) were 
counted and a total cell number was used to determine the percentage live cells (equation 
7-1) 
𝑃𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒 𝑙𝑖𝑣𝑒 𝑐𝑒𝑙𝑙𝑠 % = (
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑙𝑖𝑣𝑒 𝑐𝑒𝑙𝑙𝑠
(𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑙𝑖𝑣𝑒 𝑐𝑒𝑙𝑙𝑠 + 𝑑𝑒𝑎𝑑 𝑐𝑒𝑙𝑙𝑠)
) 100 
Equation 7-1: Calculation of percentage live cells. 
Confocal and stereo microscopy 
3D images of cells were captured using a Leica SP2 UV CLSM confocal microscope with x20 NA 
0.5 dipping lens. Images were processed using LCS 2.61 software (Leica Microsystems 
Heidelberg GMBH Germany). 
The 3D printed PLA scaffolds were imaged using a Leica M165FC with a two-armed gooseneck 
integrated LED spotlights. Images were acquired and processed using DFC310 FX camera Leica 
with the Application Suite (LAS) software (Leica Microsystems Heidelberg GMBH Germany). 
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7.3  Experimental procedures 
The procedures outlined in this section were developed at Newcastle University using 
methods attained from a variety of different sources. 
PLA construct  
PLA cages were designed by Dr. Matt Benning at the Newcastle University, School of 
Mechanical and Systems Engineering, SAgE, Newcastle upon-Tyne, to produce interconnected 
channels of approximately 600 X 600 X 600μm. 
 
   
Figure 7-2: A) Design parameters of PLA constructs, B) Layer model and C) 4x multilayer 
model with 90o rotation per layer. Designed by Dr. Matt Benning.  
To improve the wettability, 3DP PLA constructs were first plasma treated using a compact 
plasma cleaner PDC-32G (EQ-PDC-32G) (MTI Corporation, US) with an 8CFM double step 
rotary vacuum pump (2TW-4C) (MTI Corporation, US). Samples were placed in a vacuum 
chamber and the vacuum was allowed to draw for a minimum of 10 minutes. The plasma 
treatment was performed for 3 minutes at medium intensity. Samples were UV sterilised, 
washed in PBS and incubated with hMSC medium for 1 hour prior to seeding.  
A 
B 
 
C 
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In an attempt to reproducibly seed a quantifiable number of cells onto the PLA construct a 
mixture of methodologies were investigated. The hanging drop methodology is commonly 
used in-vitro for the production of cell spheroids (Kurosawa 2007). In this experiment 100,000 
in 70 μL cells were added directly onto the PLA construct in a square petri dish cover. The 
cover was inverted over a PBS filled square petri dish, the liquid, including the PLA constructs 
hydrostatically adhered to the lid as a droplet and the samples were incubated at 37oC with 
5% CO2 for 7 days (figure 7-3). 
 
Figure 7-3: Illustration of hanging drop/static seeding methodology for PLA scaffolds. 
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Fibrin hydrogels  
ID Solution Concentration Solvent Cell number HAp mg/mL 
A 
Bovine thrombin 
(T4648) 
13.25 U/L DMEM 0 0 
Bovine fibrinogen 
(Millipore, 341573) 
20 mg/mL 
0.9% w/v 
NaCl in dH2O 
100,000 ± 10 
      
B 
Bovine thrombin 
(T4648) 
13.25 U/L HBSS 0 0 
Bovine fibrinogen 
(Millipore, 341573) 
20 mg/mL hMSC media 100,000 ± 10 
 
Table 7-1: Fibrin precursor solutions and their constituents. Formulation A) (Rao et al. 2014) 
and formulation B) experiment. 
Cell survivability was first investigated, in fibrin gel encapsulated hMSC fabricated using 
formulations outlined in table 7-1. The precursors were incubated at 37oC with 5% CO2 to set 
for either 30 or 60 minutes in covered eight chamber microscope slides, before quenching 
with hMSC medium. Samples were immediately stained and visualised using live/dead 
protocol outlined in section 7.2.4 .  
 
Figure 7-4: Fibrin gels fabricated in an eight chamber microscope slide. 
Fibrin/HAp gels with hMSC for long-term in-vitro experiments were fabricated using Millicell 
Hanging Cell Culture Insert (Merk Millipore, PIHT12R48) with removed membranes as moulds. 
These inserts were pressed into a parafilm covered petri dish to create a seal and UV sterilised 
for 30 minutes. Gelation of hMSC/fibrin/HAp matrices were achieved using the formulation B 
with or without incorporation of HAp (table 7-1).  
PLA constructs for fibrin/HAp cell delivery were first plasma treated as previously outlined in 
7.2.1 , placed on a parafilm covered petri dish and UV sterilised for 30 minutes. 
Chapter 7 
213 | P a g e  
 
Gelation of hMSC/fibrin/HAp matrices were achieved using the formulation B with or without 
incorporation of HAp (table 7-1). 35 μL of the fibrinogen solution was added to the parafilm 
and mixed with 35 μL of the thrombin solution containing 100,000 hMSC and ± 10 mg/mL HAp. 
The 70 μL droplets were then immediately transferred into the moulds (figure 7-5A) and PLA 
scaffolds (figure 7-5C). The samples were incubated at 37oC in a humid atmosphere at 5% CO2 
for 30 minutes to polymerise. 
      
 
Figure 7-5: A) Fibrin gels post-gelation, B) schematic of fibrin gel fabrication/release and C) 
PLA scaffold processing and fibrin gel delivery 1- plasma treatment, 2 – UV sterilisation, 3 – 
fibrinogen/thrombin/cells/HAp mixture delivery and 4 – gelation. 
Removal of fibrin/HAp gels from moulds was achieved using a sterile needle to dislodge the 
gel from the walls of the mould and samples were carefully push the samples out (figure 7-5 
A-B). All samples were transferred into 24 well plates and incubated with 1 mL of basal or 
osteogenic hMSC media/well for 21 days; media was changed every 3 days. 
  
A B 
C 
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RNA extraction from 3D scaffolds 
TRIzol® lysates were obtained from non-caged fibrin gels by transferring samples using forceps 
into a 1.5 mL Eppendorf and homogenised using a 1.5 mL micro-centrifuge tube tissue grinder 
micro-pestle. 
 
Figure 7-6: Image of fibrin gel harvesting for RNA isolation using TRIzol®. 
TRIzol® lysates were obtained from PLA caged fibrin scaffolds by transferring samples using 
forceps into a 1.5 mL Eppendorf and freezing over night at -80oC. Samples were then thawed 
at room temperature, once thawed the lysates were centrifuged at 13,000 rpm for 5 minutes 
and mixed before transferring the lysate into a fresh 1.5 mL Eppendorf. RNA was isolated and 
purified using methods outlined in chapter 2 section 3.6.5.1  
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7.4  Results  
PLA constructs 
  
  
   
Figure 7-7: Stereomicroscope greyscale images of 3D printed PLA FFF scaffolds using design 
parameters (figure 7-2). A1-3) Top view, B1-3 side view and C1-3 bottom view. Numbers 1-3 
demote the scaffold number. 
Figure 7-7 demonstrates the morphology of the as printed PLA constructs produced using 
figure 7-2 design parameters. Images A1-3 show the top view show some very fine polymer 
filaments across the surface. The sides of the scaffolds do not appear to be uniform; some 
edges appear sloped with some curvature in the base layer. The base layer of the PLA scaffolds 
has indents and appears to have the largest diameter of the scaffold. 
3D printed PLA scaffolds were originally investigated as a control for later cell culture 
experiments. Initial seeding experiments using a direct injection method demonstrated the 
need for plasma treatment to improve the wettability of the PLA scaffolds. The direct injection 
of cells suspended in hMSC medium into the PLA scaffold in tissue culture treated plastic 
resulted in preferential adherence to the well over the construct. Therefore, a combination of 
2 mm 
A2 
B2 
C2 
A3 
B3 
C3 
A1 
B1 
C1 
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direct injection and hanging drop method was employed to encourage cell interaction with 
the scaffold.  
The seeding of PLA scaffolds was investigated using confocal microscopy to see the 
distribution of cells seeded using the procedure outlined in figure 7-3. 
   
Figure 7-8: Confocal images of Y201 hMSC cultivated on PLA constructs for 7 days. A) hMSC 
coating PLA filament and B) a cluster of cells attached to a PLA filament. Red = rhodamine 
phalloidin, Blue = DAPI and Green line & shaded area = approximate location of PLA 
filament. 
Microscopic analysis revealed spheroid formation within the vertical pores of the PLA 
constructs, however when the scaffolds were relocated into a 24 well plate with hMSC 
medium, the majority of the spheroids and non-clustered cells were not adhered to the PLA 
construct. 
Confocal images of hMSC demonstrate hMSC adhesion along the PLA filament (figure 7-8 A), 
the majority of cells appeared to align with the direction of the PLA filament axis. Image B 
shows a cluster of hMSC within the vertical pore of the PLA scaffold adhering to the edge of a 
filament (green area and line), cells can be observed coating the PLA filament in a similar 
fashion to image A (figure 7-8). The images of areas demonstrating cell attachment were 
extremely sparse throughout PLA construct and was therefore abandoned for use as a control 
for later cell laden fibrin scaffold investigation. 
A B 
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Fibrin hydrogels 
This section outlines results obtained for investigation into hMSC viability, 3D fibrin/HAp 
hMSC interaction, PLA/fibrin/HAp scaffold influence on hMSC gene expression and histology. 
7.4.2.1 Fibrin encapsulated hMSC survival 
Live/dead staining outlined in section 7.2.4 was used to demonstrate cell survival following 
fibrin encapsulation with two fibrin formulations outlined in 7.3.1 with two gelation times. 
 
 
 
 
Figure 7-9: A) Live dead images of Y201 hMSC cells captured within a fibrin matrix. 
Fluorescence from cells polymerised with formulation A (left) and B (right) for 30 minutes 
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(top) and 60 minutes (bottom). Green = living; Red = dead. B) Graph showing the percentage 
of live cells relative to total live/dead cell count. Bars represent the mean ± SEM (n = 4). 
Images of live dead staining revealed a relatively higher number of dead cells when 
encapsulated using formulation A, however this cell death appeared reduced with a decreased 
gelation time. Formulation B yielded high cell survivability following 30 and 60-minute gelation 
times (figure 7-9A). 
One-way ANOVA demonstrated a significant increase in cell survival with formulation B 
compared with A at both incubation times (p-value = 9.94 x 10-7) (figure 7-9B). No significant 
differences were observed in the percentage of live cells between different incubation times 
with both formulations A and B (figure 7-9B). 
The influence of HAp on hMSC within a 3D fibrin environment at the nanoscale was 
investigated on TEM sections of hMSC cultivated within a fibrin/HAp matrix for 24 hours 
(figure 7-10).  
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Figure 7-10: Transmission electron microscope images of 3505 hMSC incubated for 24 hours 
within a fibrin matrix. A) 2,600X, B) 4,600X and C - F) 10,500X magnification. Arrows: Red = 
vacuoles, green = peroxisomes, blue = mitochondria and black =lysosomes. 
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7.4.2.2 TEM – fibrin/HAp encapsulated hMSC 
TEM cross-sections of hMSC embedded within a fibrin matrix showed spherical cell 
morphologies (figure 7-10 A & B). Nucleus morphology showed a definitive nuclear envelope 
with areas of condensed chromatin (figure 7-10 C). Within the cell cytoplasm a variety of 
organelles were observed including vacuoles (red arrows), peroxisomes (green arrows), 
lysosomes (black arrows) and mitochondria (blue arrows). 
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To examine the effect of including HAp, synthesised using the four distinct approaches 
described earlier (chapter 4) in the fibrin studies were performed to investigate 3D HAp – 
hMSC interaction. 
TEM cross-sections of hMSC incubated with HAp encapsulated within a fibrin matrix for 24 
hours showed HAp A–D nanoparticles in vacuoles (red arrows) within the cell cytoplasm. The 
presumed HAp can be clearly observed in figure 7-14F at various processes of internalisation, 
of which appears to be absent of characteristic clathrin dependent complexes at the plasma 
membrane. 
Cross-sections also revealed debris in the extracellular vicinity with varied nanoscale 
morphologies (blue arrows) (figure 7-11, figure 7-12, figure 7-13 and figure 7-14). 
HAp B and D appeared heterogeneous in contrast with associated lighter shaded unknown 
artefact particles (green arrows), where as in HAp A and C presumed particles appeared with 
a darker contrast with no evidence of lighter particles. TEM also revealed large agglomerates 
of HAp within the fibrin matrix as is most clearly visible in figure 7-12. 
Images from HAp C (figure 7-12) show HAp not only limited to spherical membrane bound 
vesicles, but within the tubulovesicular system of the cytoplasm characterised by the 
elongated cavities (orange arrows) (Mahmoudi et al. 2011). 
7.4.2.3 Gene expression 
RT-PCR was used to quantify osteogenic differentiation at a transcriptional level, assessing 
lineage-specific to assess the influences different 3D environments on hMSC differentiation. 
Changes in mRNA levels were quantified in hMSC cultured in fibrin/HAp filled and PLA 
fibrin/HAp matrices following 21 days growth in both basal and osteogenic media.  
Reverse transcriptase – polymer chain reaction (RT-PCR) was used to quantify osteogenic 
differentiation at a transcriptional level. Messenger ribonucleic acid (mRNA) expression of 
lineage-specific markers were analysed to assess the influences of fibrin/HAp ± PLA scaffolds 
on hMSC differentiation. 
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Figure 7-15: mRNA expression of T2 Runx 2 relative to GAPDH. Bars show average gene 
expression of Y201, 3505, 3503 and 3502 hMSC cells cultivated in fibrin, fibrin/HAp, PLA 
fibrin and PLA fibrin/HAp in basal and osteogenic media groups for 21 days. (n=5). 
No significant differences in T2 Runx 2 expression was found in Y201 cultivated in osteogenic 
medium between all material groups. The hMSC cultivated in PLA caged fibrin/HAp groups 
demonstrated a significant reduction in T2 Runx 2 expression relative to fibrin/HAp in 3505, 
3503 and 3502 in both media groups. A statistical increase T2 Runx 2 mRNA expression was 
found in hMSC cultivated in fibrin/HAp materials relative to fibrin controls; this trend was also 
observed in Y201, 3505 and 3503 basal medium groups.   
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Figure 7-16: mRNA expression of OPN relative to GAPDH. Bars show average gene 
expression of Y201, 3505, 3503 and 3502 hMSC cells cultivated in fibrin, fibrin/HAp, PLA 
fibrin and PLA fibrin/HAp in basal and osteogenic media groups for 21 days. (n=5). 
Data demonstrates significant reduction in OPN mRNA levels in all hMSC cultivated in PLA 
caged fibrin/fibrin/HAp constructs in all media groups relative to non-caged fibrin/HAp.  
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Figure 7-17: mRNA expression of collagen type 1 relative to GAPDH. Bars show average gene 
expression of Y201, 3505, 3503 and 3502 hMSC cells cultivated in fibrin, fibrin/HAp, PLA 
fibrin and PLA fibrin/HAp in basal and osteogenic media groups for 21 days. (n=5). 
Collagen type 1 mRNA levels of hMSC appear to be reduced in HAp containing groups, this 
trend appears to be similar across the majority of donor sources and media groups.   
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7.4.2.4 Histology 
Histological examination was performed on hMSC encapsulated in a fibrin matrix with and 
without HAp following cultivation in basal and osteogenic media for 21 days. Histology was 
aimed to identify changes in the cell – matrix structure and organisation.  
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Figure 7-18: Histological Mayer’s haematoxylin staining of Y201 hMSC cultured for 21 days. 
A-D = fibrin and A1-D = fibrin/HAp. A-B = basal medium and C-D = osteogenic medium. 
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Arrows: green = layers of cells, black = high matrix deposition, red = sectioning streaks and 
blue = stained crystal structures. 
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Figure 7-19: Histological Mayer’s haematoxylin staining of 3505 hMSC cultured for 21 days. 
A-D = fibrin and A1-D = fibrin/HAp. A-B = basal medium and C-D = osteogenic medium. 
Arrows: green = layers of cells, black = high matrix deposition, red = sectioning streaks and 
blue = stained crystal structures.  
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Figure 7-20: Histological Mayer’s haematoxylin staining of 3503 hMSC cultured for 21 days. 
A-D = fibrin and A1-D = fibrin/HAp. A-B = basal medium and C-D = osteogenic medium. 
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Arrows: green = layers of cells, black = high matrix deposition, red = sectioning streaks and 
blue = stained crystal structures. 
Histological sections of fibrin and fibrin/HAp gels following 21 days of culture in basal and 
osteogenic medium revealed some differences in matrix deposition (figure 7-18, figure 7-19 
and figure 7-20). The majority of sections displayed highest matrix deposition around the 
periphery of the gels (black arrows), with layers of cells on the outside of the material (green 
arrows).  
In fibrin/HAp groups purple stained crystals (blue arrows) were observed at periphery which 
appeared to correlate with enhanced matrix deposition and higher numbers of cell populated 
regions. Sectioning streaks could also be observed around the regions these crystals appeared 
(red arrows). 
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7.5   Discussion 
This chapter has shown some of the challenges associated with in-vitro cell seeding of 3DP 
PLA scaffolds. Results have also demonstrated a potential delivery vehicle for viable hMSC 
using a fibrin hydrogel formulation. Investigation into hMSC - HAp interaction within a fibrin 
matrix revealed nanoparticle agglomeration and uptake into hMSC cytoplasm after 24 hours. 
A significant increase in T2 Runx2 expression was observed in hMSC cultured in non-caged 
fibrin/HAp compared with fibrin alone. The hMSC cultured in fibrin and fibrin/HAp gels had 
statistically lower gene expression of T2 Runx2 and OPN at day 21 in caged gels compared with 
non-caged gels. Histological examination of hMSC embedded fibrin/HAp hydrogels following 
21 days showed distinct regions of increased matrix deposition of which contained mineral 
crystals in HAp containing gels. 
PLA & fibrin  
The morphology of the printed PLA constructs demonstrated morphological differences from 
the top, side and base layer images (figure 7-7). The fine polymer filaments observed in figure 
7-7 A1-3 are likely ligature marks from the hot end nozzle of the extrusion process. The 
differences observed with the side of the scaffolds is likely due to the rate cooling of the 
polymer, which will differ from the base layer on the heated print bed. 
The combination of hanging drop and static seeding of PLA scaffolds was performed to 
encourage cell adherence to the PLA scaffolds alone. The observations and confocal images 
from the PLA seeded constructs allows us to determine that even with a combination of 
methodologies seeding efficiency was limited and was therefore eliminated as a control for 
later experiments (figure 7-8). Other dynamic seeding methods could have be utilised such as 
seeding cells in suspension with the PLA scaffold on an orbital shaker similar to Thevenot et 
al. (2008). A centrifugation approach by Thevenot et al. (2008) would have been inappropriate 
for this scaffold as the structure of the scaffold would have resulted in cells passing through 
the scaffold entirely.  
The quantitative representation of the live/dead performed on hMSC within fibrin 
formulations and varied gelation time demonstrated a significant increase in cell survival with 
formulation B compared with A (figure 7-9). Sodium chloride salt used in formulation A is likely 
to produce a hypertonic medium for the cells, removing water from the cell cytoplasm via 
osmosis inducing cell death. The HBSS and the hMSC medium is designed to be isotonic and 
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would therefore maintain an osmotic balance. Further investigation could include incremental 
time-point analysis and the influence of HAp filling on L/D quantification. Alternatively, 
confocal microscopy or fluorometry of digested cells could have been used to more accurately 
quantify live/dead ratios of hMSC cultured in fibrin gels. 
Fibrin/HAp 
From the TEM cross-sectional images of hMSC cultivated within a fibrin/HAp matrix for 24 
hours we can observe that HAp is taken into hMSC via clathrin-independent pinocytosis. 
Images from all types of HAp demonstrate internalisation into the cytoplasm via membrane 
bound vesicles. These vesicles, whilst forming, display no signs of clathrin mediated receptor 
– ligand complexes which would have been stained along with the other cell structures with 
the osmium tetroxide and uranyl acetate during TEM cell staining. 
Subtle differences were observed in the location of HAp within the cytoplasm and varied 
between HAp A and HAp C (figure 7-11 and figure 7-13). With HAp A, B and D the nanoparticles 
appeared restricted to definitive vacuoles, whereas images from HAp C demonstrate HAp 
within the tubulovesicular system of the cell cytoplasm (figure 7-11, figure 7-12, figure 7-13 
and figure 7-14). This is likely due to the absorptive endocytosis process, in which pinocytic 
vesicles fuse with endosomes and begin a degradation process in which the pH is lowered via 
the action of ATPase proton pumps to pH ~4.5. This process matures the endosome for later 
fusion with lysosomes containing hydrolytic enzymes to degrade the endocytosed material 
(Mahmoudi et al. 2011; Motskin et al. 2011). 
Previous work investigating various agglomerates of HAp and their uptake into human 
monocyte macrophages have demonstrated degradation of HAp through the fusion of vacuole 
bound HAp and lysosomes (Motskin et al. 2011; Motskin et al. 2009). It is likely that most of 
the HAp absorbed into the cell will undergo this process, but it is not fully evident from the 
images of hMSC 24 hours post incubation. Further investigation into different time points 
could help to pin point the specific degradation pathway for these nanoparticles. Inhibition of 
specific endocytic pathways could also be investigated to determine the specific mode of HAp 
uptake into the cell (Kastl et al. 2013). 
Clathrin-independent pinocytosis remains a poorly characterised process, however there are 
a number of articles that display nonspecific nanoparticle uptake, which have been attributed 
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to their electrostatic status (Wilhelm et al. 2003; Barnett et al. 2007). It is postulated that 
electrostatic interaction with the phospholipid bilayer lead to the formation of invaginations, 
encapsulating the nanoparticles though direct membrane bending and disruption (Barnett et 
al. 2007). Cai et al. (2007) investigated the influence of HAp size and morphology on hMSC 
uptake, they reported limited penetration of larger particle sizes (~200-500 nm length and 
~30-80 nm width rod-like morphology) with rapid absorption with small rounded HAp ~20 nm. 
The aspect ratio of nanoparticles have been shown to influence cellular uptake (Qiu et al. 
2010). However a recent study into the influence of HAp on cells demonstrated no correlation 
between aspect ratio and cellular uptake (Müller et al. 2014). Cellular uptake of nanoparticles 
and release of ions are the likely modes of action for calcium phosphate nanoparticles. Since 
hydroxyapatite does not dissolute under physiological conditions, it is likely that the cellular 
uptake of HAp is the mechanism for the observed influences on cell biology (Ha et al. 2015). 
However, there appears to be an ambiguity surrounding nanoparticle characteristics that 
enable cellular uptake. Quantum dots with a higher aspect ratios were found to uptake slower 
into the cell than spherical nanoparticles (Soenen et al. 2011). The internalisation of gold 
nano-rods also appeared to diminish with greater aspect ratios (Soenen et al. 2011). HAp with 
aspect ratios of ~1-5 have been observed internalising into a number of different cell types in-
vitro (Motskin et al. 2011; Müller et al. 2014; Motskin et al. 2009). In summary it is likely that 
a myriad of nanoparticle properties including, morphology, surface area, aspect ratio, zeta 
potential, protein absorption and elemental composition are responsible for the observation 
of HAp uptake into hMSC (Motskin et al. 2011; Müller et al. 2014). 
The noted debris surrounding the cell (figure 7-11, figure 7-12 and figure 7-14) are of a similar 
size to the HAp nanoparticles and are electron dense, this debris could be a result of 
degradation as the cell begins to digest the surrounding matrix. 
The unknown artefacts which appear to be in proximity to HAp nanoparticles observed with 
HAp synthesised at pH 8 (HAp B and D) could be due to ionic dissolution of a less stable Ca/P 
ordered nanostructure as previously postulated in chapter 4. Highly crystalline hydroxyapatite 
materials are known to further apatite deposition in simulated body fluid (SBF) experiments 
and in-vivo. The nanocrystalline forms of HAp are likely more vulnerable to cellular 
degradation processes. Further investigation might include a dissolution study to measure the 
effect of lower pH environments of HAp A, B C and D ion release over time in SBF medium. 
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Data collected from RT-PCR analysis allows us to determine that there is a significant increase 
in T2 Runx 2 gene expression in hMSC cultivated in fibrin/HAp compared with fibrin alone 
following 21 days incubation in basal medium. Collagen type 1 mRNA levels demonstrated 
variability in all data sets, however a trend can be observed showing reduced expression in all 
cells cultivated with HAp, respective of their fibrin controls. 
Due to the temporal nature of the investigated genes and lack of previous time points, it is 
unclear whether levels of expression recorded at day 21 are from lack of stimulation, or the 
initiation/termination of the expression sequence. Differences observed in gene expression 
between cell sources adds to evidence from previous chapters of donor cell heterogeneity. 
Heterogeneity in adherence isolated hMSC is a reported phenomenon (Phinney 2012). 
The histological examination allows us to determine that there was matrix deposition, which 
appeared to be located around the periphery of the hydrogel following 21 days cultivation 
with a variety of hMSC cell sources. Crystalline minerals were also observed in areas co-
located with areas of high matrix deposition and cell activity in HAp containing fibrin 
hydrogels. 
Cell matrix deposition around the periphery is a common occurrence with 3D static cultivation 
conditions (Wu et al. 2014). This observation is possibly due to mass transport limitations with 
the static culture conditions. Further study may include the use of a perfusion bioreactor 
system to improve mass transport or modification of the fibrin gel to improve permeability.  
The influence of HAp filled hydrogels has been investigated on capillarity network formation 
using co-cultures of MSC and endothelial cells in a fibrin/collagen composite scaffolds. The 
results demonstrated inhibition of capillary network formation in-vitro with constrained 
hydrogels, however with unconstrained hydrogels an increase in total network length was 
measured with 2.5 mg/mL HAp filling (Rao et al. 2014). 
PLA caged fibrin/HAp  
A significant reduction in T2 Runx 2 expression was found in hMSC cultivated in PLA caged 
fibrin/HAp constructs following 21 days incubation relative to fibrin/HAp in all medium 
groups. Expression of OPN at day 21 revealed significantly reduced mRNA levels in hMSC 
cultivated in PLA caged fibrin/HAp constructs, biologically however the levels were low 
relative to previous reports OPN expression at ~ 0.25 2-ΔCt GAPDH (Köllmer et al. 2013). Again 
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due to the single time point of measurement it is indistinguishable whether these results are 
suggestive of any positive or negative biological influences. 
In most studies conducted in-vitro the 3D hydrogels are constrained preventing remodelling 
and compaction by contractile forces exerted by the cells. In this chapter hMSC embedded 
within the fibrin ± HAp were either unconstrained or constrained by a PLA scaffold. It has been 
suggested that unconstrained gel compaction leads to increased matrix density and associated 
increase in matrix stiffness (Rao et al. 2014). This information may explain the observed 
reduction in osteogenic associated gene expression in the PLA caged fibrin groups compared 
with non-caged fibrin groups (figure 7-15, figure 7-16 and figure 7-17). 
In a study by Endres & Hutmacher (2003) fibrin was used as a vehicle for hMSC delivery into 
3D printed polymeric scaffolds. No significant differences were observed in this study 
following 3 weeks in-vitro incubation with honeycomb PCL and PCL hydroxyapatite scaffolds.  
An article by Jung et al. (2014) investigated the osteogenic potential of rat MSC within a fibrin 
HAp (Ostim™) filled matrix caged within a 3-D mesh scaffold. Their results showed an increase 
in ALP activity from day 14-21 and cell cytotoxicity from day 1-14. More experiments are 
required to compare results from this chapter with this work, however the delayed osteogenic 
response could have implications for future work. 
7.6  Conclusion 
The results from this chapter demonstrate a variety of challenges with static in-vitro 
cultivation of 3D constructs. Fibrin hydrogels were successfully used as a delivery vehicle for 
viable patient derived hMSC. Fibrin/HAp matrices displayed hMSC nanoparticle uptake 
following 24 hours cultivation, with some morphological differences in HAp from different 
synthesis methods outlined in chapter 4. Osteogenic gene expression data requires further 
investigation, however it did demonstrate an increase in T2 Runx2 expression in hMSC 
cultivated in non-caged fibrin/HAp relative to control. PLA caged fibrin and fibrin HAp 
materials appeared to have a significant influence on T2 Runx2 and OPN expression compared 
with non-caged counterparts. Histology demonstrates regions of cell activity corresponding 
with increased matrix deposition from cells located at the periphery of the fibrin hydrogel. 
Mineral deposits were also observed within fibrin/HAp hydrogels following 21 days static 
cultivation, however their origin and composition requires further elucidation. 
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Chapter 8 – Discussion 
8.1  Summary of Results 
Chapter 4 describes the synthesis and characterisation of HAp synthesised using an automated 
component addition rate and pH regulation sol-gel synthesis methodology. Results 
demonstrated control of HAp particle a-axis (width) by the modification of the reaction pH 
during titration. The availability of calcium present during HAp formation, through alteration 
in either titration methods or rates, appeared to significantly influence HAp crystal c-axis 
(length). HAp lattice carbonate ion absorption was found to decrease in HAp synthesised at 
higher rates and with the simultaneous addition titration methodology. The cytotoxicity of the 
HAp to hMSC indicated ≥75% viability to various forms and concentrations of synthesised HAp. 
Results from chapters 5 and 6 provide evidence of the maintenance of hMSC capacity to 
adhere, grow and differentiate when cultivated on 2D PLA, fibrin and HAp filled/coated 
materials. Differentiation towards the osteoblast lineage was observed in hMSC cultured on 
fibrin/HAp filled substrates with differences in hMSC cell morphology and an increase in 
osteogenic gene induction. Donor hMSC morphology, proliferation and gene expression 
changes however varied notably from patient-to-patient, illustrating that despite broadly 
similar trilineage potential and flow marker profile, the significant heterogeneity of these cells.  
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8.2  Novelty 
As introduced in the literature survey, there are currently a number of systems to produce 
nanoscale apatite derivatives. The experimental methods used in chapter 4 provide a 
systematic evaluation of parameters known to influence sol-gel HAp crystal nucleation and 
growth providing greater insight into titration variation than previously published studies. 
Other research articles have used DMF as a dispersant solvent for HAp prior to polymeric 
incorporation and composite fabrication (Deng et al. 2001; Deng et al. 2007; Patlolla et al. 
2010). However, the novelty described here is in the processing. Dispersion of HAp followed 
by PLA incorporation, gelation, DMF removal and composite powder fabrication is a new 
approach to the fabrication of monodispersed nanocomposite materials. As demonstrated in 
chapter 4 the composite powder was used in a pressure moulding technique yielding a 
monodisperse solid nanocomposite PLA/HAp bar. 
The dispersion and phase transfer of nanoparticles using a surfactant aided process is not a 
novel process. Previous research using the phase transfer of gold and silver nanoparticles has 
been widely reported. However, the application of this technique to HAp is a novel approach 
for HAp polymer nanocomposite fabrication. 
The use of 3D printed PLA scaffold followed by fibrin/HAp hydrogel hMSC encapsulation and 
infiltration is a novel combination of materials.   
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8.3  Implications for tissue engineering 
2D vs 3D models 
Investigations into 2D material substrates were designed to include a number of principles 
associated with a 3D biodegradable scaffold surface. Firstly cytoskeletal tensions are known 
to influence hMSC lineage commitment on substrates of different elasticities (Engler et al. 
2006).  
Gupta et al. (2015) proposed a number of theories regarding the adaptive nature of the cell 
cytoskeleton depending on substrate stiffness. Images of hMSC cultured on the glass PLA and 
PLA HAp substrates in chapter 5 (figure 5-21 and figure 5-22) clearly demonstrate cells with a 
nematic cytoskeletal arrangement (figure 2-8A). Whereas images of hMSC cultivated on fibrin 
and fibrin HAp coated substrates in chapter 6 (figure 6-5 and figure 6-6) appear to show 
isotropic characteristics (figure 2-8A) of less stiff substrates. This appears to happen due to 
inherent differences in substrate stiffness, however further investigation is required to give a 
definitive answer. Figure 8-1 demonstrates hypothetical differences in substrate elasticity as 
a result of subsurface particle agglomeration. 
 
Figure 8-1: A) Illustration of dispersed vs agglomerated HAp filled matrices with hypothetical 
changes in elasticity across the surface illustrated below.  
As previously introduced the substrate stiffness can have a variety of influences on cell 
biology, such as proliferation, apoptosis, migration and stem cell differentiation (Engler et al. 
2006; Park et al. 2011; Yeung et al. 2005).Current studies investigating the influence of 
mechanical anisotropy have utilised pillars of deformable materials such as silicon nanowires 
(Park et al. 2016), however the influence of anisotropic substrate stiffness patterns 
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irrespective of surface topography has not yet been investigated. In the body, cells are 
exposed to a number of different micro and nano substrate patterns of elasticity. A good 
example of this would be in the bone, where collagen fibres are intercalated with HAp. This 
nanoscale range of mechanical anisotropy in bone is likely masked by the dense distribution 
of HAp within the collagen fibres. However, in an elegant study by McNamara et al. (2014) 
hMSC were found to directly sense 8 nm high pillars using nanoscale membrane projectors, 
demonstrating the extremely sensitive nature extracellular interaction. The threshold of the 
cells mechanosensing apparatus is no doubt limited within a range of biological substrate 
stiffness’s. Therefore, it is plausible that the size and mechanical properties of fillers within 
artificial polymeric matrices will influence cell behaviour, given that the materials can be 
subject to deformation by cell contractile processes. 
For the literature the elastic modulus of PLA substrates vary from 1.9 – 2.7 GPa depending on 
the content of L/D isomers (Middleton & Tipton 2000). The Natureworks PLA used in this thesis 
according to the data sheet has an elastic modulus of 3.45 GPa. Results from chapter 5 did not 
specifically address the differences in substrate elasticity due to difficulties with HAp 
dispersion within PLA. However, one cell viability assay demonstrated no significant difference 
between PLA and PLA (non-dispersed) HAp. Further investigations are required in order to 
determine any potential effects of this principle. However, it is likely that the inherent stiffness 
of PLA hides any elasticity changes caused by HAp inclusion to the hMSC. 
Fibrin substrate stiffness can vary from 16.1 – 80.9 kPa depending on fibrinogen and thrombin 
concentrations (Thomson et al. 2013). This is within the range for a number of other biological 
tissues, including liver, muscle and cartilage. Results from chapter 6 demonstrate hMSC 
responses to fibrin and fibrin/HAp filled substrates. As was evident from SEM and TEM images, 
the HAp within the fibrin was agglomerated. Results from morphological analysis of hMSC 
demonstrated some decrease in cell spreading on fibrin/HAp compared with fibrin substrates. 
It is probable that differences observed between fibrin and fibrin/HAp substrates are due in 
part to changes in substrate elasticity (Guthold et al. 2007).  
Further investigation could use techniques such as AFM and nanoindentation to directly 
measure differences in substrate elasticity as a result of HAp filling. 
Secondly, protein adhesion is a fundamental facilitator of cell adhesion. Figure 8-2 
demonstrates hypothetical differences in protein binding on HAp filled and coated substrates. 
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Figure 8-2: Illustration of protein absorption on material surface and HAp filled coated 
substrates. 
Chapter 5 investigated the differences between HAp coated and non-coated PLA substrates. 
Results showed 50% of the hMSC donors had higher levels of proliferation on PLA+ HAp coated 
vs. PLA+ control. However, results from fibrin experiments demonstrated the exact opposite 
with a reduction in proliferation on HAp functionalised substrates. These results could be due 
to a number of factors including degree of adhesion and likelihood of triggering 
differentiation, the population doublings each cell line had to have sufficient cells for the 
experiment. More targeted investigations are required to determine any potential influences 
of this theory. 
SEM analysis revealed topographical differences between control substrates and HAp 
filled/coated materials. Topography is known to influence osteoblast adhesion and 
differentiation making it a factor requiring further characterisation.  
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Figure 8-3: Illustration of the theoretical 3D influence of; A) dispersed HAp, B) agglomerated 
HAp, C) unconfined fibrin and D) PLA confined fibrin matrix on cells in 3D. 
Figure 8-3 demonstrates the 3D equivalence of figure 8-1. Chapter 7 demonstrated the 
influence of HAp within a 3D matrix, although the role of particle dispersion was not 
specifically investigated, it is likely to cause regional differences in substrate stiffness. In a 
similar fashion, cells encapsulated within a uniform fibrin matrix are likely to have 
homogenous cytoskeletal tensions depending on the cross-link density. Whereas fibrin 
confined within a PLA pore is likely to have distinct regions of increased cross-link density 
closer to the PLA filaments. The effect of heterogeneous cytoskeletal tensions could be a 
determining factor in the gene expression results observed in chapter 7. It is also possible that 
the marked differences in hMSC mRNA expression as a result of PLA confinement is caused by 
differences in mass transport throughout the fibrin matrix.  
A 
C 
D 
B HAp 
Cytoskeletal 
tension 
Cell 
Fibrin 
PLA 
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HAp 
The influence of HAp on cell behaviour is the primary motive for its use in bone tissue 
engineering. Remarkably, the effects of HAp on cell function is relatively unknown. Recently, 
Ha et al. (2015) demonstrated modulation of a specific gene expression regulatory programme 
through promotor methylation by HAp in osteoblasts. This is the first exciting report 
unravelling the mode of action for HAp on cell biology. With the recognised dissimilarities 
between 2D and 3D cell behaviour it would be interesting to see if this result is reciprocated 
in a 3D environment.  
Chapter 5 shows HAp uptake by hMSC encapsulated within a fibrin matrix following 24 hours 
incubation. HAp uptake into cells is not new to tissue engineering, however uptake into hMSC 
within a 3D matrix is. Stem cells are known to have enhanced protective mechanisms to avoid 
damage and maintain their ‘stemness’ (Bosco et al. 2015). The result demonstrates that hMSC 
actively sample their surrounding microenvironment and are likely subject to similar effects 
as terminally differentiated cell types in response to HAp. 
The influence of substrate stiffness has recently been linked to changes in the cells ability to 
endocytose (Missirlis 2014). In the study by Missirlis (2014) clathrin dependent endocytosis 
was measurably lower in fibroblasts cultured in substrates with an elasticity modulus of 5 kPa 
compared with 40 and 85 kPa. Although there was no evidence for clathrin-dependent 
endocytosis demonstrated in chapter 7, this information may have implications to the field of 
nanoparticle research for biological applications. 
Polymer cages for ‘soft’ materials within a ‘hard’ scaffold 
Previous literature has investigated the use of relatively hard polymer cages to house hydrogel 
encapsulated cells for bone tissue engineering (Shao et al. 2006; Lee et al. 2010). Data from 
chapter 6 demonstrates the ability of hMSC to modify their environment with enhanced 
matrix deposition and mineralisation observed in groups cultured in fibrin/HAp hydrogels. 
The contraction of fibrin/HAp hydrogel discs following culture with hMSC is likely due to cell 
induced contraction of the ECM. Within the PLA caged scaffolds the fibrin is likely to more 
robustly anchor to the PLA filaments locally increasing the network strength within the PLA 
structure. An increase in cytoskeletal tension is known to enhance hMSC osteogenesis 
(Mcnamara et al. 2012). 
Chapter 8 
247 | P a g e  
 
The mass transport limitations with current static tissue culture practices makes the growth 
of large tissues ex-vivo unlikely. Bone is a highly vascularised tissue and, without the 
simulation of interstitial fluid flow or in-vivo experimentation, it is difficult to determine the 
effectiveness of 3D materials on the regeneration of bone tissue. 
The observed crystalline structures in histology images (figure 7-18, figure 7-19 and figure 
7-20) could potentially be the original HAp filled within the fibrin matrix. However, their size 
and morphology are more representative of a large crystalline hydroxyapatite. TEM 
examination in figure 7-12 demonstrated agglomerates of HAp nanoparticles with an 
approximate size of 5 – 20 μm. Minerals observed in histological examination ranged from 20 
– 50+ μm in size with what appears to be large planar surface features. Alternatively, apatite 
formation of Ca2+ and PO32- ions from the culture media may have amalgamated the 
nanoparticles into a single planar structure. Further examination of these minerals by TEM 
and EDX are required to pinpoint their origin. 
The results from RT-PCR analysis and histological examination raise a number of interesting 
questions: 1. Are the observed differences in mRNA expression due to the late in-vitro time 
point or is it due to the mobility, communicative and proliferative capability of cells embedded 
within these matrices? 2. What are the reasons for the observed differences in mRNA 
expression with the hMSC within the PLA scaffolds? 3. Are the minerals observed in the 
histological images new or agglomerated forms of the HAp introduced within the material 
from the beginning? 
To address these questions, a number of further studies are required: 1. To elucidate the 
mobility, communicative potential of hMSC within the fibrin matrix. 2. To investigate the 
proliferation and differentiation of hMSC in respect to their seeding density and HAp quantity 
per mm3. 3. Further investigation into previous time points is required to clarify the 
differences observed in hMSC mRNA levels over the 21-day period. 4. To investigate the final 
mineral content either through quantification of total calcium using AES-ICP or with EDX. 
Isolated human OA MSCs 
The hMSC that were used in this thesis were isolated from OA patients that had undergone 
total hip replacement. All the samples that were used were from female patients (table 3-2) 
simply because there was higher percentage of female hips that were received. It was noticed 
that there was a higher prevalence for females to undergo THR from the data that our 
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department has acquired (figure 0-16). It has been reported that oestrogens related genes are 
associated with the risk of severe OA of the large joints of the lower limbs (Riancho et al. 
2010). 
In chapter 5, chapter 6 and chapter 7, it was shown that the patient derived hMSC did not 
behave in the same manner on or inside the matrices sometimes providing inconclusive 
results. This could be a consequence of the nature of cell isolation. First of all, using the specific 
isolation protocol not all the cell population have the same purity, so possible contamination 
from other cell populations could have an influence. In addition, at every isolation a different 
number of cells will adhere on the tissue culture plastic. This means that the cells from passage 
0 to passage 1 have undergone different number of cell population doublings and this can 
result in discrepancies in the number of cell doublings for the same theoretical passage 
number. It has been demonstrated that replicative senescence starts from the first passage 
and it is a continuous process influencing the phenotype and differentiation potential of the 
cells (Wagner et al. 2008).  
A way to limit these issues of senescence mentioned above would have been to count and 
calculate the number of cell doublings that the cells undergone from passage 0. Then, only 
cells with similar number of doublings could have been used. However, this plan was not 
feasible taking into consideration the number of samples that were collected, the researchers 
that need them, the length of time needed to expand the cells and do the experiments. 
The results gathered from experiments using patient derived hMSC presented in this thesis 
demonstrates the complexity of patient variability. Using a variety of hMSC from a number of 
patients certainly holds greater value that investigations using a clonally expanded cell lines, 
however may be prohibitive to the discovery of specific cell response mechanisms. In-vitro 
experimentation is far removed from conditions present with in-vivo studies but is a useful 
model for assessing the potential of biomaterials, 
8.4  Implications for the treatment of osteoarthritis 
A more consistent positive response over multiple donors and hence better cell selection 
would be required in order to develop cell-material combinations for clinical application. 
Types of treatment for OA that could be developed from the elements described in this work 
are the reconstruction of defects that include the subchondral bone region by using a 
multiphase bioresorbable scaffold. Specifically, this could contain a load bearing 
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nanocomposite material with graded mechanical properties/porosity coupled with the 
delivery of autologous cells within a gel to locally stabilise within the load bearing device. 
These therapies could be combined with an approach to regenerate the cartilage region, such 
as ACI. 
With FDA approval for the use of PLA, fibrin and HAp materials already in place; the hurdle 
from bench to bedside is only dependent on pre-clinical trials. Work performed by our group 
with collaborators from the Karolinska Institute Sweden using these 3D printed PLA constructs 
in-vivo has already demonstrated their biocompatibility and osteogenic potential in a mouse 
calvarial defect model (figure 8-4). 
 
Figure 8-4: “The representative morphology of the calvarial defects treated with PLA discs, 
12 weeks after surgery; overview image. (A) HB – host bone; defect margins indicated by 
arrow heads; Bar = 1 mm; (a) and (b) new bone formation indicated by arrows; Bar = 100 
µm. Haematoxylin & Eosin staining.” Dr Ion Tcacencu - 24-month review - Restoration FP7 
project in Karolinska Institute Sweden. 
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8.5  Conclusions 
Hydroxyapatite nanoparticle synthesis 
 The controlled low temperature synthesis of nanocrystalline forms of HAp was 
achieved using a well-regulated sol-gel synthesis methodology. 
 HAp can be tailored using reaction pH, titration speed and addition methodology.  
o The important parameters for governing the width and length of HAp using a 
sol-gel synthesis method were OH- and Ca2+ ion availability respectively. 
o Decreased titration rates yield increased HAp lattice carbonation. 
o Ca/P ratio can be altered through the control of HAp formation, namely by 
regulation of pH and titration rate. 
Nanocomposites 
 A novel processing route was demonstrated using DMF as a solvent to disperse HAp 
within PLA matrices, subsequent processing resulted in a near monodispersed 
nanocomposite material. 
 The novel CTAB aided fabrication of nanocomposite surfaces resulted in good 
nanoscale dispersion, however results in cytotoxic responses from hMSC following >7 
days in culture. 
Biological responses to PLA/fibrin/HAp scaffolds 
 hMSC uptake of HAp nanoparticles was observed following 24 hours incubation 
encapsulated within a fibrin/HAp filled matrix. 
 The delivery of cells using fibrin into a PLA 3D printed construct appears to be a useful 
way to provide implanted materials with a locally situated, stabilised, specific cell type 
for tissue regeneration. 
 Responses gained from donors was too variable to determine any potential influences 
of the effect of HAp on hMSC behaviour. 
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Appendix 
8.6  Chapter 3 
Differential Scanning Calorimetry 
Differential scanning calorimetry (DSC) is a technique used to determine the thermal 
transition states of a material. Glass transition temperature and melting point of polymer 
composite materials can provide information into the changes between chemical bond 
strength within a material. 
A Mettler Toledo DSC823 (Mettler-Toledo international inc., Greifensee, Switzerland) was 
used to analyse the thermal properties of PLA and PLA nanocomposites. Sample/reference 
aluminium crucibles and sample were weighed using a Mettler Toledo AJ100 analytical 
balance and loaded in to the sample chamber. The thermal cycle of the DSC comprised of two 
10oC/min ramp cycles from 25oC – 200oC with 5-minute equilibrium plateaus (figure 0-1). 
 
Figure 0-1: DSC melt and re-melt temperature program. 
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Flow Cytometry 
The flow cytometry methodology uses lasers to simultaneously measure distinct fluorescent 
and morphological parameters of particles in a hydrodynamically focused stream of liquid. 
Development of multicolour systems has enriched the quantity of data provided at the cellular 
level. Cell surface marker expression can be characterised using this technique when 
combined with immunocytochemistry to target specific protein antigens using fluorescently 
conjugated antibodies. This method requires stringent control parameters to reproducibly 
distinguish between positive and negative results. Below outlines the antibodies/isotypes 
used for the characterisation of hMSC (Dominici et al. 2006)  populations. Isotypes are 
required to ensure the absence of false positive detection. 
Fluorochr-
ome 
Absorption/E
mission 
wavelength 
nm 
Isotype Ag/control 
Protein 
conc. 
(μg/mL) 
Clone Supplier 
Catalogue 
number 
PE (+) 488-585 mIgG1 
CD73 12.5 AD2 BD 550257 
control 50 MOPC-21 BD 555749 
APC (+) 635-660 mIgG1 
CD105 100 266 BD 562408 
control 12.5 MOPC-21 BD 555751 
FITC (-) 488-530 
mIgG1 
CD34 12.5 581/CD34 BD 555821 
CD45 50 2D1 BD 345808 
CD19 25 4G7 BD 345776 
control 50 MOPC-21 BD 555748 
mIgG2b 
CD14 25 MφP9 BD 345784 
control 50 27-35 BD 555742 
PerCPCy5.5 
(+) 
488-670 mIgG1 
CD90 50 5E10 BD 561557 
control 12.5 MOPC-21 BD 552834 
APC-H7 (-) 635-750 mIgG2a 
HLA-DR 50 L243 BD 641411 
control 200 G155-178 BD 560897 
Table 0-1: List of antibodies used for flow cytometry characterisation of hMSC surface 
antigens. 
A FACSCanto II (Becton Dickinson Biosciences, Oxford, UK) instrument was used to analyse cell 
surface markers. Compensation for various fluorochromes was achieved using a mixture of 
positively and negatively charged Compbeads® (table 0-2). The compensation was determined 
by manually setting median fluorescence channel of labelled and unlabelled beads for each 
fluorochrome.  
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Tube Beads Antibody Volume 
1 – Unstained -ve - 4 μl 
2 – APC -ve/+ve APC-CD105 4 μl 
3 – PerCP Cy5.5 -ve/+ve PerCP Cy5.5 – CD90 4 μl 
4 – FITC -ve/+ve FITC – CD45 4 μl 
6 – APC-H7 -ve/+ve APC-H7-HLA-DR 4 μl 
Table 0-2: List of FACS tubes and components for compensation analysis. 
Cells were cultured to confluence in a 75cm2 flask. Upon confluence cells were raised from 
tissue culture plastic substrate using 0.05% trypsin-EDTA (Life-Technologies, UK) centrifuged 
at 200g and washed in 0.2 μm filtered FACS buffer containing 0.5% BSA w/v and 2mM EDTA 
in PBS. Cells separated into 3 FACS tubes and centrifuged at 200g. These pellets were 
suspended in 50μl FACS buffer incubated with various quantities (table 0-3) of 
antibodies/isotypes for 15 minutes in the dark at 4oC.  
Tube Antibody/Isotype/DAPI Volume 
1 – Unstained DAPI 50 μl 
2 – Isotype 
PE-mIgG1 
APC-mIgG1 
FITC-mIgG1 
FITC-mIgG2b 
PerCP Cy5.5-mIgG1 
APC-H7-mIgG2a 
DAPI 
1 μl 
16 μl 
4 μl 
2 μl 
8 μl 
1 μl 
50 μl 
3 – Test 
PE – CD73 
APC – CD105 
FITC – CD14 
FITC – CD19 
FITC – CD34 
FITC – CD45 
PerCP Cy5.5 – CD90 
APC-H7 – HLA-DR 
DAPI 
4 μl 
2 μl 
4 μl 
4 μl 
4 μl 
4 μl 
2 μl 
4 μl 
50 μl 
Table 0-3: List of FACS tubes and components for testing hMSC surface marker expression. 
Dead cells were excluded from analysis through using a double-strand nucleic acid intercalant 
DAPI (PARTC – Phywe Systeme GmbH, Göttingen, Germany). 5,000 to 10,000 events were 
acquired per test. The figures presented in this thesis show a representative experiment of 
three to four repeated experiments. 
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Calibration curves 
 
Figure 0-2: p-nitrophenol absorbance calibration curve at λ 405nm. 
 
Figure 0-3: MTT assay formazan absorbance calibration curve at λ 570nm. 
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Figure 0-4: Crystal violet absorbance calibration curve at λ 570nm. 
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Tri-lineage differentiation 
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Figure 0-5: Trilineage differentiation of human mesenchymal stem cells A) 3503 P4, B) 3502 
P4 and C) 3505 P4. A-C = 10x, A1-C1 = 20x magnification.  
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8.7  Chapter 4 
FWHM measurement from XRD spectra 
 
Figure 0-6: Representative measurement of the FWHM diffraction peak at position [002] on 
XRD HAp spectra. 
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Titration type Crystal size (002) SEM 
Ca  P 45.420 1.459 
P  Ca 54.390 7.851 
Ca + P 70.040 8.116 
 Crystal size (110) SEM 
Ca  P 16.340 1.176 
P  Ca 28.374 0.330 
Ca + P 25.942 0.483 
   
 Crystal size (002)  
0.1 mL/min 45.420 1.459 
1.0 mL/min 88.390 6.806 
10 mL/min 70.390 11.201 
 Crystal size (110)  
0.1 mL/min 16.340 1.176 
1.0 mL/min 26.687 1.610 
10 mL/min 26.253 0.770 
   
 Crystal size (002)  
pH 10 45.42 1.46 
pH 9 64.97 10.57 
pH 8 66.04 7.77 
 Crystal size (110)  
pH 10 16.34 1.18 
pH 9 24.41 1.86 
pH 8 34.05 5.33 
   
 Crystal size (002)  
pH 10, 0.1 mL/min 45.420 1.459 
pH 8, 0.1 mL/min 66.040 7.767 
pH 10, 1.0 mL/min 88.390 6.806 
pH 8, 1.0 mL/min 88.390 6.797 
 Crystal size (110)  
pH 10, 0.1 mL/min 16.340 1.176 
pH 8, 0.1 mL/min 34.047 5.330 
pH 10, 1.0 mL/min 26.687 1.610 
pH 8, 1.0 mL/min 28.068 0.640 
Figure 0-7: Numerical data from XRD HAp crystal measurements  
Appendix 
276 | P a g e  
 
8.8  Chapter 5 
DSC 
 
Figure 0-8: DSC graphs from DMF processed PLA and PLA/HAp 10% wt/v samples.  
Appendix 
277 | P a g e  
 
8.9  Chapter 7 
 
Figure 0-9: Average GAPDH Ct value of hMSC encapsulated in fibrin/HAp with and without 
PLA cage following 21 days in basal/osteogenic media. 
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Figure 0-10: Total RNA isolated form hMSC encapsulated in fibrin, fibrin/HAp, PLA fibrin and 
PLA fibrin/HAp cultivated in basal and osteogenic media for 21 days. 
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Figure 0-11: Histological Mayer’s haematoxylin staining of Y201 hMSC cultured in basal 
medium for 21 days. FIBRIN 
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Figure 0-12: Histological Masson’s trichrome staining of Y201 hMSC cultured in basal 
medium for 21 days. FIBRIN 
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Figure 0-13: Histological Mayer’s haematoxylin staining of Y201 hMSC cultured in 
osteogenic medium for 21 days. Fibrin/HAp 
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Figure 0-14: Histological Masson’s trichrome staining of Y201 hMSC cultured in osteogenic 
medium for 21 days. Fibrin/HAp 
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Figure 0-15: Histological staining controls of a rat knee. Left = Haematoxylin and right = 
Massons Trichrome.  25X, 50X and 100X magnifications.  
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8.10  Chapter 8 
 
Figure 0-16: Patient age histogram of donated hips for hMSC isolation from 23/07/2012 – 
27/03/2015. Female = 66.10 % and male = 33.90%. Range = 26 – 92 years. Average = 67.34 
years. n = 354 
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